Publications
2025
Scholarly publications
Falke, C., Karapinar-Carkit, F., Knol, W., Bouvy, M., Egberts, T., Kempen, T., Vervloet, M., & Heringa, M. (2026). Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100692. Advance online publication. [DOI] [Portal]
Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(12), 1873-1874. [DOI]
van Rijt-Weetink, Y. R. J., van Gendt, J., Egberts, T. C. G., van Hunsel, F. P. A. M., Lewis, D. J., Yates, L. M., Winterfeld, U., & van Puijenbroek, E. P. (2025). Quality of Clinical Information in Pregnancy Pharmacovigilance Data Sources-A Contribution of the ConcePTION Project. Pharmacoepidemiology and Drug Safety, 34(7), Article e70182. [DOI] [Portal]
Houwen, J. P. A., Lalmohamed, A., Zwaan, J., Egberts, T. C. G., Duyvendak, M., Fiolet, A. T. L., & Mosterd, A. (2025). The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists. European Journal of Clinical Pharmacology, 81(5), 719-725. [DOI] [Portal]
Verschueren, M. V., Tassopoulou, V. P., Visscher, R., Schuurkamp, J., Peters, B. J. M., Koopman, M., van de Garde, E. M. W., Egberts, A. C. G., & Bloem, L. T. (2025). Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review. ESMO Real World Data and Digital Oncology, 7, Article 100118. [DOI] [Portal]
Van Gelder, T. G., Vergoossen, D., Zonnenberg, I. A., Lalmohamed, A., Koole-Oostveen, M. I., van Reij, E. M. L., van Loon, A., & Egberts, T. C. G. (2025). Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit. European Journal of Hospital Pharmacy, 33(1), 73-79. [DOI] [Portal]
Professional publications
Ambrosio, L., Kamerling, C., de Jong, C. D. C., Herder, J. G. J. M., Egberts, T. A. C. G., & Deneer, V. V. H. M. (2025). Associatie tussen genetische varianten an oesofagitis bij NSCLC-patiënten behandeld met platinahoudend chemotherapie en radiotherapie: een prospectieve observationele studie. Pharmaceutisch Weekblad, 160(38), 19-24. https://www.knmp.nl/resolveuid/dac4022ca9e645a4ac285f4ed3f97d01 [Portal]
2024
Scholarly publications
Schmidt, M., Vernooij, R., van Nuland, M., Smeijsters, E., Devriese, L., Mohammad, N. H., Hermens, T., Stammers, J., Swart, C., Egberts, T., Haitjema, S., & Lammers, L. (2024). Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival. BMC Cancer, 24(1), Article 1553. [DOI] [Portal]
Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15, 1725-1730. [DOI] [Portal]
Smale, E. M., Ottenbros, A. B., van den Bemt, B. J. F., Heerdink, E. R., Verploegen, J., van Zelm, R., Egberts, T. C. G., & Bekker, C. L. (2024). Environmental Outcomes of Reducing Medication Waste by Redispensing Unused Oral Anticancer Drugs. JAMA network open, 7(10), Article e2438677. [DOI] [Portal]
Van De Burgt, B. W. M., Wasylewicz, A. T. M., Dullemond, B., Jessurun, N. T., Grouls, R. J. E., Bouwman, R. A., Korsten, E. H. M., & Egberts, T. C. G. (2024). Development of a text mining algorithm for identifying adverse drug reactions in electronic health records. JAMIA Open, 7(3), Article ooae070. [DOI] [Portal]
Smale, E. M., Verkerk, E. W., Heerdink, E. R., Egberts, T. C. G., van den Bemt, B. J. F., & Bekker, C. L. (2024). Barriers and facilitators to implement the redispensing of unused oral anticancer drugs in clinical care: A hybrid-effectiveness type I study. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100493. [DOI] [Portal]
Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O’Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15(6), 1713–1723. [DOI] [Portal]
Bognàr, T., Garcia-Rosa, M., Lalmohamed, A., Güngör, T., Hauri-Hohl, M. M., Prockop, S. E., Oram, L. M., Pai, S.-Y., Brooks, J., Savic, R. M., Dvorak, C. C., Long-Boyle, J. R., Krajinovic, M., Bittencourt, H., Teyssier, A.-C., Theoret, Y., Martinez, C., Egberts, T. C. G., Morales, E., ... Bartelink, I. H. (2024). Association of Busulfan Exposure and Outcomes after HCT for Patients with an Inborn Error of Immunity. Blood advances, 8(19), 5137-5145. [DOI] [Portal]
Bognàr, T., Bartelink, I. H. I., van der Elst, K. C. M., Kingma, J. S., Smeijsters, E. H., Lindemans, C. A. C., Egberts, A. C. G. T., Kuball, J. H. E., de Witte, M. A., De Vries Schultink, A. H. M., & Lalmohamed, A. (2024). Busulfan exposure target attainment in adults undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiple day therapeutic drug monitoring regimen. Transplantation and Cellular Therapy, 30(10), 1007.e1-1007.e10. [DOI] [Portal]
van Nuland, M., Lobbezoo, A.-F. H., van de Garde, E. M. W., Herbrink, M., van Heijl, I., Bognàr, T., Houwen, J. P. A., Dekens, M., Wannet, D., Egberts, T., & van der Linden, P. D. (2024). Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100464. [DOI] [Portal]
van Dommelen, J. E. M., Grootjans, H., Uijtendaal, E. V., Ruigrok, D., Luijk, B., van Luin, M., Bult, W., de Lange, D. W., Kusadasi, N., Droogh, J. M., Egberts, T. C. G., Verschuuren, E. A. M., & Sikma, M. A. (2024). Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration. Clinical Pharmacokinetics, 63(5), 683-693. [DOI] [Repository]
Rijt-Weetink, Y. R. J. V., Egberts, T. C. G., Hunsel, F. P. A. M. V., Lewis, D. J., Yates, L. M., Winterfeld, U., & Puijenbroek, E. P. V. (2024). Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project. Drug Safety, 47(3), 261-270. [DOI] [Repository]
Verschueren, M. V., Peters, B. J., Bloem, L. T., Kruik, V. R., Uitvlugt, E. B., Bijsmans, A. R., Egberts, A. C., & van de Garde, E. M. (2024). Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy. Clinical Lung Cancer, 25(2), 119-127.e1. [DOI] [Repository]
ROAD Study Group (2024). Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study. JAMA Oncology, 10(1), 87-94. [DOI] [Repository]
Professional publications
de Koning, G. H. P., Egberts, TCG., & Zijl, T. (2024). Het echte probleem is niet terugmelden. Pharmaceutisch Weekblad, 159(23), 20-21. https://www.pw.nl/achtergrond/2024/het-echte-probleem-is-2018niet-terugmelden2019 [Portal]
Houwen, J., Zwaan, J., Egberts, T., Duyvendak, M., Lalmohamed, A., Fiolet, A., & Mosterd, A. (2024). De invloed van colchicine op de bloedstolling bij patiënten met chronische coronaire aandoeningen die vitamine-K antagonisten gebruiken. Pharmaceutisch Weekblad, 159(38), 23-28. Article e1784. https://www.knmp.nl/resolveuid/20da6d7d876d4d83944f44ff0282626c [Portal]
Van Gelder, T. G., Lalmohamed, A., Dorst-Mooiman, K. D., Dekker, J. C., Schinkel, M. J., Sikma, M. A., Uijtendaal, E. V., Kemper, M. M., & Egberts, T. C. G. (2024). Significante daling in verspilling RTA-spuiten. Pharmaceutisch Weekblad, 159(9), 15-17. https://www.pw.nl/achtergrond/2024/significante-daling-in-verspilling-rta-spuiten
2023
Scholarly publications
van Moll, C., Egberts, T., Wagner, C., Zwaan, L., & Ten Berg, M. (2023). The Nature, Causes, and Clinical Impact of Errors in the Clinical Laboratory Testing Process Leading to Diagnostic Error: A Voluntary Incident Report Analysis. Journal of Patient Safety, 19(8), 573-579. [DOI] [Repository]
van Gelder, T. G., Lalmohamed, A., Dorst-Mooiman, K. D., Dekker, J. C., Schinkel, M. J., Sikma, M. A., Uijtendaal, E. V., & Egberts, T. C. G. (2023). Drug waste of ready-to-administer syringes in the intensive care unit: Aseptically prepared syringes versus prefilled sterilized syringes. European Journal of Pharmaceutical Sciences, 191, 1-7. Article 106590. [DOI] [Repository]
Meijboom, R. W., Gardarsdottir, H., Becker, M. L., Movig, K. L. L., Kuijvenhoven, J., Egberts, T. C. G., & Giezen, T. J. (2023). Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar. Therapeutic Advances in Gastroenterology, 16, 1-15. [DOI] [Repository]
Alsamil, A. M., Gardarsdottir, H., Leufkens, H. G., Egberts, T. C., & Giezen, T. J. (2023). Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019. Drug Discovery Today, 28(10), Article 103725. [DOI] [Repository]
Donners, A., van der Zwet, K., Egberts, A. C. G., Fijnvandraat, K., Mathôt, R., Kruis, I., Cnossen, M. H., Schutgens, R., Urbanus, R. T., & Fischer, K. (2023). DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ Open, 13(6), Article e072363. [DOI] [Repository]
Bognàr, T., Kingma, J. S., Smeijsters, E. H., van der Elst, K. C. M., de Kanter, C. T. M., Lindemans, C. A., Egberts, A. C. G., Bartelink, I. H., & Lalmohamed, A. (2023). Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen. Bone Marrow Transplantation, 58(7), 762-768. [DOI] [Repository]
Donners, A. A. M. T., van der Zwet, K., Rademaker, C. M. A., Egberts, T. C. G., Schutgens, R. E. G., & Fischer, K. (2023). The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. Research and practice in thrombosis and haemostasis, 7(2), Article 100074. [DOI] [Repository]
Verschueren, M. V., Dijs, T., Gulikers, J. L., Veelen, A. V., Croes, S., Hendriks, L. E., Smit, A. A., Bloem, L. T., Egberts, A. C., van de Garde, E. M., & Peters, B. J. (2023). Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results. Immunotherapy, 15(11), 839-851. [DOI] [Repository]
Meijboom, R. W., Barbier, L., Druedahl, L. C., Sarnola, K., Tolonen, H. M., Gardarsdottir, H., Egberts, A., & Giezen, T. J. (2023). Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance. Expert Opinion on Biological Therapy, 23(8), 801-817. [DOI] [Repository]
van de Burgt, B. W. M., Wasylewicz, A. T. M., Dullemond, B., Grouls, R. J. E., Egberts, T. C. G., Bouwman, A., & Korsten, E. M. M. (2023). Combining text mining with clinical decision support in clinical practice: a scoping review. Journal of the American Medical Informatics Association : JAMIA, 30(3), 588-603. [DOI] [Repository]
de Jong, C., Herder, G. J. M., van Haarlem, S. W. A., van der Meer, F. S., van Lindert, A. S. R., Ten Heuvel, A., Brouwer, J., Egberts, T. C. G., & Deneer, V. H. M. (2023). Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy. Genes, 14(1), 1-13. Article 170. [DOI] [Repository]
Melis, E. J., Zwart-van Rijkom, J. E., Egberts, T. C., van den Bemt, B. J., Witteveen, P. O., & Gardarsdottir, H. (2023). The association between patient satisfaction with information and adherence to oral anticancer agents. Journal of Oncology Pharmacy Practice, 29(3), 637–645. [DOI] [Repository]
Professional publications
Sallevelt, B. T. G. M., Huibers, CJA., Hij, J., Egberts, TCG., Van Puijenbroek, E. P., Wilting, I., & Knol, W. (2023). Frequentie en acceptatie van door beslisondersteuning gegenereerde STOPP/START-signalen bij ouderen met polofarmacie en multimorbiditeit opgenomen in het ziekenhuis. Nederlands Platform voor Farmaceutisch Onderzoek, 2023(8), Article a1767. https://www.knmp.nl/resolveuid/df339554bd184b6d92f7b8fe9504d2c0 [Repository]
Other output
Verschueren, M., Kruik, V., Peters, B., Bloem, L., Bijsmans, A. R., Egberts, T., & van de Garde, E. (2023). Real-world versus clinical trial outcomes of pembrolizumab plus chemotherapy in patients with stage IV non-squamous non-small cell lung cancer. Journal of Thoracic Oncology, 18(4), S72-S72.
2022
Scholarly publications
Noorda, N. M. F., Sallevelt, B. T. G. M., Langendijk, W. L., Egberts, T. C. G., van Puijenbroek, E. P., Wilting, I., & Knol, W. (2022). Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward. European Geriatric Medicine, 13(4), 837-847. [DOI] [Repository]
Sallevelt, B. T. G. M., Egberts, T. C. G., Huibers, C. J. A., Ietswaart, J., Drenth-van Maanen, A. C., Jennings, E., O’Mahony, C., Jungo, K. T., Feller, M., Rodondi, N., Sibille, F. X., Spinewine, A., van Puijenbroek, E. P., Wilting, I., & Knol, W. (2022). Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission. Drug Safety, 45(12), 1501-1516. [DOI] [Repository]
Huibers, C. J. A., Sallevelt, B. T. G. M., Heij, J. M. J. O., O'Mahony, D., Rodondi, N., Dalleur, O., van Marum, R. J., Egberts, A. C. G., Wilting, I., & Knol, W. (2022). Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting. European Geriatric Medicine, 13(3), 541-552. [DOI] [Repository]
de Jong, C., Chargi, N., Herder, G. J. M., van Haarlem, S. W. A., van der Meer, F., van Lindert, A. S. R., Ten Heuvel, A., Brouwer, J., de Jong, P. A., Devriese, L. A., Huitema, A. D. R., Egberts, T. C. G., de Bree, R., & Deneer, V. H. M. (2022). The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle, 13(3), 1554-1564. [DOI] [Repository]
van Gelder, T. G., Lalmohamed, A., van Diem-Zaal, I. J., Egberts, T. C. G., & Slooter, A. J. C. (2022). Systemic glucocorticoid use during ICU admission and symptoms of posttraumatic stress disorder in intensive care unit survivors. Intensive Care Medicine, 48(6), 762-764. [DOI] [Repository]
Alsamil, A. M., Giezen, T. J., Egberts, T. C., Doevendans, E., Leufkens, H. G., & Gardarsdottir, H. (2022). Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars. European Journal of Pharmaceutical Sciences, 175, 1-8. Article 106227. [DOI] [Repository]
Donners, A. A. M. T., Gerencsér, L., Elst, K. C. M. V. D., Egberts, T. C. G., Maat, M. P. M. D., Huisman, A., Urbanus, R. T., & Amrani, M. E. (2022). Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study. Research and Practice in Thrombosis and Haemostasis, 6(4), 1-9. Article e12725. [DOI] [Repository]
Wasylewicz, A. T. M., Burgt, B. W. M. V. D., Manten, T., Kerskes, M., Compagner, W. N., Korsten, E. H. M., Egberts, T. C. G., & Grouls, R. J. E. (2022). Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients. Clinical Pharmacology & Therapeutics, 112(2), 382-390. [DOI] [Repository]
Bognàr, T., Bartelink, I. H., Egberts, T. C. G., Rademaker, C. M. A., Versluys, A. B., Slatter, M. A., Kletzel, M., Nath, C. E., Cuvelier, G. D. E., Savic, R. M., Dvorak, C., Long-Boyle, J. R., Cowan, M. J., Bittencourt, H., Bredius, R. G. M., Güngör, T., Shaw, P. J., Ansari, M., Hassan, M., ... Lalmohamed, A. (2022). Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(4), 196-202. [DOI] [Repository]
Minjon, L., Aarts, J. W., van den Ban, E., Egberts, T. C., & Heerdink, E. R. (2022). Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: A review of six clinical practice guidelines. BMJ Open, 12(3), 1-9. Article e058940. [DOI] [Repository]
De Wit, L. E., Wilting, I., Souverein, P. C., van der Pol, P., & Egberts, T. C. G. (2022). Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase. European Neuropsychopharmacology, 58, 30-38. [DOI] [Repository]
Smale, E. M., Egberts, T. C. G., Heerdink, E. R., van den Bemt, B. J. F., & Bekker, C. L. (2022). Key factors underlying the willingness of patients with cancer to participate in medication redispensing. Research in Social and Administrative Pharmacy, 18(8), 3329-3337. [DOI] [Repository]
Wasylewicz, A., van de Burgt, B., Weterings, A., Jessurun, N., Korsten, E., Egberts, T., Bouwman, A., Kerskes, M., Grouls, R., & van der Linden, C. (2022). Identifying adverse drug reactions from free-text electronic hospital health record notes. British Journal of Clinical Pharmacology, 88(3), 1235-1245. [DOI] [Repository]
Hashemi, F., van Gelder, T. G., Bollen, C. W., Liem, Y. T. B., & Egberts, T. C. G. (2022). The effect of a decision support system on the incidence of prescription errors in a PICU. Journal of Clinical Pharmacy and Therapeutics, 47(3), 330-344. [DOI] [Repository]
Sallevelt, B. T. G. M., Huibers, C. J. A., Heij, J. M. J. O., Egberts, T. C. G., van Puijenbroek, E. P., Shen, Z., Spruit, M. R., Jungo, K. T., Rodondi, N., Dalleur, O., Spinewine, A., Jennings, E., O'Mahony, D., Wilting, I., & Knol, W. (2022). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & Aging, 39(1), 59-73. [DOI] [Repository]
Meijboom, R. W., Gardarsdottir, H., Egberts, T. C. G., & Giezen, T. J. (2022). Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review. BioDrugs, 36(1), 27-39. [DOI] [Repository]
Minjon, L., van den Ban, E., Bazelier, M. T., Lalmohamed, A., Egberts, T. C. G., & Heerdink, E. R. (2022). Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners. Journal of Child and Adolescent Psychopharmacology, 32(1), 36-44. [DOI] [Repository]
Professional publications
Jongsma, M. E., Bogaards, M. J., Grassi, J. B., van der Valk, R., Egberts, T. CG., & Ossebaard, H. C. (2022). Geneesmiddelverspilling in het ziekenhuis. Nederlands Tijdschrift voor Geneeskunde, 166, Article D7044. https://www-ntvg-nl.proxy.library.uu.nl/artikelen/geneesmiddelverspilling-het-ziekenhuis [Repository]
2021
Scholarly publications
Minjon, L., Egberts, TCG., Heerdink, R., & van den Ban, E. (2021). Bijwerkingen antipsychotica: monitoren van somatische parameters bij kinderen en adolescenten. Psyfar, 16(4), 57-63. https://www.psyfar.nl/tijdschrift/editie/artikel/t/bijwerkingen-antipsychotica-monitoren-van-somatische-parameters-bij-kinderen-en-adolescenten
Papazisis, G., Siafis, S., Cepatyte, D., Giannis, D., Stamoula, E., Tzachanis, D., & Egberts, T. (2021). Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database. European Review for Medical and Pharmacological Sciences, 25(19), 6003-6012. [DOI] [Repository]
Tillemans, M. P. H., Butterhoff-Terlingen, M. H., Stuffken, R., Vreeswijk, R., Egberts, T. C. G., & Kalisvaart, K. J. (2021). The effect of the anticholinergic burden on duration and severity of delirium in older hip-surgery patients with and without haloperidol prophylaxis: A post hoc analysis. Brain and Behavior, 11(12), 1-7. Article e2404. [DOI] [Repository]
Donners, A. A. M. T., Rademaker, C. M. A., Bevers, L. A. H., Huitema, A. D. R., Schutgens, R. E. G., Egberts, T. C. G., & Fischer, K. (2021). Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review. Clinical Pharmacokinetics, 60(11), 1395-1406. [DOI] [Repository]
Zazuli, Z., Jong, C. D. D., Xu, W., Vijverberg, S. J. H., Masereeuw, R., Patel, D., Mirshams, M., Khan, K., Cheng, D., Ordonez-Perez, B., Huang, S. H., Spreafico, A., Hansen, A. R., Goldstein, D. P., Almeida, J. R. D. D., Bratman, S. V., Hope, A., Knox, J. J., Wong, R. K. S., ... Liu, G. (2021). Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. Journal of Personalized Medicine, 11(11), 1-19. Article 1233. [DOI] [Repository]
Meijboom, R. W., Gardarsdottir, H., Becker, M. L., ten Wolde, S., Egberts, T. C. G., & Giezen, T. J. (2021). Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept. BioDrugs, 35(6), 765–772. [DOI] [Repository]
Meijboom, R. W., Gardarsdottir, H., Becker, M. L., de Groot, M. C. H., Movig, K. L. L., Kuijvenhoven, J., Egberts, T. C. G., Leufkens, H. G. M., & Giezen, T. J. (2021). Switching TNFα inhibitors: Patterns and determinants. Pharmacology Research and Perspectives, 9(4), 1-9. Article e00843. [DOI] [Repository]
Abdullah-Koolmees, H., Nawzad, S., Egberts, T. C. G., Vuyk, J., Gardarsdottir, H., & Heerdink, E. R. (2021). The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders. Therapeutic Advances in Psychopharmacology, 11, 1-12. [DOI] [Repository]
Smale, E. M., Egberts, T. C. G., Heerdink, E. R., van den Bemt, B. J. F., & Bekker, C. L. (2021). Waste-minimising measures to achieve sustainable supply and use of medication. Sustainable Chemistry and Pharmacy, 20, 1-7. Article 100400. [DOI] [Repository]
Minjon, L., Brozina, I., Egberts, T. C. G., Heerdink, E. R., & van den Ban, E. (2021). Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics. Frontiers in Psychiatry, 12, Article 640377. [DOI] [Repository]
Alsamil, A. M., Giezen, T. J., Egberts, T. C., Leufkens, H. G., & Gardarsdottir, H. (2021). Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study. Biologicals, 69, 30-37. [DOI] [Repository]
Alsamil, A. M., Giezen, T. J., Egberts, T. C., Leufkens, H. G., & Gardarsdottir, H. (2021). Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars. Pharmaceuticals (Basel, Switzerland), 14(3), 1-14. Article 189. [DOI] [Repository]
Wasylewicz, A. T. M., van Grinsven, R. J. B., Bikker, J. M. W., Korsten, H. H. M., Egberts, T. C. G., Kerskes, C. H. M., & Grouls, R. J. E. (2021). Clinical Decision Support System-Assisted Pharmacy Intervention Reduces Feeding Tube–Related Medication Errors in Hospitalized Patients: A Focus on Medication Suitable for Feeding-Tube Administration. Journal of Parenteral and Enteral Nutrition, 45(3), 625-632. [DOI] [Repository]
Cepaityte, D., Siafis, S., Egberts, T., Leucht, S., Kouvelas, D., & Papazisis, G. (2021). Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study. Schizophrenia Bulletin, 47(3), 672-681. [DOI] [Repository]
van Loon, W. E., Borgsteede, S. D., Baas, G. W., Kruijtbosch, M., Buurma, H., De Smet, P. A. G. M. P., Egberts, A. C. G., Bouvy, M., & Floor-Schreudering, A. (2021). Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands. British Journal of Clinical Pharmacology, 87(3), 1455-1465. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Hoekman, J., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2021). Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors. Clinical Pharmacology and Therapeutics, 110(1), 123-131. [DOI] [Repository]
Houwen, J. P. A., Egberts, A. C. G., de Boer, A., van Maarseveen, E. M., Houwen, R. H. J., & Lalmohamed, A. (2021). Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study. British Journal of Clinical Pharmacology, 87(5), 2333-2340. [DOI] [Repository]
Professional publications
Bouvy, M., & Egberts, T. (2021). Maak gebruik van bestaande zorginfrastructuur voor vaccineren: Huisartsen en apotheken hebben fijnmazig netwerk in de wijken. Pharmaceutisch Weekblad, 156(7), 18-19. https://www.pw.nl/achtergrond/2021/maak-gebruik-van-bestaande-zorginfrastructuur-voor-vaccineren [Repository]
2020
Scholarly publications
Sallevelt, B. TGM., Smeijsters, E. H., Egberts, T. CG., van der Elst, K. CM., & Mudrikova, T. (2020). Acute renal and neurotoxicity due to weight-based dosing of intravenous acyclovir: How to dose in obese patients? Clinical Infection in Practice, 7-8, Article 100046. [DOI]
Donners, A. A. M. T., van Maarseveen, E. M., Weetink, Y. R. J., El Amrani, M., Fischer, K., Rademaker, C. M. A., Egberts, T. C. G., Huisman, A., & Musson, R. E. A. (2020). Comparison between coagulation factor VIII quantified with one-stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle. International Journal of Laboratory Hematology, 42(6), 819-826. [DOI] [Repository]
Favié, L. M. A., de Haan, T. R., Bijleveld, Y. A., Rademaker, C. M. A., Egberts, T. C. G., Nuytemans, D. H. G. M., Mathôt, R. A. A., Groenendaal, F., & Huitema, A. D. R. (2020). Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five Metabolites. Clinical Pharmacology and Therapeutics, 108(5), 1098-1106. [DOI] [Repository]
Favié, L. M. A., Peeters-Scholte, C. M. P. C. D., Bakker, A., Tjabbes, H., Egberts, T. C. G., van Bel, F., Rademaker, C. M. A., Vis, P., & Groenendaal, F. (2020). Translation from animal to clinical studies, choosing the optimal moment. Pediatric Research, 88(6), 836-837. [DOI] [Repository]
Alsamil, A. M., Giezen, T. J., Egberts, T. C., Leufkens, H. G., Vulto, A. G., van der Plas, M. R., & Gardarsdottir, H. (2020). Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review. European Journal of Pharmaceutical Sciences, 154, Article 105501. [DOI] [Repository]
Krediet, E., Janssen, D. G., Heerdink, E. R., Egberts, T. C., & Vermetten, E. (2020). Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion. European Neuropsychopharmacology, 36, 244-254. [DOI] [Repository]
Janssen, D. G. A., Jonker, J., van Dijk, D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2020). Psychotropic medication use in former ICU patients with mental health problems: A prospective observational follow-up study. Journal of Critical Care, 59, 112-117. [DOI] [Repository]
de Jong, C., Deneer, V. H. M., Kelder, J. C., Ruven, H., Egberts, T. C. G., & Herder, G. J. M. (2020). Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thoracic Cancer, 11(7), 1790-1800. [DOI] [Repository]
Langenhorst, J. B., Boss, J., van Kesteren, C., Lalmohamed, A., Kuball, J., Egberts, A. C. G., Boelens, J. J., Huitema, A. D. R., & van Maarseveen, E. M. (2020). A semi-mechanistic model based on glutathione depletion to describe intra-individual reduction in busulfan clearance. British Journal of Clinical Pharmacology, 86(8), 1499-1509. [DOI] [Repository]
Vondeling, A. M., Knol, W., Egberts, T. C. G., & Slooter, A. J. C. (2020). Anticholinergic drug exposure at intensive care unit admission affects the occurrence of delirium. A prospective cohort study. European Journal of Internal Medicine, 78, 121-126. [DOI] [Repository]
Wasylewicz, A. T. M., Korsten, E. H. M., Egberts, T. C. G., & Grouls, R. J. E. (2020). Clinical rule-guided pharmacists' intervention in hospitalized patients with hypokalaemia: A time series analysis. Journal of Clinical Pharmacy and Therapeutics, 45(3), 520-529. [DOI] [Repository]
Man, W. H., Wilting, I., Souverein, P., Meyboom, R., Egberts, T., & Heerdink, E. R. (2020). Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase. Journal of Clinical Psychopharmacology, 40(3), 283-286. [DOI] [Repository]
Aguiar, J. P., Alves da Costa, F., Egberts, T., Leufkens, H., & Souverein, P. (2020). The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase. European Neuropsychopharmacology, 35, 30-38. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2020). Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community. European Journal of Neurology, 27(7), 1250-1256. [DOI] [Repository]
Favié, L. M. A., Peeters-Scholte, C. M. P. C. D., Bakker, A., Tjabbes, H., Egberts, T. C. G., van Bel, F., Rademaker, C. M. A., Vis, P., & Groenendaal, F. (2020). Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia. Pediatric Research, 87(4), 689-696. [DOI] [Repository]
Sallevelt, B. T. G. M., Huibers, C. J. A., Knol, W., Puijenbroek, E. V., Egberts, T., & Wilting, I. (2020). Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study. BMJ Open, 10(2), Article e033721. [DOI] [Repository]
PharmaCool study group* (2020). Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen. British Journal of Clinical Pharmacology, 86(1), 75-84. [DOI] [Repository]
Professional publications
Bekker, C. L., van den Bemt, B. J. F., Gardarsdottir, H., Egberts, A. C. G., & Bouvy, M. L. (2020). Geneesmiddelverspilling verminderen. Nederlands Tijdschrift voor Geneeskunde, 164. [Repository]
2019
Scholarly publications
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2019). Discontinuation Rates of Antidepressant Use by Dutch Soldiers. Pain Medicine, 184(11-12), 868-874. [DOI] [Repository]
Karapinar-Çarkıt, F., Borgsteede, S. D., Janssen, M. J. A., Mak, M., Yildirim, N., Siegert, C. E. H., Mol, P. G. M., Egberts, T. C. G., & van den Bemt, P. M. L. A. (2019). The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series study. BMC Health Services Research, 19(1), Article 717. [DOI] [Repository]
Bekker, C., Van Den Bemt, B. J., Egberts, A. C., Bouvy, M. L., & Gardarsdottir, H. (2019). Willingness of patients to use unused medications returned to the pharmacy by another patient. International Journal of Clinical Pharmacy, 41(1), 302-303. [DOI]
Meijboom, R. W., Gardarsdottir, H., Becker, M. L., Egberts, T. C. G., Leufkens, H. G. M., & Giezen, T. J. (2019). TNF-alpha inhibitor treatment patterns in patients with rheumatic diseases and those with inflammatory bowel disease. Pharmacoepidemiology and Drug Safety, 28(S2), 265-265. [DOI]
on behalf of the PharmaCool study group, Favié, L. M. A., Groenendaal, F., van den Broek, M. P. H., Rademaker, C. M. A., de Haan, T. R., van Straaten, H. L. M., Dijk, P. H., van Heijst, A., Simons, S. H. P., Dijkman, K. P., Rijken, M., Zonnenberg, I. A., Cools, F., Zecic, A., van der Lee, J. H., Nuytemans, D. H. G. M., van Bel, F., Egberts, T. C. G., & Huitema, A. D. R. (2019). Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Neonatology, 116(2), 154-162. [DOI] [Repository]
Vlieland, N. D., van den Bemt, B. J. F., Wouters, H., Egberts, A. C. G., Bouvy, M., & Gardarsdottir, H. (2019). Associations between personality traits and adequate home storage of drugs in older patients. Psychology, Health and Medicine, 24(10), 1255-1266. [DOI] [Repository]
van Gorp, F., Kuck, E. M., Sonnen, M. P. A. M., Hugenholtz, G. W. K., Egberts, T. C. G., & Wilting, I. (2019). Pharmacist-Psychiatrist Interventions Triggered by Clinical Decision Support System Improve Monitoring of Patients Using Lithium in a General Hospital. Journal of Clinical Psychopharmacology, 39(5), 532-533. [DOI] [Repository]
Stoker, L. J., Heerdink, E. R., Janssen, R., & Egberts, T. C. G. (2019). Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis. BMJ Open, 9, Article e029148. [DOI] [Repository]
Man, W. H., Wilting, I., Heerdink, E. R., Hugenholtz, G. W. K., Bognár, T., Ten Berg, M. J., van Solinge, W. W., Egberts, T. C. G., & van Maarseveen, E. M. (2019). Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein. Clinical Pharmacokinetics, 58(8), 1069-1075. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Souverein, P. C., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2019). Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study. Drug Safety, 42(7), 887-895. [DOI] [Repository]
Bekker, C., van den Bemt, B., Egberts, T. CG., Bouvy, M., & Gardarsdottir, H. (2019). Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey. BMJ Open, 9(5), Article e024767. [DOI] [Repository]
Bekker, C. L., Gardarsdottir, H., Egberts, A. C. G., Molenaar, H. A., Bouvy, M. L., van den Bemt, B. J. F., & Hövels, A. M. (2019). What does it cost to redispense unused medications in the pharmacy? A micro-costing study. BMC Health Services Research, 19(1), Article 243. [DOI] [Repository]
Wouters, H., Rhebergen, D., Vervloet, M., Egberts, A., Taxis, K., van Dijk, L., & Gardarsdottir, H. (2019). Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants. Drugs, 79(6), 647-654. [DOI] [Repository]
PharmaCool study group, Favié, L. M. A., Groenendaal, F., van den Broek, M. P. H., Rademaker, C. M. A., de Haan, T. R., van Straaten, H. L. M., Dijk, P. H., van Heijst, A., Dudink, J., Dijkman, K. P., Rijken, M., Zonnenberg, I. A., Cools, F., Zecic, A., van der Lee, J. H., Nuytemans, D. H. G. M., van Bel, F., Egberts, T. C. G., & Huitema, A. D. R. (2019). Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia. PLoS One, 14(2), Article e0211910. [DOI] [Repository]
Minjon, L., van den Ban, E., de Jong, E., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2019). Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. Journal of Child and Adolescent Psychopharmacology, 29(2), 124-132. [DOI] [Repository]
Bekker, C. L., Kalicharan, R. W., Melis, E. J., Gardarsdottir, H., van den Bemt, B. J. F., Bouvy, M. L., van Maarseveen, E. M., & Egberts, A. C. G. (2019). Redispensing of unused HIV post-exposure prophylaxis for medical students. Travel Medicine and Infectious Disease, 29, 82-83. [DOI] [Repository]
Minnema, L. A., Giezen, T. J., Gardarsdottir, H., Egberts, T. C. G., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2019). Post-marketing dosing changes in the label of biologicals. British Journal of Clinical Pharmacology, 85(4), 715-721. [DOI] [Repository]
Nederlof, M., Egberts, T. C. G., van Londen, L., de Rotte, M. C. F. J., Souverein, P. C., Herings, R. C. M., & Heerdink, E. R. (2019). Compliance with the guidelines for laboratory monitoring of patients treated with lithium: a retrospective follow-up study among ambulatory patients in the Netherlands. Bipolar Disorders, 21(5), 419-427. [DOI] [Repository]
Bekker, C. L., Melis, E. J., Egberts, A. C. G., Bouvy, M. L., Gardarsdottir, H., & van den Bemt, B. J. F. (2019). Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy. Research in Social and Administrative Pharmacy, 15(1), 100-105. [DOI] [Repository]
Vlieland, N. D., van den Bemt, B., van Riet-Nales, D. A., Bouvy, M. L., Egberts, T., & Gardarsdottir, H. (2019). Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes. Journal of Oncology Pharmacy Practice, 25(2), 382-389. [DOI] [Repository]
2018
Scholarly publications
Nederlof, M., Cath, D. C., Stoker, L. J., Egberts, A. C. G., & Heerdink, E. R. (2018). Begeleiding door artsen en apothekers tijdens antidepressivagebruik: behoeften van patienten en suggesties ter verbetering. Pharmaceutisch Weekblad, 153(46), 25-27. [Repository]
Man, W. H., Pérez-Pitarch, A., Wilting, I., Heerdink, E. R., van Solinge, W. W., Egberts, A. C. G., & Huitema, A. D. R. (2018). Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence. British Journal of Clinical Pharmacology, 84(6), 1228-1237. [DOI] [Repository]
Bartels, M., Govers, A., Polak, R., Vervoort, S., van Boxtel, R., Pals, C., Bierings, M., van Solinge, W., Egberts, T., Nieuwenhuis, E., Mokry, M., & Coffer, P. J. (2018). Megakaryocyte lineage development is controlled by modulation of protein acetylation. PLoS One, 13(4), Article e0196400. [DOI] [Repository]
van Stiphout, F., Zwart- van Rijkom, J. E. F., Versmissen, J., Koffijberg, H., Aarts, J. E. C. M., van der Sijs, I. H., van Gelder, T., de Man, R. A., Roes, C. B., Egberts, A. C. G., & ter Braak, E. W. M. T. (2018). Effects of training physicians in electronic prescribing in the outpatient setting on clinical, learning and behavioural outcomes: a cluster randomized trial. British Journal of Clinical Pharmacology, 84(6), 1187-1197. [DOI] [Repository]
Liem, T. B. Y., Slob, E., Termote, J. U. M., Wolfs, T. F. W., Egberts, A. C. G., & Rademaker, C. M. A. (2018). Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources. International Journal of Clinical Pharmacy, 40(2), 436-443. [DOI] [Repository]
van Keulen, K., Knol, W., Belitser, S. V., Zaal, I. J., van der Linden, P. D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2018). Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study. PLoS One, 13(11), Article 0205637. [DOI] [Repository]
Minnema, L., Giezen, T., Souverein, P., Egberts, T., Leufkens, B., & Gardarsdottir, H. (2018). Exploring the association between monoclonal antibodies and depression and suicidal ideation and behavior: A vigibase study. Drug Safety, 41(11), 1197-1198. [DOI]
Minnema, L. A., Giezen, T. J., Souverein, P. C., Egberts, T. C. G., Leufkens, H. G. M., & Gardarsdottir, H. (2018). Exploring the association between monoclonal antibodies and depression and suicidal ideation and behaviour: A VigiBase study. Pharmacoepidemiology and Drug Safety, 27, 50. [DOI]
Vlieland, N. D., Van Den Bemt, B. J. F., Bekker, C. L., Bouvy, M. L., Egberts, A. C. G., & Gardarsdottir, H. (2018). The compliance with drug storage recommendations of elderly patients. International Journal of Clinical Pharmacy, 40(1), 238-239. [DOI]
Bekker, C. L., Gardarsdottir, H., Egberts, A. C. G., Bouvy, M. L., & van den Bemt, B. J. F. (2018). Pharmacists' Activities to Reduce Medication Waste: An International Survey. Pharmacy, 6(3), Article 94. [DOI] [Repository]
van Keulen, K., Knol, W., Belitser, S. V., van der Linden, P. D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2018). Diabetes and Glucose Dysregulation and Transition to Delirium in ICU Patients. Critical Care Medicine, 46(9), 1444-1449. [DOI] [Repository]
Nederlof, M., Kupka, R. W., Braam, A. M., Egberts, A., & Heerdink, E. R. (2018). Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disorders, 20(8), 708-720. [DOI] [Repository]
Minjon, L., van den Ban, E., de Jong, E., Egberts, T. C. G., & Heerdink, E. R. (2018). Monitoring of metabolic, cardiac, and endocrine indicators in youth treated with antipsychotics as reported by health care professionals. Journal of Clinical Psychopharmacology, 38(5), 489-493. [DOI] [Repository]
Bekker, C. L., Gardarsdottir, H., Egberts, A., Bouvy, M., & van den Bemt, B. J. F. (2018). Pharmacists' activities to reduce medication waste: An international survey. 228. Abstract from 46th ESCP symposium on clinical pharmacy “Science meets practice: towards evidence-based clinical pharmacy services”, Heidelberg, Germany. [DOI]
Vlieland, N. D., Van Den Bemt, B. J. F., van Riet-Nales, D. A., Bouvy, M. L., Egberts, A. C. G., & Gardarsdottir, H. (2018). Actual versus recommended storage temperatures of oral anticancer drugs. 296. Abstract from ESCP symposium on clinical pharmacy, Heidelberg, Germany. [DOI]
Abdullah-Koolmees, H., Gardarsdottir, H., Egberts, T. C. G., Minnema, L. A., Elmi, K., Stoker, L. J., Vuyk, J., Goedhard, L. E., & Heerdink, E. R. (2018). Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study. Therapeutic Advances in Psychopharmacology, 8(8), 213-229. [DOI] [Repository]
Bekker, C., Gardarsdottir, H., Melis, E. J., Egberts, A. C., Bouvy, M. L., & Van Den Bemt, B. J. (2018). Quantity and economic value of unused oral cancer drugs among patients who discontinue their therapy. International Journal of Clinical Pharmacy, 40(3), 732. [DOI]
Nederlof, M., Heerdink, E. R., Egberts, A. C. G., Wilting, I., Stoker, L. J., Hoekstra, R., & Kupka, R. W. (2018). Monitoring of patients treated with lithium for bipolar disorder: an international survey. International Journal of Bipolar Disorders, 6(1). [DOI] [Repository]
Favié, L. M. A., Cox, A. R., van den Hoogen, A., Nijboer, C. H. A., Peeters-Scholte, C. M. P. C. D., van Bel, F., Egberts, T. C. G., Rademaker, C. M. A., & Groenendaal, F. (2018). Nitric Oxide Synthase Inhibition as a Neuroprotective Strategy Following Hypoxic-Ischemic: Evidence From Animal Studies. Frontiers in Neurology, 9, Article 258. [DOI] [Repository]
Dautzenberg, G., Nederlof, M., Beekman, A., Egberts, T., & Heerdink, E. R. (2018). Severe Cognitive Impairment Associated with a High Free but Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient with Bipolar Disorder. Journal of Clinical Psychopharmacology, 38(3), 265-268. [DOI] [Repository]
Bekker, C. L., van den Bemt, B. J. F., Egberts, A. C. G., Bouvy, M. L., & Gardarsdottir, H. (2018). Patient and medication factors associated with preventable medication waste and possibilities for redispensing. International Journal of Clinical Pharmacy, 40(3), 704-711. [DOI] [Repository]
Vlieland, N. D., Nejadnik, M. R., Gardarsdottir, H., Romeijn, S., Sediq, A. S., Bouvy, M. L., Egberts, A. C. G., van den Bemt, B. J. F., & Jiskoot, W. (2018). The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors. Pharmaceutical Research, 35(2), Article 42. [DOI] [Repository]
Vlieland, N. D., van Den Bemt, B. J. F., Bekker, C. L., Bouvy, M. L., Egberts, T. C. G., & Gardarsdottir, H. (2018). Older Patients’ Compliance with Drug Storage Recommendations. Drugs and Aging, 35(3), 233-241. [DOI] [Repository]
Zwart, T., Smits, M. G., Egberts, T. C. G., Rademaker, C. M. A., & van Geijlswijk, I. M. (2018). Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts. Healthcare (Basel, Switzerland), 6(1), Article 23. [DOI] [Repository]
Professional publications
Risselada, A. J., Heerdink, E. R., Gonera, R. K., Egberts, T. C. G., & Mulder, H. (2018). Associatie tussen HTR2C-polymorfismen en gewichtsverlies bij patiënten met obesitas. Pharmaceutisch Weekblad, 153(6), 22-26. [Repository]
Vlieland, N. D., Gardarsdottir, H., Egberts, A. C. G., Bouvy, M. L., & Van Den Bemt, B. J. F. (2018). Bewaren geneesmiddelen thuis gaat vaak niet goed: Mogelijke gevolgen voor kwaliteit en effectiviteit. Pharmaceutisch Weekblad, 153(47), 10-11. https://www.pw.nl/achtergrond/2018/bewaren-geneesmiddelen-thuis-gaat-vaak-niet-goed [Repository]
Bekker, C. L., Gardarsdottir, H., Egberts, T. C. G., Bouvy, M. L., & Van Den Bemt, B. J. F. (2018). Heruitgifte van ongebruikte geneesmiddelen: Een kwalitatief onderzoek onder stakeholders. Pharmaceutisch Weekblad, 153(1-2), 25-27. https://www.knmp.nl/resolveuid/6031edfda9cd4bb2a60500e60ddbfae0 [Repository]
2017
Scholarly publications
Minnema, L. A., Giezen, T. J., Gardarsdottir, H., Egberts, T. C. G., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2017). Post-marketing label changes in dosing information of biopharmaceuticals-different from small molecules? Pharmacoepidemiology and Drug Safety, 26, 606-607. [DOI]
Lalmohamed, A., Bartelink, I. H., van Reij, E. M. L., Egberts, A. C. G., & Boelens, J. J. (2017). Busulfanblootstelling geassocieerd met event-vrije overleving na allogene stamceltransplantatie bij kinderen: een retrospectieve multicentrumstudie. Pharmaceutisch Weekblad, 152(9), 17-21. [Repository]
Nederlof, M., Cath, D. C., Stoker, L. J., Egberts, T. C. G., & Heerdink, E. R. (2017). Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement. BMC Psychiatry, 17(1), Article 388. [DOI] [Repository]
Bekker, C. L., Gardarsdottir, H., Egberts, T., van de Bemt, B. J. F., & Bouvy, M. (2017). Unused medicines returned to community pharmacy: An analysis of medication waste and possibilities for redispensing. International Journal of Clinical Pharmacy, 39(1), 240. [DOI] [Repository]
Man, W. H., Colen-de Koning, J. C. A., Schulte, P. F. J., Cahn, W., van Haelst, I. M. M., Doodeman, H. J., Egberts, T. C. G., Heerdink, E. R., & Wilting, I. (2017). The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Psychopharmacology, 37(2), 155-161. [DOI] [Repository]
Karapinar-Çarkıt, F., van der Knaap, R., Bouhannouch, F., Borgsteede, S. D., Janssen, M. J. A., Siegert, C. E. H., Egberts, T. C. G., van den Bemt, P. M. L. A., van Wier, M. F., & Bosmans, J. E. (2017). Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital. PLoS One, 12(4), Article e0174513. [DOI] [Repository]
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2017). Prevalence of Psychotropic Medication Use Among Dutch Military Personnel Between 2003 and 2012 and Its Comparison to the Dutch General Population. Pain Medicine, 182(1), e1584-e1588. [DOI] [Repository]
Bekker, C. L., Gardarsdottir, H., Egberts, T. C. G., Bouvy, M. L., & van den Bemt, B. J. F. (2017). Redispensing of medicines unused by patients: a qualitative study among stakeholders. International Journal of Clinical Pharmacy, 39(1), 196-204. [DOI] [Repository]
Snijder, R. A., Knape, J. T. A., Egberts, T. C. G., & Timmerman, A. M. D. E. (2017). Hypertensive Crisis During Norepinephrine Syringe Exchange. BMJ Case Reports, 8(7), 178-181. [DOI] [Repository]
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2017). Prevalence of use of erectile dysfunction medication by Dutch military personnel between 2003 and 2012. International Journal of Impotence Research, 29, 54-65. [DOI] [Repository]
Nales, D. A., Kozarewicz, P., Aylward, B., de Vries, R., Egberts, T. C. G., Rademaker, C. M. A., & Schobben, A. F. A. M. (2017). Paediatric Drug Development and Formulation Design-a European Perspective. AAPS PharmSciTech, 18(2), 241-249. [DOI] [Repository]
Professional publications
Nales, D. A., Schobben, F., Vromans, H., Egberts, T., & Rademaker, C. M. (2017). Kindvriendelijke geneesmiddelen. Huisarts en Wetenschap, 60(1), 15-19. [DOI] [Repository]
Other output
Vlieland, N. D., Van Den Bemt, B. J. F., Bekker, C. L., Bouvy, M. L., Egberts, T. C. G., & Gardarsdottir, H. (2017). Patient compliance with drug storage recommendations. Pharmacoepidemiology and Drug Safety, 26(S2), 516-517. Article 854. [DOI]
2016
Scholarly publications
Bekker, C., Gardarsdottir, H., Egberts, A., Bouvy, M., & Van Den Bemt, B. (2016). Stakeholders' views on and their minimal requirements for redispensing unused medicines: A qualitative study. International Journal of Clinical Pharmacy, 38(6), 591. [DOI] [Repository]
Abdullah, H., Gardarsdottir, H., Yazir, D., Stoker, L. J., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2016). Zorgen om medicatiegebruik psychiatrische patient na ontslag: Bijna 70% patiënten stopt met een of meer geneesmiddelen. Pharmaceutisch Weekblad, 151(7), 14-15. https://www.pw.nl/achtergrond/2016/zorgen-om-medicatiegebruik-psychiatrische-patient-na-ontslag [Repository]
Nederlof, M., Stoker, L., Egberts, T., & Heerdink, R. (2016). Instructies voor monitoren van klinische parameters in de registratieteksten van psychofarmaca: Overzicht en toepasbaarheid voor de klinische praktijk. Tijdschrift voor Psychiatrie, 58(8), 593-598. [Repository]
Wouters, H., Amin, D. F. H., Taxis, K., Heerdink, E. R., Egberts, A. C. G., & Gardarsdottir, H. (2016). Associations between personality traits and adherence to antidepressants assessed through self-report, electronic monitoring, and pharmacy dispensing data: A Pilot Study. Journal of Clinical Psychopharmacology, 36(5), 465-471. [DOI] [Repository]
Bartelink, I. H., Lalmohamed, A., van Reij, E. M. L., Dvorak, C. C., Savic, R. M., Zwaveling, J., Bredius, R. G. M., Egberts, A. C. G., Bierings, M., Kletzel, M., Shaw, P. J., Nath, C. E., Hempel, G., Ansari, M., Krajinovic, M., Théorêt, Y., Duval, M., Keizer, R. J., Bittencourt, H., ... Boelens, J. J. (2016). Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. The Lancet Haematology, 3(11), e526-e536. [DOI] [Repository]
Snijder, R. A., Egberts, T. C. G., Lucas, P., Lemmers, P. M. A., van Bel, F., & Timmerman, A. M. D. E. (2016). Dosing errors in preterm neonates due to flow rate variability in multi-infusion syringe pump setups: An in vitro spectrophotometry study. European Journal of Pharmaceutical Sciences, 93, 56-63. [DOI] [Repository]
Klungel, O. H., Kurz, X., de Groot, M. C. H., Schlienger, R. G., Tcherny-Lessenot, S., Grimaldi, L., Ibáñez, L., Groenwold, R. H. H., Reynolds, R. F., Alvarez, Y., Candore, G., Durand, J., Slattery, J., Hasford, J., Rottenkolber, M., Schmiedl, S., de Abajo Iglesias, F., Gil, M., Gonzalez, R., ... On behalf of the members of work-package 2 of PROTECT (2016). Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project. Pharmacoepidemiology and Drug Safety, 25(supplement S1), 156-165. [DOI] [Repository]
Nales, D. A., Schobben, A. F. A. M., Vromans, H., Egberts, T. C. G., & Rademaker, C. M. A. (2016). Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects. Archives of Disease in Childhood, 101, 662-669. [DOI] [Repository]
Jessurun, J. G., van Harten, P. N., Egberts, T. C. G., Pijl, Y. J., Wilting, I., & Tenback, D. E. (2016). The Relation between Psychiatric Diagnoses and Constipation in Hospitalized Patients: A Cross-Sectional Study. Psychiatry journal, 2016, Article 2459693. [DOI] [Repository]
Nederlof, M., Frederix, G. W. J., Stoker, L. J., van Solinge, W. W., Egberts, T. C. G., & Heerdink, E. R. (2016). Patient monitoring: the hidden costs of antipsychotic treatment. British Journal of Clinical Pharmacology, 82(2), 570-572. [DOI] [Repository]
Souverein, P. C., Abbing-Karahagopian, V., Martin, E., Huerta, C., de Abajo, F., Leufkens, H. G. M., Candore, G., Alvarez, Y., Slattery, J., Miret, M., Requena, G., Gil, M. J., Groenwold, R. H. H., Reynolds, R., Schlienger, R. G., Logie, J. W., de Groot, M. C. H., Klungel, O. H., van Staa, T. P., ... Gardarsdottir, H. (2016). Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures. Pharmacoepidemiology and Drug Safety, 25 (Suppl 1), 88-102. [DOI] [Repository]
Scheifes, A., Walraven, S., Stolker, J. J., Nijman, H. L. I., Tenback, D. E., Egberts, T. C. G., & Heerdink, E. R. (2016). Movement Disorders in Adults With Intellectual Disability and Behavioral Problems Associated With Use of Antipsychotics. Journal of Clinical Psychopharmacology, 36(4), 308-313. [DOI] [Repository]
Wassenaar, M., Leijten, F. S. S., Sander, J. W., Uijl, S. G., & Egberts, A. C. G. (2016). Anti-epileptic drug changes and quality of life in the community. Acta Neurologica Scandinavica, 133, 421-426. [DOI] [Repository]
van der Stelt, C. A. K., Vermeulen Windsant-van den Tweel, A. M. A., Egberts, A. C. G., van den Bemt, P. M. L. A., Leendertse, A. J., Hermens, W. A. J. J., van Marum, R. J., & Derijks, J. (2016). The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study. Drug Safety, 39(1), 79-87. [DOI] [Repository]
Vermeer, N. S., Ebbers, H. C., Straus, S. M. J. M., Leufkens, H. G. M., Egberts, T. C. G., & De Bruin, M. L. (2016). The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: A simulation study. Pharmacoepidemiology and Drug Safety, 297-306. [DOI] [Repository]
Vlieland, N. D., Gardarsdottir, H., Bouvy, M. L., Egberts, T. C. G., & van den Bemt, B. J. F. (2016). The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range. Rheumatology (Oxford, England), 55, 704-709. [DOI] [Repository]
Udo, R., Maitland-van der Zee, A. H., Egberts, T. C. G., den Breeijen, J. H., Leufkens, H. G. M., van Solinge, W. W., & De Bruin, M. L. (2016). Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database. Pharmacoepidemiology and Drug Safety, 25(Suppl. S1), 21–28. [DOI] [Repository]
Scheifes, A., Egberts, T. C. G., Stolker, J. J., Nijman, H. L. I., & Heerdink, E. R. (2016). Structured medication review to improve pharmacotherapy in people with intellectual disability and behavioural problems. Journal of Applied Research in Intellectual Disabilities, 29(4), 346–355. [DOI] [Repository]
Scheifes, A., Walraven, S., Stolker, J. J., Nijman, H. L. I., Egberts, T. C. G., & Heerdink, E. R. (2016). Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Research in Developmental Disabilities, 49-50, 13-21. [DOI] [Repository]
Professional publications
Van Reij, E. M. L., Van Maarseveen, E. M., Egberts, A. C. G., Boelens, J. J., & Rademaker, C. M. A. (2016). Evaluatie van een geïndividualiseerd doseerschema voor busulfan bij kinderen die een allogene hematopoëtische stamceltransplantatie ondergaan. Pharmaceutisch Weekblad, 151(24), 25-28. [Repository]
2015
Scholarly publications
Vlieland, N. D., Gardarsdottir, H., Bouvy, M. L., Egberts, A. C., & Van Den Bemt, B. J. (2015). Majority of patients do not store their biological disease modifying antirheumatic drugs within recommended temperature range. Annals of the Rheumatic Diseases, 74, 710-711. [DOI]
Abbing-Karahagopian, V., Souverein, P. C., Korevaar, J. C., Leufkens, H. G. M., Egberts, T. C. G., Gardarsdottir, H., & De Bruin, M. L. (2015). Concomitant medication use and its implications on the hazard pattern in pharmacoepidemiological studies: Example of antidepressants, benzodiazepines and fracture risk. Epidemiology Biostatistics and Public Health, 12(3), Article e11273. [DOI] [Repository]
Van Riet-Nales, D., Schobben, A., Egberts, T., & Rademaker, K. (2015). Ouders zoeken creatief naar bruikbare toedieningsvormen: Hulpmiddel medebepalend of kind geneesmiddel inneemt. Pharmaceutisch Weekblad, 150(5), 16-17. [Repository]
Van Riet-Nales, D., Schobben, A., Egberts, T., & Rademaker, K. (2015). Onvoldoende geneesmiddelen voor kinderen voorhanden: Beschikbaarheid afhankelijk van indicatie en toedieningsweg. Pharmaceutisch Weekblad, 150(3), 10-11. [Repository]
Sallevelt, B. T. G. M., Van Aarle, M. C. W., & Egberts, A. C. G. (2015). Nodig: In HIV gespecialiseerde anderhalvelijns-apotheker. Pharmaceutisch Weekblad, 150(42), 22-23.
Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Risk of Hospitalization for Hypoglycemia in Older Patients with Diabetes Using Antipsychotic Drugs. American Journal of Geriatric Psychiatry, 23(11), 1144-1153. [DOI] [Repository]
Van Stiphout, F., Zwart-Van Rijkom, J. E. F., Maggio, L. A., Aarts, J. E. C. M., Bates, D. W., Van Gelder, T., Jansen, P. A. F., Schraagen, J. M. C., Egberts, A. C. G., & Ter Braak, E. W. M. T. (2015). Task analysis of information technology-mediated medication management in outpatient care. British Journal of Clinical Pharmacology, 80(3), 415-424. [DOI] [Repository]
Van Den Broek, M. P. H., Van Straaten, H. L. M., Huitema, A. D. R., Egberts, T., Toet, M. C., De Vries, L. S., Rademaker, K., & Groenendaal, F. (2015). Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia. Neonatology, 107(2), 150-156. [DOI] [Repository]
Kroger, E., Van Marum, R., Souverein, P., Carmichael, P. H., & Egberts, T. (2015). Treatment with rivastigmine or galantamine and risk of urinary incontinence: Results from a Dutch database study. Pharmacoepidemiology and Drug Safety, 24(3), 276-285. [DOI] [Repository]
van Stiphout, F., Zwart-van Rijkom, J. E. F., Aarts, J. E. C. M., Koffijberg, H., Klarenbeek-deJonge, E., Krulder, M., Roes, K. C. B., Egberts, A. C. G., & ter Braak, E. W. M. T. (2015). MEDUCATE trial: effectiveness of an intensive EDUCATional intervention for IT-mediated MEDication management in the outpatient clinic - study protocol for a cluster randomized controlled trial. Trials, 16(223). [DOI] [Repository]
Drenth-van Maanen, A. C., van Marum, R. J., Jansen, P. A. F., Zwart, J. E. F., van Solinge, W. W., & Egberts, T. C. G. (2015). Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital Discharge. PLoS One, 10(6), 1-14. Article e0128237. [DOI] [Repository]
Uijtendaal, E. V., Zwart-van Rijkom, J. E. F., de Lange, D. W., Lalmohamed, A., van Solinge, W. W., & Egberts, T. C. G. (2015). Influence of a strict glucose protocol on serum potassium and glucose concentrations and their association with mortality in intensive care patients. Critical Care, 19(270). [DOI] [Repository]
van Riet-Nales, D. A., Ferreira, J. A., Schobben, A. F. A. M., de Neef, B. J., Egberts, T. C. G., & Rademaker, C. M. A. (2015). Methods of administering oral formulations and child acceptability. International Journal of Pharmaceutics, 491(1-2), 261-267. [DOI] [Repository]
Kröger, E., Mouls, M., Wilchesky, M., Berkers, M., Carmichael, P.-H., van Marum, R., Souverein, P., Egberts, T., & Laroche, M.-L. (2015). Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. Annals of Pharmacotherapy, 49(11), 1197-1206. [DOI] [Repository]
Snijder, R. A., Konings, M. K., Lucas, P., Egberts, T. C., & Timmerman, A. D. (2015). Flow variability and its physical causes in infusion technology: a systematic review of in vitro measurement and modeling studies. Biomedizinische Technik, 60(4), 277-300. [DOI] [Repository]
Timmerman, A. M., Oliveira-Martens, S. M., Snijder, R. A., Nieman, A. K., & Egberts, T. C. (2015). How to use current practice, risk analysis and standards to define hospital-wide policies on the safe use of infusion technology. Biomedizinische Technik, 60(4), 381-7. [DOI] [Repository]
Admiraal, R., van Kesteren, C., Jol-van der Zijde, C. M., Lankester, A. C., Bierings, M. B., Egberts, T. C. G., van Tol, M. J. D., Knibbe, C. A. J., Bredius, R. G. M., & Boelens, J. J. (2015). Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. The Lancet. Haematology, 2(5), e194-203. [DOI] [Repository]
Vermeer, N. S., Straus, S. M. J. M., Mantel-Teeuwisse, A. K., Hidalgo-Simon, A., Egberts, A. C. G., Leufkens, H. G. M., & De Bruin, M. L. (2015). Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab. Clinical Pharmacology and Therapeutics, 98(5), 542-550. [DOI] [Repository]
Notenboom, K., Beers, E., Van Riet-Nales, D. A., Egberts, T. C. G., Leufkens, H. G. M., Jansen, P. A. F., & Bouvy, M. L. (2015). Ouderen krijgen tablet of capsule moeilijk uit blister. Pharmaceutisch Weekblad, 150(39), 12-13. [Repository]
Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Associatie tussen antipsychoticagebruik en hypoglykemie bij oudere patiënten met diabetes mellitus. Pharmaceutisch Weekblad, 150(16), 88-92. [Repository]
de Haan, L., Egberts, A. C. G., & Heerdink, E. R. (2015). The relation between risk-taking behavior and alcohol use in young adults is different for men and women. Drug and Alcohol Dependence, 155, 222-227. Article 5706. [DOI] [Repository]
Colen-De Koning, J. C. A., Man, W. H., Wilting, I., Schulte, P. F. J., Doodeman, H. J., Cahn, W., Heerdink, E. R., Egberts, A. C. G., & Van Haelst, I. M. M. (2015). Effect van glycopyrroniumbromide op nachtelijk clozapinegeïnduceerd speekselverlies bij patiënten met een psychiatrische aandoening. Pharmaceutisch Weekblad, 150(43), 219-222. [Repository]
van den Ban, E. F., Souverein, P. C., van Engeland, H., Swaab, H., Egberts, T. C. G., & Heerdink, E. R. (2015). Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Social Psychiatry and Psychiatric Epidemiology, 50(7), 1153-1162. [DOI] [Repository]
Einarson, A., Egberts, T. C., & Heerdink, E. R. (2015). Antidepressant use in pregnancy: knowledge transfer and translation of research findings. Journal of Evaluation in Clinical Practice, 21(4), 579-83. [DOI] [Repository]
Abdullah, H., Gardarsdottir, H., Yazir, D., Stoker, L. J., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2015). Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital. Annals of Pharmacotherapy, 49(10), 1085-95. [DOI] [Repository]
Nederlof, M., Stoker, L. J., Egberts, T. C., & Heerdink, E. R. (2015). Instructions for clinical and biomarker monitoring in the Summary of Product Characteristics (SmPC) for psychotropic drugs: Overview and applicability in clinical practice. Journal of Psychopharmacology, 29(12), 1248-54. [DOI] [Repository]
Vermeer, N. S., Spierings, I., Mantel-Teeuwisse, A. K., Straus, S. M., Giezen, T. J., Leufkens, H. G., Egberts, T. C., & De Bruin, M. L. (2015). Traceability of biologicals: present challenges in pharmacovigilance. Expert Opinion on Drug Safety, 14(1), 63-72. [DOI] [Repository]
Professional publications
Van Riet-Nales, D., Vroom, F., De Vries, R., Egberts, T., Rademaker, K., & Schobben, A. (2015). EU-regels borgen ontwikkeling van kindergeneesmiddelen. Pharmaceutisch Weekblad, 150(7), 14-15.
Van Riet-Nales, D., Schobben, A., Egberts, T., & Rademaker, K. (2015). Streven naar fundamentele kennis moet leidend zijn: Weinig onderzoek beschikbaar voor de ontwikkeling naar kindergeneesmiddelen. Pharmaceutisch Weekblad, 150(4), 8-9. [Repository]
Van Der Stelt, C. A. K., Vermeulen Windsant-Van Den Tweel, A. M. A., Egberts, A. C. G., Van Den Bemt, P. M. L. A., Leendertse, A. J., Hermens, W. A. J. T., Van Marum, R. J., & Derijks, H. J. (2015). Medicatiescreening met Beers-criteria en STOPP/START-criteria bij de oudere patiënt: Associatie tussen potentieel ongewenst geneesmiddelengebruik en geneesmiddelgerelateerde ziekenhuisopnamen. Pharmaceutisch Weekblad, 150(25), 132-135. [Repository]
2014
Scholarly publications
Eppenga, W. L., Lalmohamed, A., Geerts, A. F., Derijks, H. J., Wensing, M., Egberts, A., De Smet, P. A., & de Vries, F. (2014). Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care, 37(8), 2218–2224. [DOI]
Klop, C., De Vries, F., Vinks, T., Kooij, M. J., Van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., & Bouvy, M. L. (2014). Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: A randomised controlled trial. Osteoporosis International. [DOI]
Van Haelst, I. M. M., Van Klei, W. A., Doodeman, H. J., Warnier, M. J., De Bruin, M. L., Kalkman, C. J., & Egberts, T. C. G. (2014). QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: A cross-sectional study. Journal of Clinical Psychiatry, 75(1), 15-21. [DOI]
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., De Abajo, F., Leufkens, H. G. M., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., De Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., De Groot, M. C. H., Klungel, O. H., ... De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications. European Journal of Clinical Pharmacology, 70(7), 849-857. [DOI]
Beers, E., Moerkerken, D. C., Leufkens, H. G. M., Egberts, T. C. G., & Jansen, P. A. F. (2014). Participation of older people in preauthorization trials of recently approved medicines. Journal of the American Geriatrics Society, 62(10), 1883-90. [DOI]
Karapinar-Çarkıt, F., van Breukelen, B. R. L., Borgsteede, S. D., Janssen, M. J. A., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2014). Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after study. International Journal of Clinical Pharmacy, 36(4), 807-14. [DOI]
van Melick, E. J. M., Wilting, I., Ziere, G., Kok, R. M., & Egberts, T. C. G. (2014). The influence of lithium on calcium homeostasis in older patients in daily clinical practice. International Journal of Geriatric Psychiatry, 29(6), 594-601. [DOI]
van den Ban, E., Souverein, P., Meijer, W., van Engeland, H., Swaab, H., Egberts, T., & Heerdink, R. (2014). Association between ADHD drug use and injuries among children and adolescents. European child & adolescent psychiatry, 23(2), 95-102. [DOI]
van Riet-Nales, D. A., Römkens, E. G. A. W., Saint-Raymond, A., Kozarewicz, P., Schobben, A. F. A. M., Egberts, T. C. G., & Rademaker, C. M. A. (2014). Oral medicines for children in the European paediatric investigation plans. PLoS One, 9(6), Article e98348. [DOI] [Repository]
Abbing-Karahagopian, V., Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L. V., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C. G., Reynolds, R. F., & Klungel, O. H. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Current Clinical Pharmacology, 9(2), 130-138. [DOI]
Eppenga, W. L., Lalmohamed, A., Geerts, A. F., Derijks, H. J., Wensing, M., Egberts, T., De Smet, P. A. G. M., & de Vries, F. (2014). Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study. Diabetes Care, 37(8), 2218-24. [DOI]
Notenboom, K., Beers, E., Van Riet-Nales, D. A., Egberts, T. C. G., Leufkens, H. G. M., Jansen, P. A. F., & Bouvy, M. L. (2014). Practical problems with medication use that older people experience: A qualitative study. Journal of the American Geriatrics Society, 62(12), 2339-2344. [DOI]
Gardarsdottir, H., Stoker, L. J., Vuyk, J., Egberts, T. C. G., Heerdink, E. R., & Abdullah, H. (2014). Discontinuation of somatic medication during psychiatric hospitalization. Annals of Pharmacotherapy, 48(11), 1415-24. [DOI]
Risselada, A. J., Mulder, H., Heerdink, E. R., Gregoor, J. G., Gonera, R. K., & Egberts, T. C. G. (2014). Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs. Journal of Clinical Psychopharmacology, 34(2), 266-268. [DOI]
Klop, C., de Vries, F., Vinks, T., Kooij, M. J., van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., & Bouvy, M. L. (2014). Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial. Osteoporosis International, 25(1), 385-92. [DOI] [Repository]
Vermeer, N. S., Duijnhoven, R. G., Straus, S. M. J. M., Mantel - Teeuwisse, A. K., Arlett, P. R., Egberts, A. C. G., Leufkens, H. G. M., & De Bruin, M. L. (2014). Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in europe. Clinical Pharmacology and Therapeutics, 96(6), 723-31. [DOI]
Lefeber, G. J., Drenth-van Maanen, A. C., Wilting, I., Jansen, P. A. F., van Marum, R. J., & Egberts, T. C. (2014). Effect of a transitional pharmaceutical care intervention at hospital discharge on registration of changes in medication regimens in primary care. Journal of the American Geriatrics Society, 62(3), 565-7.
Sino, C. G. M., Sietzema, M., Egberts, T. C., & Schuurmans, M. J. (2014). Medication management capacity in relation to cognition and self-management skills in older people on polypharmacy. The Journal of Nutrition, Health & Aging, 18(1), 44-9.
Uijtendaal, E. V., van Harssel, L. L. M., Hugenholtz, G. W. K., Kuck, E. M., Zwart-van Rijkom, J. E. F., Cremer, O. L., & Egberts, T. C. (2014). Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy, 34(3), 213-9.
Kleijer, B. C., van Marum, R. J., Frijters, D. H. M., Jansen, P. A. F., Ribbe, M. W., Egberts, A. C. G., & Heerdink, E. R. (2014). Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. International Psychogeriatrics, 26(3), 363-71.
Vingerhoets, R. W., Wieringa, M. H., Egberts, T. C., Jansen, M. M., & Jansen, P. A. F. (2014). Multiple physicians are not independently associated with inappropriate prescribing: a cross-sectional study of geriatric patients. British Journal of Clinical Pharmacology, 77(1), 213-215.
Maat, B., Bollen, C. W., Vught, A. J., Egberts, T. C., & Rademaker, C. M. (2014). Impact of computerized physician order entry (CPOE) on PICU prescribing errors. Intensive Care Med, 40(3), 458-9.
Other output
Abbing-Karahagopian, V., Souverein, P., Martin, E., Huerta, C., de Abajo, F., Leufkens, H., Candore, G., Alvarez, Y., Slattery, J., Miret, M., Requena, G., Gil, M., Groenwold, R., Reynolds, R., Schlienger, R., de Groot, M., Klungel, O. H., van Staa, T., Egberts, T., ... Gardarsdottir, H. (2014). Understanding Inconsistent Results from Observational Pharmacoepidemiological Studies: the Case of Antidepressant Use and Risk of Hip Fracture. Pharmacoepidemiology and Drug Safety, 23, 36-36.
2013
Scholarly publications
Van Melick, E. J. M., Souverein, P. C., Den Breeijen, J. H., Tusveld, C. E., Egberts, T. C. G., & Wilting, I. (2013). Age as a determinant of instability of serum lithium concentrations. Therapeutic Drug Monitoring, 35(5), 643-648. [DOI]
Bartelink, I. H., Boelens, J. J., Danhof, M., Knibbe, C. A. J., & Egberts, A. C. G. (2013). Doseringen bij conditionering voor beenmergtransplantatie: Busulfan bij kinderen geïndividualiseerd. Pharmaceutisch Weekblad, 148(10), 22-24.
Vermeer, N., Duijnhoven, R., Straus, S., Blackburn, S., Hoogendoorn, L., Mantel-Teeuwisse, A., Egberts, T., Leufkens, H., & De Bruin, M. (2013). Development of safety concerns within RMPs after approval: A cohort study of biologicals. Drug Safety, 36(9), 908-909. [DOI]
Vermeer, N. S., Straus, S. M. J. M., Mantel - Teeuwisse, A., Domergue, F., Egberts, T. C. G., Leufkens, H. G. M., & De Bruin, M. L. (2013). Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases. Drug Safety, 36(8), 617-25. [DOI]
Beers, E., Egberts, T. C. G., Leufkens, H. G. M., & Jansen, P. A. F. (2013). Information for adequate prescribing to older patients: an evaluation of the product information of 53 recently approved medicines. Drugs & Aging, 30(4), 255-262. [DOI]
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G. M., Slattery, J., Alvarez, Y., Montserrat, M., Gil, M., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlinger, R., de Groot, M., Klungel, O. H., van Staa, T. P., ... De Bruin, M. L. (2013). Antidepressant Prescribing in Five European Countries: Application of Common Methods to Assess the Variation in Prevalence. Pharmacoepidemiology and Drug Safety, 22(S1), 279-280. [DOI]
Van Der Baan, F. H., Knol, M. J., Maitland-Van Der Zee, A. H., Regieli, J. J., Van Iperen, E. P. A., Egberts, A. C. G., Klungel, O. H., Grobbee, D. E., & Jukema, J. W. (2013). Added value of pharmacogenetic testing in predicting statin response: Results from the REGRESS trial. The Pharmacogenomics Journal, 13(4), 318-324. [DOI]
Jessurun, J. G., van Harten, P. N., Egberts, A. C. G., Pijl, B. J., Wilting, I., & Tenback, D. E. (2013). The Effect of Psychotropic Medications on the Occurrence of Constipation in Hospitalized Psychiatric Patients. Journal of Clinical Psychopharmacology, 33(4), 587-590.
Sino, C. G. M., Bouvy, J. C., Jansen, P. A. F., Schop, I., Egberts, A. C. G., & Schuurmans, M. J. (2013). Signs and symptoms indicative of potential adverse drug reactions in homecare patients. Journal of the American Medical Directors Association, 14(12), 920-925. http://www.ncbi.nlm.nih.gov/pubmed/24286711
van Haelst, I. M. M., Egberts, A. C. G., Doodeman, H. J., van Solinge, W. W., Kalkman, C. J., Bennis, M., Traast, H. S., & van Klei, W. A. (2013). Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment. Acta Anaesthesiologica Scandinavica, 57(3), 350-357. http://www.ncbi.nlm.nih.gov/pubmed/23186063
Vader, P., Fens, M. H. A. M., Sachini, N., van Oirschot, B. A., Andringa, G., Egberts, A. C. G., Gaillard, C. A. J. M., Rasmussen, J. T., van Wijk, H. A., van Solinge, W. W., & Schiffelers, R. M. (2013). Taxol((R))-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor((R)) EL. Nanomedicine (London), 8(7), 1127-1135. [DOI]
Drenth - van Maanen, A. C., Jansen, P. A. F., Proost, J. H., Egberts, A. C. G., van Zuilen, A. D., van der Stap, D., & Marum, R. (2013). Renal function assessment in older adults. British Journal of Clinical Pharmacology, 76(4), 616-623. http://onlinelibrary.wiley.com/doi/10.1111/bcp.12199/abstract;jsessionid=3FDD9D67E2D31DEF2BC650E18A4AF47A.f03t01
Maat, B., Rademaker, C. M., Oostveen, M. I., Krediet, T. G., Egberts, A. C. G., & Bollen, C. W. (2013). The effect of a computerized prescribing and calculating system on hypo- and hyperglycemias and on prescribing time efficiency in neonatal intensive care patients. Journal of Parenteral and Enteral Nutrition, 37(1), 85-91. http://www.ncbi.nlm.nih.gov/pubmed/22535919
Abdullah-Koolmees, H., Gardarsdottir, H., Stoker, L. J., Vuyk, J., Egberts, A. C. G., & Heerdink, E. R. (2013). Prevalence of medication use for somatic disease in institutionalized psychiatric patients. Pharmacopsychiatry, 46(7), 274-280. [DOI]
Leendertse, A. J., de Koning, G. H. P., Goudswaard, A. N., Belitser, S. V., Verhoef, M., de Gier, H. J., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2013). Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. Journal of Clinical Pharmacy and Therapeutics, 38(5), 379-87.
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Schuurmans, M. J., Souverein, P. C., & Egberts, A. C. G. (2013). The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC pharmacology & toxicology, 14, 39.
Man, W. H., ten Berg, M. J., Wilting, I., Huisman, A., Cahn, W., Douma, J. W., den Breeijen, H., Heerdink, E. R., Egberts, A. C. G., & van Solinge, W. W. (2013). Fluorescence of neutrophil granulocytes as a biomarker for clozapine use. European Neuropsychopharmacology, 23(11), 1408-1413. http://www.ncbi.nlm.nih.gov/pubmed/24074821
Mannesse, C. K., Vondeling, A. M., van Marum, R. J., van Solinge, W. W., Egberts, A. C. G., & Jansen, P. A. F. (2013). Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systematic review. Ageing Research Reviews, 12(1), 165-173. http://www.sciencedirect.com/science/article/pii/S1568163712000724
Drenth - van Maanen, A. C., Wilting, I., Jansen, P. A. F., Marum, R., & Egberts, A. C. G. (2013). Effect of a discharge medication intervention on the incidence and nature of medication discrepancies in older adults. Journal of the American Geriatrics Society, 61(3), 456-8.
Knol, W., van Marum, R. J., Jansen, P. A. F., Strengman, E., Al Hadithy, A. F., Wilffert, B., Schobben, A. F. A. M., Ophoff, R. A., & Egberts, A. C. G. (2013). Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach. Journal of Clinical Psychopharmacology, 33(3), 405-10.
Beers, E., Egberts, A. C. G., Leufkens, H. G. M., & Jansen, P. A. F. (2013). The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription. PLoS One, 16(8), e72060. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072060
Wassenaar, M., van Heijl, I., Leijten, F. S. S., van der Linden, P., Uijl, S. G., Egberts, A. C. G., & carpay, J. A. M. (2013). Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years? Journal of Neurology, 260(11), 2736-43.
van Riet-Nales, D. A., de Neef, J. E., Schobben, A. F. A. M., Ferreira, J., Egberts, A. C. G., & Rademaker, C. M. A. (2013). Acceptability of different oral formulations in infants and preschool children. Archives of Disease in Childhood, 98, 725-731.
Wassenaar, M., Leijten, F. S. S., Egberts, A. C. G., Moons, K. G., & Uijl, S. G. (2013). Prognostic factors for medically intractable epilepsy: A systematic review. Epilepsy Research, 106(3), 301-310.
Geerts, A. F. J., Eppenga, W. L., Heerdink, R., Derijks, H. J., Wensing, M. J., Egberts, T. C., & Smet, P. A. G. M. (2013). Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care. European Journal of Clinical Pharmacology, 69(9), 1701-7. [DOI]
van Melick, E. J. M., Souverein, P. C., den Breeijen, J. H., Tusveld, C. E., Egberts, A. C. G., & Wilting, I. (2013). Age as a Derminant of Instability of Serum Lithium Concentrations. Therapeutic Drug Monitoring, 35(5), 643-648.
Bartelink, I. H., Belitser, S. V., Knibbe, C. A. J., Danhof, M., de Pagter, A. J., Egberts, A. C. G., & Boelens, J. J. (2013). Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in Children. Biology of Blood and Marrow Transplantation, 19(2), 305-13.
Gregoor, J. G., van der Weide, K., van der Weide, J., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2013). The association between CYP2D6 genotype and switching antipsychotic medication to clozapine. European Journal of Clinical Pharmacology, 69(11), 1927-32.
van der Linden, C. M. J., Jansen, P. A. F., Grouls, R. J. E., van Marum, R. J., Verberne, M., Aussems, M., Egberts, A. C. G., & Korsten, E. H. M. (2013). Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review. Therapeutic Advances in Drug Safety, 4(2), 73-90. http://www.medscape.com/viewarticle/781849
Boessen, R., van der Baan, F. H., Groenwold, R. H. H., Egberts, A. C. G., Klungel, O. H., Grobbee, D. E., Knol, M. J., & Roes, K. C. B. (2013). Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements. Pharmaceutical Statistics, 12, 366-374.
Scheifes, A., de Jong, D., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2013). Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability. Research in Developmental Disabilities, 34, 3159-3167.
Doodeman, H. J., van Haelst, I. M. M., Egberts, A. C. G., Bennis, M., Traast, H. S., van Solinge, W. W., Kalkman, C. J., & van Klei, W. A. (2013). The effect of a preoperative erythropoietin protocol as a part of a multifaceted blood management program in daily clinical practice (CME). Transfusion, 53(9), 1930-1939. http://www.ncbi.nlm.nih.gov/pubmed/23240859
Bartelink, I. H., Wolfs, T., Jonker, M., de Waal, M., Egberts, A. C. G., Ververs, T. T., Boelens, J. J., & Bierings, M. B. (2013). Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients. Antimicrobial Agents and Chemotherapy, 57(1), 235-40. http://www.ncbi.nlm.nih.gov/pubmed/23114771
van den Broek, M. P. H., Rademaker, C. M., van Straaten, H. L., Huitema, AD., Toet, M. C., de Vries, L. S., Egberts, A. C. G., & Groenendaal, F. (2013). Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing. Archives of Disease in Childhood Fetal and Neonatal Edition, 98(4), F341-5.
Mannesse, C. K., Jansen, P. A. F., van Marum, R. J., Sival, R. C., Kok, R. M., Haffmans, P. M. J., & Egberts, A. C. G. (2013). Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: A cross-sectional study. Maturitas, 76(4), 357-363. http://www.sciencedirect.com/science/article/pii/S0378512213002788
Maat, B., Au, Y. S., Bollen, C. W., van Vught, A. J., Egberts, A. C. G., & Rademaker, C. M. (2013). Clinical pharmacy interventions in paediatric electronic prescriptions. Archives of Disease in Childhood, 98(3), 222-7.
Geerts, A. F. J., De Koning, F. H. P., de Vooght, K. M. K., Egberts, A. C. G., Smet, P. A. G. M., & van Solinge, W. W. (2013). Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients. Journal of Clinical Pharmacy and Therapeutics, 38(5), 416-22. [DOI]
Professional publications
Stuffken, R., Souverein, P. C., Egberts, A. C. G., & Heerdink, E. R. (2013). Discontinuïteit in gebruik van psychofarmaca bij ziekenhuisopname. PW Wetenschappelijk Platform, 7(7), a1322.
Drenth - van Maanen, A. C., Leendertse, A. J., van Marum, R. J., Verduijn, M. M., Egberts, A. C. G., & Jansen, P. A. F. (2013). Highlights uit de richtlijn ‘Polyfarmacie bij ouderen’. Ins&Ouds, Tijdschrift voor Geriatrie, 1, 17-21.
Beers, E., Egberts, A. C. G., Leufkens, H. G. M., & Jansen, P. A. F. (2013). Informatie over ouderen in het Kompas en de productinformatie van antipsychotica. Informatie over ouderen in het Farmacotherapeutisch Kompas en de officiële productinformatie van antipsychotica. Ins&Ouds, Tijdschrift voor Geriatrie, 1, 4-8.
Geerts, A. F. J., De Koning, F. H. P., de Vooght, K. M. K., Egberts, A. C. G., de Smet, P. G. A. M., & van Solinge, W. W. (2013). Nierfunctiemeting bij ambulante oudere patiënten in de openbare apotheek. PW Wetenschappelijk Platform, 7, 156-162.
Other output
van Haelst, I. M. M., van Klei, W. A., Doodeman, H. J., Warnier, M. J., de Bruin, M. L., Kalkman, C. J., & Egberts, A. C. G. (2013). QT interval prolongation in elderly users of selective serotonin reuptake inhibitors.. Abstract from Annual International Conference on Pharmaco-epidemiology 2013, Montreal, Canada.
2012
Scholarly publications
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, T. C. G. (2012). Ander type bijwerkingen: Veiligheid biologicals vanuit regulatoir en klinisch perspectief. Pharmaceutisch Weekblad, 147(6), 15-17.
Van Den Broek, M. P. H., Groenendaal, F., Toet, M. C., Van Straaten, H. L. M., Van Hasselt, J. G. C., Huitema, A. D. R., De Vries, L. S., Egberts, A. C. G., & Rademaker, C. M. A. (2012). Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with therapeutic hypothermia. Archives of Disease in Childhood, 97, 36-37. [DOI]
Willemen, M. J. C., Mantel-Teeuwisse, A. K., Buggy, Y., Layton, D., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, T. C. G. (2012). Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study. Drug Safety, 35(12), 1147-58. [DOI]
Giezen, T. J., Mantel-Teeuwisse, A. K., ten Berg, M. J., Straus, S. M. J. M., Leufkens, H. G. M., van Solinge, W. W., & Egberts, T. C. G. (2012). Rituximab-induced thrombocytopenia: a cohort study. European Journal of Haematology, 89(3), 256-66. [DOI]
Van Dijk, M. H., Bulk, S., Van Oppen, A. C. C., Egberts, A. C. G., Heerdink, E. R., & Lindhout, D. (2012). Spectrum of neural tube defects after prenatal antiepileptic drug exposure: Extensive case series. Archives of Disease in Childhood, 97, 427-428. [DOI]
Uijtendaal, E. V., Zwart-van Rijkom, J. E. F., van Solinge, W. W., & Egberts, A. C. G. (2012). Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuation. Annals of Pharmacotherapy, 46(2), 176-182.
Geerts, A. F. J., De Koning, F. H. P., Egberts, A. C. G., de Smet, P. G. A. M., & van Solinge, W. W. (2012). Information comparison of the effects of drugs on laboratory tests in drug labels and Young's book. Clinical Chemistry and Laboratory Medicine, 50(10), 1765-1768.
Geerts, A. F. J., de Koning, G. H. P., van Solinge, W. W., de Smet, P. G. A. M., & Egberts, A. C. G. (2012). Instructions on laboratory monitoring in 200 drug labels. Clinical Chemistry and Laboratory Medicine, 50(8), 1351-1358.
van der Baan, F. H., Knol, M. J., Klungel, O. H., Egberts, A. C. G., Grobbee, D. E., & Roes, C. B. (2012). Potential of adaptive clinical trial designs in pharmacogenetic research. Pharmacogenomics, 13(5), 571-578. http://www.ncbi.nlm.nih.gov/pubmed/22462749
Arbouw, M. E. L., Movig, K. L. L., Guchelaar, H. J., Neef, C., & Egberts, T. C. (2012). Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study. European Journal of Clinical Pharmacology, 68, 83-88.
Leendertse, A. J., van Dijk, E. A., de Smet, P. G. A. M., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2012). Contribution of renal impairment to potentially preventable medication-related hospital admission. Annals of Pharmacotherapy, 46(5), 625-633.
van Haelst, I. M. M., van Klei, W. A., Doodeman, H. J., Kalkman, C. J., & Egberts, A. C. G. (2012). Antidepressive treatment with monoamine Oxidase Inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study. Journal of Clinical Psychiatry, 73(8), 1103-1109. [DOI]
Risselada, A. J., Mulder, H., Heerdink, E. R., Gonera, R. K., & Egberts, T. C. (2012). Association Between HTR2C Polymorphisms and Obesity in Patients Without Antipsychotic Drugs. Journal of Clinical Psychopharmacology, 32(5), 715-740. http://www.ncbi.nlm.nih.gov/pubmed/22926610
Schouten, H. J., Knol, W., Egberts, A. C. G., Schobben, A. F. A. M., Jansen, P. A. F., & van Marum, R. J. (2012). Quality of life of elderly patients with antipsychotic-induced parkinsonism: a cross-sectional study. Journal of the American Medical Directors Association, 13(1), e1-e5. http://www.sciencedirect.com/science/article/pii/S1525861010003993
van den Broek, M. P. H., Groenendaal, F., Toet, M. C., van Straaten, H. L., van Hasselt, J. G. C., Huitema, AD., de Vries, L. S., Egberts, A. C. G., & Rademaker, C. M. (2012). Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia : a thermopharmacological approach. Clinical Pharmacokinetics, 51(10), 671-9. http://www.ncbi.nlm.nih.gov/pubmed/23018530
Wilting, I., Drenth - van Maanen, A. C., Jansen, P. A. F., van Marum, R. J., & Egberts, A. C. G. (2012). The effect of a multicomponent transitional pharmaceutical care intervention on the incidence and nature of unintentional medication discrepancies in Geriatric patients after hospital discharge. European Geriatric Medicine, 3, 118.
Knol, W., van Marum, R. J., Jansen, P. A. F., Egberts, A. C. G., & Schobben, A. F. A. M. (2012). Parkinsonism in Elderly Users of Haloperidol: Associated With Dose, Plasma Concentration, and Duration of Use. Journal of Psychopharmacology, 32, 688-693. http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=QgXYbrCXjGWbZT2vffyfT8yVvzGs7XKg5yPbHyhtGSX8tNP1WhN1!-1679462956!181195629!8091!-1?issn=0271-0749&volume=32&issue=5&spage=688
van Melick, E. J., Wilting, I., Souverein, P. C., & Egberts, A. C. G. (2012). Differences in lithium use patterns in the Netherlands: comparing middle-aged and older patients in a database study. American Journal of Geriatric Pharmacotherapy, 10(3), 193-200. http://www.ncbi.nlm.nih.gov/pubmed/22417731
van Haelst, I. M. M., van Klei, W. A., Doodeman, H. J., Kalkman, C. J., & Egberts, A. C. G. (2012). Selective serotonin reuptake inhibitors and intraoperative blood pressure. American Journal of Hypertension, 25(2), 223-228. http://www.ncbi.nlm.nih.gov/pubmed/22012207
Kleijer, B. C., Koek, H. L., Van Marum, R. J., Jansen, P. A. F., Egberts, T. C. G., & Heerdink, E. R. (2012). Risk of acute coronary syndrome in elderly users of antipsychotic drugs: A nested case-control study. Heart, 98(15), 1166-1171. [DOI]
Kroger, E., Berkers, M., Carmichael, P. H., Souverein, P. C., van Marum, R. J., & Egberts, A. C. G. (2012). Use of rivastigmine or galantamine and risk of adverse cardiac events: a database study from the Netherlands. American Journal of Geriatric Pharmacotherapy, 10(6), 373-380. http://www.ncbi.nlm.nih.gov/pubmed/23217530
Bartels, M., van Solinge, W. W., den Breeijen, H., Bierings, M. B., Coffer, P. J., & Egberts, T. C. (2012). Valproic Acid treatment is associated with altered leukocyte subset development. Journal of Clinical Psychopharmacology, 32(6), 832-834. [DOI]
Bartelink, I. H., van Kesteren, C., Boelens, J. J., Egberts, T. C., Bierings, M. B., Cuvelier, G. D., Wynn, R. F., Slatter, M. A., Chiesa, R., Danhof, M., & Knibbe, C. A. (2012). Predictive performance of a busulfan pharmacokinetic model in children and young adults. Therapeutic Drug Monitoring, 34(5), 574-583.
van der Linden, C. M. J., Jansen, P. A. F., Marum, R., Grouls, R. J. E., Egberts, A. C. G., & Korsten, E. H. M. (2012). An electronic system to document reasons for medication discontinuation and to flag unwanted represcriptions in geriatric patients. Drugs & Aging, 29(12), 957-962. http://www.ncbi.nlm.nih.gov/pubmed/23143942
Bartelink, I. H., Boelens, J. J., Bredius, R. G. M., Egberts, A. C. G., Wang, C., Bierings, M. B., Shaw, P. J., Nath, C. E., Hempel, G., Zwaveling, J., Danhof, M., & Knibbe, C. A. J. (2012). Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing. Clinical Pharmacokinetics, 51(5), 331-45.
Karapinar, F., Borgsteede, S. D., Zoer, J., Egberts, A. C. G., van den Bemt, P. M. L. A., & van Tulder, M. (2012). Effect of Medication Reconciliation on Medication Costs After Hospital Discharge in Relation to Hospital Pharmacy Labor Costs. Annals of Pharmacotherapy, 46, 329-338.
Mannesse, C. K., Vondeling, A. M., van Marum, R. J., van Solinge, W. W., Egberts, A. C. G., & Jansen, P. A. F. (2012). Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systemeatic review. Ageing Research Reviews, 12, 165-173.
Professional publications
Beers, E., Egberts, T. C., Leufkens, H. G. M., & Jansen, P. A. F. (2012). Voorschrijven van antipsychotica. Wat staat er in Kompas en productinformatie. Tijdschrift voor Ouderengeneeskunde, 03, 127-131.
Knol, W., Kleijer, B. C., Heerdink, E. R., Schobben, A. F. A. M., Egberts, A. C. G., van Marum, R. J., & Jansen, P. A. F. (2012). Bijwerkingen van antipsychotica. Tijdschrift voor Ouderengeneeskunde, 3, 148-152.
ten Berg, M. J., den Breeijen, J. H., Egberts, A. C. G., & van Solinge, W. W. (2012). Biomarkers voor de effecten van geneesmiddelen: het UPOD-initiatief. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 37, 7-10.
van Harssel, L. L. M., Uijtendaal, E. V., Hugenholtz, G. W. K., Kuck, E. M., Zwart-van Rijkom, J. E. F., Cremer, O. L., & Egberts, A. C. G. (2012). Frequentie en aard van interacties tussen geneesmiddelen bij intensive-carepatiënten. Pharmaceutisch Weekblad, 6, 1218-1218.
Douma, J. W., Wilting, I., ten Berg, M. J., den Breeijen, J. H., Huisman, A., Egberts, A. C. G., & van Solinge, W. W. (2012). Associatie tussen clozapinegebruik en FL3-fluorescentie: een mogelijke biomarker voor therapie (on)trouw? Pharmaceutisch Weekblad, 147, a1210.
Beers, E., Egberts, A. C. G., Leufkens, H. G. M., & Jansen, P. A. F. (2012). informatie over ouderen in het Kompas en de productinformatie van antipsychotica. Psyfar, 4, 49-53.
Drenth - van Maanen, A. C., Leendertse, A. J., van Marum, R. J., Verduijn, M. M., Egberts, A. C. G., & Jansen, P. A. F. (2012). Polyfarmacie bij ouderen. Wat gaat er mis en hoe kan het beter? Tijdschrift voor Ouderengeneeskunde, 3, 114-119.
Other output
Abdullah-Koolmees, H., Gardarsdottir, H., Stoker, L. S., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2012). Prevalence of Medication Use for Somatic Disease in Hospitalized Psychiatric Patients. Pharmacoepidemiology and Drug Safety, 21, 435-436.
Abbing-Karahagopian, V., Gardarsdottir, H., Souverein, P. C., Klungel, O. H., Leufkens, B. G. M., Egberts, T. C. G., & De Bruin, M. L. (2012). Timing of concomitant drug use in pharmacoepidemiological studies. Pharmacoepidemiology and Drug Safety, 21(S3), 423. Article 914. [DOI]
van Haelst, I. M. M., van Klei, W. A., Doodeman, H. J., Kalkman, C. J., & Egberts, A. C. G. (2012). Monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events.. Abstract from Dutch Hospital Pharmacists Annual Meeting 2012, Apeldoorn, Nederland.
van Haelst, I. M. M., van Klei, W. A., Doodeman, H. J., Kalkman, C. J., & Egberts, A. C. G. (2012). Monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events.. Abstract from International Anesthesia Research Society Annual Meeting 2012, Boston, Verenigde Staten.
2011
Scholarly publications
Derijks, H. J., Heerdink, E. R., De Koning, G. H. P., Janknegt, R., & Egberts, A. C. G. (2011). Invloed van antidepressiva op de glucosehuishouding: Farmacologisch profielvoorspelt risico. Pharmaceutisch Weekblad, 146(22-23), 30-33.
Vermeer, N. S., Straus, S. M., Mantel Teeuwisse, A. K., Egberts, T. C., Leufkens, H. G., & De Bruin, M. L. (2011). Sparse batch number reporting for biologicals in FDA's adverse event reporting system (AERS). Drug Safety, 34(10), 1002.
Willemen, M. J., Mantel-Teeuwisse, A. K., Straus, S. M., Meijboom, R., Egberts, T. C., & Leufkens, H. G. (2011). Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase. Diabetes Care, 34(2), 369-74. [DOI]
Leendertse, A. J., de Koning, F. H. P., Goudswaard, A. N., Jonkhoff, A. R., van den Bogert, S. C. A., de Gier, H. J., Egberts, T. C. G., & van den Bemt, P. M. L. A. (2011). Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Services Research, 11, 4. [DOI]
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2011). Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporosis International, 22(7), 2197-204. [DOI]
Gregoor, J. G., van der Weide, J., Loovers, H. M., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2011). Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics, 12(6), 919-23.
van den Broek, M. P. H., Huitema, AD., van Hasselt, J. G. C., Groenendaal, F., Toet, M. C., Egberts, A. C. G., de Vries, L. S., & Rademaker, C. M. A. (2011). Lidocaine (Lignocaine) Dosing Regimen Based upon a Population Pharmacokinetic Model for Preterm and Term Neonates with Seizures. Clinical Pharmacokinetics, 50(7), 461-9.
Leendertse, A. J., van den Bemt, P. M. L. A., Poolman, J. B., Stoker, L. J., Egberts, A. C. G., & Postma, M. J. (2011). Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value in Health, 14(1), 34-40. http://www.ncbi.nlm.nih.gov/pubmed/21211484
van Geffen, E. C. G., Hermsen, J. H., Heerdink, E. R., Egberts, A. C. G., Verbeek-Heida, P. M., & van Hulten, R. (2011). The decision to continue or discontinue treatment: Experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months-A qualitative study. Research in Social and Administrative Pharmacy, 7(2), 134-50. http://www.ncbi.nlm.nih.gov/pubmed/21272543
Meulendijks, D., Mannesse, C. K., Jansen, P. A. F., van Marum, R. J., & Egberts, A. C. G. (2011). Attribution hyponatraemia to treatment with antipsychotic medications. The Authors’ Reply. Drug Safety, 34, 354-355.
Verdel, B. M., Souverein, P. C., Meenks, S. D., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2011). Use of serotonergic drugs and the risk of bleeding. Clinical Pharmacology and Therapeutics, 89(1), 89-96.
Scheifes, A., Stolker, J. J., Egberts, A. C. G., Nijman, H. L. I., & Heerdink, E. R. (2011). Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems. Journal of Intellectual Disability Research, 55(7), 650-664.
Drenth - van Maanen, A. C., Spee, J., Marum, R., Egberts, A. C. G., van Hensbergen, L., & Jansen, P. A. F. (2011). Structured history taking of medication use reveals iatrogenic harm due to discrepancies in medication histories in hospital and phamacy records. Journal of the American Geriatrics Society, 59(10), 1976-1977.
Bulatovic, M., Heijstek, M. W., Verkaaik, M., van Dijkhuizen, E. H. P., Armbrust, W., Hoppenreijs, E. P. A. H., Kamphuis, S., Kuis, W., Egberts, A. C. G., Sinnema, G., Rademaker, C. M. A., & Wulffraat, N. M. (2011). High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score. Arthritis and Rheumatism, 63(7), 2007-2013. http://www.ncbi.nlm.nih.gov/pubmed/21437879
van Riet-Nales, D. A., de Jager, JE., Schobben, A. F. A. M., Egberts, A. C. G., & Rademaker, C. M. A. (2011). The availability and age-appropriateness of medicines authorized for children in The Netherlands. British Journal of Clinical Pharmacology, 72(3), 465-473. [DOI]
ten Berg, M. J., van den Bemt, P. M. L. A., Shantakumar, S., Bennett, D., Voest, E. E., Huisman, A., van Solinge, W. W., & Egberts, A. C. G. (2011). Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study. Drug Safety, 34(12), 1151-1160.
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2011). Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporosis International, 22(7), 2197-204. http://www.ncbi.nlm.nih.gov/pubmed/20967420
van der Baan, F. H., Klungel, O. H., Egberts, A. C. G., Leufkens, H. G. M., Grobbee, D. E., Roes, K. C. B., & Knol, M. J. (2011). Pharmacogenetics in randomized controlled trials: considerations for trial design. Pharmacogenomics, 12(10), 1485-1492. http://www.ncbi.nlm.nih.gov/pubmed/22008051
Beers, E., Jansen, P. A. F., Egberts, A. C. G., & Leufkens, H. G. M. (2011). Quality of information on older persons in the product characteristics and public assessment reports of recently approved medicines. British Journal of Pharmacology, 72, 844-845.
Risselada, A. J., Mulder, J., Heerdink, E. R., & Egberts, A. C. G. (2011). Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review. Pharmacogenomics, 12(8), 1213-1227.
van Geijlswijk, I. M., Mol, R. H., Egberts, A. C. G., & Smits, M. G. (2011). Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. Psychopharmacology, 216(1), 111-20. [DOI] [Repository]
ten Berg, M. J., Huisman, A., van den Bemt, P. M. L. A., den Breeijen, H., Egberts, A. C. G., & van Solinge, W. W. (2011). Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia. Biomarkers, 16(1), 51-7.
Uijtendaal, E. V., Zwart-van Rijkom, J. E. F., van Solinge, W. W., & Egberts, A. C. G. (2011). Frequency of laboratory measurement and hyperkalaemia in hospitalized patients using serum potassium concentration increasing drugs. European Journal of Clinical Pharmacology, 67, 933-940. http://www.ncbi.nlm.nih.gov/pubmed/21424384
Other output
Van Der Baan, F. H., Knol, M. J., Klungel, O. H., Egberts, T. C. G., Grobbee, D. E., & Roes, K. C. B. (2011). Potential of adaptive clinical trial designs in pharmacogenetic research, A simulation based on the IPASS trial. Pharmacoepidemiology and Drug Safety, 20(18), S8-S9. Article 18. [DOI]
Van Der Baan, F. H., Gregoor, J. G., Loovers, H. M., Klungel, O. H., Egberts, T. C. G., Grobbee, D. E., Knol, M. J., & Van Der Weide, J. (2011). Cytochrome P-450 2D6 and 2C19 polymorphisms and consumption of care in psychiatric practice. Pharmacoepidemiology and Drug Safety, 20(S1), S6-S7. Article 14. [DOI]
van Haelst, I. M. M., Egberts, A. C. G., Doodeman, J., Bennis, M., Kalkman, C. J., & van Klei, W. A. (2011). The effect of a preoperative erythropoietin protocol on allogeneic blood transfusions in daily clinical practice. Poster session presented at IARS Annual Meeting, Vancouver, Canada.
2010
Scholarly publications
van den Ban, E., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, T. C. G., & Heerdink, E. R. (2010). Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2(4), 213-220. [DOI] [Portal]
Arbouw, M., Lalmohamed, A., Souverein, P., Egberts, A., Bazelier, M., & De Vries, F. (2010). Use of dopaminergic drugs and risk of hip or femur fracture: A population-based case-control study. Bone, 47, 29. [DOI]
Gardarsdottir, H., Egberts, T. C. G., & Heerdink, E. R. (2010). The association between patient-reported drug taking and gaps and overlaps in antidepressant drug dispensing. Annals of Pharmacotherapy, 44(11), 1755-1761. [DOI]
Giezen, T. J., Mantel-Teeuwisse, A. K., Meijboom, R., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, T. C. G. (2010). Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Drug Safety, 33(10), 865-78. [DOI]
Egberts, A. C. G., & De Boer, A. (2010). Gescheiden farmaceutische budgetten: Dansen over ijsschotsen. Nederlands Tijdschrift voor Geneeskunde, 154(51-52), 2376-2378. Article A3004.
Gardarsdottir, H., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2010). Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. Journal of Clinical Epidemiology, 63(4), 422-7. [DOI]
Gardarsdottir, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Transitions from General Practitioner to Psychiatrist Care (or vice versa) during a first antidepressant treatment episode. Pharmacopsychiatry, 43(5), 179-183. [DOI]
van Geffen, E. C. G., Heerdink, E. R., Hugtenburg, J. G., Siero, F. W., Egberts, A. C. G., & van Hulten, R. (2010). Patients' perceptions and illness severity at start of antidepressant treatment in general practice. The International Journal of Pharmacy Practice, 18(4), 217-25.
van Geijlswijk, I. M., van der Heijden, K. B., Egberts, A. C. G., Korzilius, H. P., & Smits, M. G. (2010). Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology, 212(3), 379-91. [DOI] [Repository]
Leendertse, A. J., Visser, D., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2010). The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Safety, 33(3), 233-44.
Verdel, B. M., Souverein, P. C., Egberts, T. C. G., van Staa, T. P., Leufkens, H. G. M., & de Vries, F. (2010). Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures: Focus on the affinity for the serotonin receptor. Bone, 47(3), 604-609. [DOI]
Gardarsdottir, H., Egberts, T. C. G., van Dijk, L., & Heerdink, E. R. (2010). Seasonal patterns of initiating antidepressant therapy in general practice in the Netherlands during 2002-2007. Journal of Affective Disorders, 122(3), 208-12. [DOI]
Gregoor, J. G., Mulder, H., Cohen, D., Megen, H. J. G. M., Egberts, A. C. G., Heerdink, E. R., & van der Weide, J. (2010). Combined HTR2C-LEP Genotype as a Determinant of Obesity in Patients Using Antipsychotic Medication. Journal of Clinical Psychopharmacology, 30(6), 702-705.
Risselada, A. J., Mulder, H., Heerdink, E. R., Grube, A. M., Wilmink, F. W., & Egberts, A. C. G. (2010). The association between serotonin 2C receptor polymorphisms and weight gain and eating behavior in patients using mirtazapine: a prospective follow-up study. Journal of Clinical Psychopharmacology, 30(2), 207-9.
Kleijer, B. C., Heerdink, E. R., Egberts, A. C. G., Jansen, P. A. F., & van Marum, R. J. (2010). Antipsychotic drug use and the risk of venous thromboembolism in elderly patients. Journal of Clinical Psychopharmacology, 30(5), 526-530.
Knol, M. J., Janssen, K. J. M., Donders, A. R. T., Egberts, A. C. G., Heerdink, E. R., Grobbee, D. E., Moons, K. G. M., & Geerlings, M. I. (2010). Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. Journal of Clinical Epidemiology, 63(7), 728-36. http://www.ncbi.nlm.nih.gov/pubmed/20346625
van den Ban, E. F., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Less discontunuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2, 213-220.
van Haelst, I. M. M., Egberts, A. C. G., Doodeman, H. J., Traast, H. S., Burger, B. J., Kalkman, C. J., & van Klei, W. A. (2010). Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology, 112(3), 631-6.
van Waes, J. A. R., de Graaff, J. C., Egberts, A. C. G., & van Klei, W. A. (2010). Medication discontinuity errors in the perioperative period. Acta Anaesthesiologica Scandinavica, 54(10), 1185-91.
Gregoor, J. G., van der Weide, J., Loovers, H. M., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2010). Association between LEP- and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication. Psychiatric Genetics, 20, 311-316.
Liem, T. B. Y., van den Hoogen, A., Rademaker, K. J., Egberts, A. C. G., Fleer, A., & Krediet, T. G. (2010). Antibiotic weight-watching: slimming down on antibiotic use in a NICU. Acta Paediatrica, 99, 1900-1902.
Meulendijks, L. A., Mannesse, C. K., Jansen, P. A. F., van Marum, R. J., & Egberts, A. C. G. (2010). Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Safety, 33(2), 101-114. [DOI]
van den Ban, E. F., Souverein, P., Swaab, H., van Engeland, H., Heerdink, R., & Egberts, A. C. G. (2010). Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. Journal of Child and Adolescent Psychopharmacology, 20(1), 55-61.
Zwart-van Rijkom, J. E. F., Uijtendaal, E. V., ten Berg, M. J., van Solinge, W. W., & Egberts, A. C. G. (2010). Frequency and nature of drug-drug interactions in a Dutch university hospital. British Journal of Clinical Pharmacology, 70, 618-618.
Zaal, R. J., van Doormaal, J. E., Lenderink, A. W., Mol, P. G. M., Kosterink, J. G. W., Egberts, A. C. G., Haaijer-Ruskamp, F. M., & van den Bemt, P. M. L. A. (2010). Comparison of potential risk factors for medication errors with and without patient harm. Pharmacoepidemiology and Drug Safety, 19(8), 825-33.
van Melick, E. J., Wilting, I., Meinders, A. E., & Egberts, A. C. G. (2010). Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients. The American Journal of Geriatric Psychiatry, 18(5), 395-403.
van der Linden, C. M. J., Jansen, P. A. F., Geerenstein, E. V., van Marum, R. J., Grouls, R. J. E., Egberts, A. C. G., & Korsten, E. H. M. (2010). Reasons for discontinuation of medication during hospitalization and documentation thereof: a descriptive study of 400 geriatric and internal medicine patients. Archives of Internal Medicine, 170(12), 1085-1087. http://archinte.ama-assn.org/cgi/content/full/170/12/1085
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2010). Trials assessing parmacotherapeutic management of aggression in psychiatric patients: comparability with clinical practice. Pharmacopsychiatry, 43(6), 205-9.
Dezentje, V. O., van Blijderveen, N. J., Gelderblom, H., Putter, H., van Herk-Sukel, M. P., Casparie, M. K., Egberts, A. C. G., Nortier, JW., & Guchelaar, H. J. (2010). Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. Journal of Clinical Oncology, 28(14), 2423-9.
Smink, B. E., Egberts, A. C. G., Lusthof, K. J., Uges, D. R. A., & de Gier, J. J. (2010). The relationship between benzodiazepine use and traffic accidents: A systematic literature review. CNS Drugs, 24(8), 639-53.
Kroger, E., van Marum, R. J., Souverein, P., & Egberts, A. C. G. (2010). Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study. Drugs & Aging, 27(8), 663-675.
van der Linden, C. M. J., Jansen, P. A. F., van Marum, R. J., Grouls, R. J. E., Korsten, E. H. M., & Egberts, A. C. G. (2010). Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are needed. Drug Safety, 33(7), 535-8.
Mannesse, C. K., van Puijenbroek, E. P., Jansen, P. A. F., van Marum, R. J., Souverein, P. C., & Egberts, A. C. G. (2010). Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Drug Safety, 33(7), 569-78. [DOI]
van den Broek, M. P. H., Groenendaal, F., Egberts, A. C. G., & Rademaker, C. M. A. (2010). Effects of hypothermia on pharmacolinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clinical Pharmacokinetics, 49, 277-94. http://www.ncbi.nlm.nih.gov/pubmed/20384391
Liem, T. B. Y., Heerdink, E. R., Egberts, A. C. G., & Rademaker, C. M. A. (2010). Quantifying antibiotic use in paediatrics: a proposal for neonatal DDDs. European Journal of Clinical Microbiology & Infectious Diseases, 29(10), 1301-3.
Liem, T. B. Y., Krediet, T. G., Fleer, A., Egberts, A. C. G., & Rademaker, C. M. A. (2010). Variation in antibiotic use in neonatal intensive care units in the Netherlands. Journal of Antimicrobial Chemotherapy, 65(6), 1270-5.
Arbouw, M. E. L., Movig, K. L. L., Koopmann, M., Poels, P. J. E., Guchelaar, H. J., Egberts, A. C. G., Neef, C., & van Vugt, J. P. P. (2010). Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology, 74(15), 1203-7.
Karapinar-Carkit, F., Borgsteede, S. D., Zoer, J., Siegert, C., van Tulder, M., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2010). The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients. BMC Health Services Research, 10, 39. http://www.ncbi.nlm.nih.gov/pubmed/20156368
van Riet-Nales, D. A., Schobben, A. F. A. M., Egberts, A. C. G., & Rademaker, C. M. A. (2010). Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review. Clinical Therapeutics, 32(5), 924-38.
Arbouw, M. E. L., Guchelaar, H. J., & Egberts, A. C. G. (2010). Novel insights in pharmacogenetics of drug response in Parkinson's disease. Pharmacogenomics, 11(2), 127-9.
Professional publications
Spee, J., van Marum, R. J., Egberts, T. C. G., Drenth-van Maanen, A. C., & Jansen, P. A. F. (2010). Gestructureerde medicatieanamnese bij opname: helpt een juist overzicht van de thuismedicatie te verkrijgen. Nederlands Tijdschrift voor Geneeskunde, 154(11).
Kleijer, B. C., Van Marum, R. J., Egberts, A. C. G. T., Jansen, P. A. F., Frijters, D. H. M., Heerdink, E. R. R., & Ribbe, M. W. (2010). Het beloop van gedragsproblemen bij oudere verpleeghuispatiënten met dementie die worden behandeld met antipsychotica. Tijdschrift voor Ouderengeneeskunde, 2010(2), 70-79.
Jansen, P. A. F., & Egberts, A. C. G. (2010). Optimaliseren en beheersen van chronische polyfarmacie. In Handboek multidisciplinaire zorg (pp. 176-185)
Gombert-Handoko, K. B., van Puijenbroek, E. P., Bijl, A. H., Hermens, W. A. J. J., Zwart-van Rijkom, J. E. F., Hekster, Y. A., & Egberts, T. C. (2010). Anti-epileptica en overgevoeligheidsreacties: geeft de chemische structuur een verklaring? Pharmaceutisch Weekblad, 4(3), 38-41.
Spee, J., van Marum, R. J., Egberts, T. C., Drenth - van Maanen, A. C., & Jansen, P. A. F. (2010). Gestructureerde medicatieanamnese bij opname. Nederlands Tijdschrift voor Geneeskunde, 154(1), A904-8.
Meulenhoff, P. C. W., van Reij, E. M. L., & Egberts, A. C. G. (2010). Infectierisico's door contaminatie van geneesmiddelen. Nederlands Tijdschrift voor Geneeskunde, 154(5), A1723.
Zaal, R. J., van Doormaal, J. E., Lenderink, B. W., Mol, P. G. M., Kosterink, J. G. W., Egberts, T. C., Haaijer-Ruskamp, F. M., & van den Bemt, P. M. L. A. (2010). Vergelijking van potentiele risicofactoren voor medicatiefouten met en zonder schade. Pharmaceutisch Weekblad, 4(1), 2-6.
Karapinar, F., Borgsteede, S. D., Zoer, J., Siegert, C., van Tulder, M., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2010). ontslagrecept: stap naar ideale transmurale overdracht. Praktisch, veilig en helder. Pharmaceutisch Weekblad, 15-17.
Derijks, H. J., Heerdink, E. R., Janknegt, R., de Koning, G. H. P., Olivier, B., Loonen, A. J. M., & Egberts, T. C. (2010). Farmacologische profielen van antidepressiva. Pharmaceutisch Weekblad, 4(5), 79-85.
Other output
Gregoor, J. G., van der Weide, J., Loovers, H. M., Megens, H. J., Egberts, A. C. G., & Heerdink, E. R. (2010). Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication. S278, 657. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Kröger, E., van Marum, R. J., Souverein, P. C., Carmichael, P. H., & Egberts, A. C. G. (2010). Treatment with Cholinesterase Inhibitors May Increase the Risk of Urinary Incontinence. S131, 305. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Willemen, M. J. C., Mantel, A. K., Straus, S. M. J. M., Egberts, A. C. G., & Leufkens, H. G. M. (2010). DPP-4 Inhibitors and the Occurrence of Infections A Nested Case-Control Study. S168, S 395. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Willemen, M. J. C., Mantel, A. K., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, A. C. G. (2010). Lifestyle Drugs and Psychiatric Adverse Events in Randomised Clinical Trials. S180, 424. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
van der Baan, F. H., Klungel, O. H., Grobbee, D. E., Egberts, A. C. G., & Knol, M. J. (2010). Suitable Study Designs for Pharmacogenetic Research. S90, 210. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Goedhard, L. E., Stolker, J. J., Nijman, H. L., Egberts, A. C. G., & Heerdink, E. R. (2010). The Association of Aggression and Medication Use with Treatment Outcome of Hospitalized Psychiatric Patients. S151, 354. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Klungel, O. H., Rietveld, M., de Groot, M. C. H., Stolk, R. P., Postma, M. J., Leufkens, H. G. M., Egberts, A. C. G., Hövels, A. M., van de Langerijt, L., de Bruijn, W., Hoes, A. W., & Grobbee, D. E. (2010). The Mondriaan Project: The Dutch Healthcare Landscape as a Population Laboratory. S177, 418. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Karapinar, F., Borgsteede, S. D., Zoer, J., Janssen, M. J. A., Egberts, A. C. G., van den Bemt, P. M. L. A., & van Tulder, M. (2010). Economic Evaluation of an Inpatient Medication Reconciliation Process on Medication and Labour Costs. S65, 153. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Gardarsdottir, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Transitions from General Practitioner to Psychiatrist Care (Or Vice Versa) During a First Antidepressant Treatment Episode. S272, 643. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Goedhard, L. E., Stolker, J. J., Nijman, H. L., Egberts, T. C., & Heerdink, E. R. (2010). Trials Assessing Pharmacotherapeutical Management of Aggression in Psychiatric Patients: Comparability with Clinical Practice. S153-S153. Abstract from 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. [Repository]
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, A. C. G. (2010). Evaluation of a Proposed Classification System for Adverse Drug Reactions for Biologicals Using The WHO-ADR Database VigiBase. S126, 295. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Verdel, B. M., Souverein, P. C., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2010). Use of Serotonergic Drugs and the Risk of Bleeding. S166, 390. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
2009
Scholarly publications
Van Den Brand, M. W. M., Pouwels, S., Samson, M. M., Van Staa, T. P., Thio, B., Cooper, C., Leufkens, H. G. M., Egberts, A. C. G., Verhaar, H. J. J., & De Vries, F. (2009). Erratum: Use of anti-depressants and the risk of fracture of the hip or femur (Osteoporos Int (DOI 10.1007/s00198-009-0849-6)). Osteoporosis International, 20, 1715. [DOI] [Portal]
Arbouw, M., Movig, K., van Staa, T., Egberts, T., Souverein, P., & de Vries, F. (2009). Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study. Pharmacoepidemiology and Drug Safety, 18, S201-S202.
Ten Berg, M. J., Van Den Bemt, P. M. L. A., Huisman, A., Schobben, A. F. A. M., Egberts, T. C. G., & Van Solinge, W. W. (2009). Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. Annals of Pharmacotherapy, 43(9), 1405-1412. [DOI]
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2009). Unexpected lower prevalence of depression in patients with diabetes: Selection bias in a waiting room population. Epidemiology, 20(3), 419-423. [DOI]
Knol, W., Keijsers, C. J. P. W., Jansen, P. A. F., Belitser, S. V., Schobben, A. F. A. M., Egberts, A. C. G., & van Marum, R. J. (2009). Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced Parkinsonism in the elderly. International Journal of Geriatric Psychiatry, 24(2), 183-189. [DOI]
Karapinar-Çarkit, F., Borgsteede, S. D., Zoer, J., Smit, H. J., Egberts, A. C. G., & Van Den Bemt, P. M. L. A. (2009). Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Annals of Pharmacotherapy, 43(6), 1001-1010. [DOI]
van Doormaal, J. E., van den Bemt, P. M. L. A., Zaal, R. J., Egberts, A. C. G., Lenderink, B. W., Kosterink, J. G. W., Haaijer-Ruskamp, F. M., & Mol, P. G. M. (2009). The Influence that Electronic Prescribing Has on Medication Errors and Preventable Adverse Drug Events: an Interrupted Time-series Study. Journal of the American Medical Informatics Association, 16(6), 816-825. [DOI] [Portal]
Zwart-Van Rijkom, J. E. F., Uijtendaal, E. V., Ten Berg, M. J., Van Solinge, W. W., & Egberts, A. C. G. (2009). Frequency and nature of drug-drug interactions in a Dutch university hospital. British Journal of Clinical Pharmacology, 68(2), 187-193. [DOI]
Stuijt, C. C. M., Franssen, E. J. F., Egberts, A. C. G., & Hudson, S. A. (2009). Reliability of the medication appropriateness index in Dutch residential home. Pharmacy World and Science, 31(3), 380-386. [DOI]
Van Geffen, E. C. G., Kruijtbosch, M., Egberts, A. C. G., Heerdink, E. R., & Van Hulten, R. (2009). Patients' perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment: Implications for community pharmacy. Annals of Pharmacotherapy, 43(4), 642-649. [DOI] [Portal]
Klungel, O. H., Rietveld, A. C. M., De Groot, M. C., Stolk, R. P., Postma, M. J., Leufkens, H. G., Egberts, T. C., Hövels, A. M., van de Langerijt, L., Hoes, A. W., & Grobbee, D. E. (2009). The mondriaan project: The dutch health care landscape as a population laboratory. Value in Health, 12(7), 392.
Brassé, B. P., Roijers, J. F. M., Chahid, Y., Van Geest-Daalderop, J. H. H., De Vries-Goldschmeding, H., Van Wijk, E. M., De Boer, A., Egberts, A. C. G., & Schalekamp, T. (2009). VKORC1 en CYP2C9 genotype beinvloeden acenocoumarol antistolling: Interactie tussen genotypes en overantistolling. Pharmaceutisch Weekblad, 144(4), 4-8.
Willemen, M. J. C., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Leufkens, H. G. M., Egberts, A. C. G., & Sturkenboom, M. C. J. M. (2009). Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti-obesity drugs. Pharmacoepidemiology and Drug Safety, 18(7), 631-8. [DOI]
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Egberts, T. C. G., Blackburn, S., Persson, I., & Leufkens, H. G. M. (2009). Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval. Drug Safety, 32(12), 1175-87. [DOI]
Gardarsdottir, H., Egberts, T. C., Stolker, J. J., & Heerdink, E. R. (2009). Gardarsdottir et al. Respond to "Assessing Treatment Effects With Observational Analyses". American Journal of Epidemiology, 170(3), 288-288. [DOI]
van Geffen, E. C. G., Gardarsdottir, H., van Hulten, R., van Dijk, L., Egberts, A. C. G., & Heerdink, E. R. (2009). Initiation of antidepressant therapy: do patients follow the GP's prescription? British Journal of General Practice, 59(559), 81-87. [DOI]
Gardarsdottir, H., van Geffen, E. C. G., Stolker, J. J., Egberts, T. C. G., & Heerdink, E. R. (2009). Does the Length of the First Antidepressant Treatment Episode Influence Risk and Time to a Second Episode? Journal of Clinical Psychopharmacology, 29(1), 69-72. [DOI]
Gardarsdottir, H., Egberts, T. C., Stolker, J. J., & Heerdink, E. R. (2009). Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias. American Journal of Epidemiology, 170(3), 280-285. [DOI]
Mulder, H., Cohen, D., Scheffer, H., Gispen-de Wied, C. C., Arends, J., Wilmink, F. W., & Egberts, A. C. G. (2009). HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. Journal of Clinical Psychopharmacology, 29(1), 16-20.
Wilting, I., Egberts, A. C. G., Heerdink, E. R., Ververs, F. F. T., Meulenbelt, J., & Nolen, W. A. (2009). Evaluation of available treatment guidelines for the management of lithium intoxication. Therapeutic Drug Monitoring, 31(2), 247-260.
van Doormaal, J. E., van den Bemt, P. M. L. A., Zaal, R. J., Egberts, A. C. G., Lenderink, A. W., Kosterink, J. G. W., Haaijer-Ruskamp, F. M., & Mol, P. G. M. (2009). The influence that electronic prescribing has on medciation errors and preventable adverse drug events: an interrupted time-series study. Journal of the American Medical Informatics Association, 16, 816-825.
van den Brand, M. W. M., Pouwels, S., Samson, M. M., van Staa, T. P., Thio, B., Cooper, C., Leufkens, H. G. M., Egberts, A. C. G., Verhaar, H. J. J., & de Vries, F. (2009). Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporosis International, 20(10), 1705-1713. [DOI]
Geerts, A. F. J., de Koning, G. H. P., de Smet, P. G. A. M., van Solinge, W. W., & Egberts, A. C. G. (2009). Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions. A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmacies. Drug Safety, 32(12), 1189-1197.
Zwart-van Rijkdom, J. E. F., Uijtendaal, E. V., ten Berg, M. J., van Solinge, W. W., & Egberts, A. C. G. (2009). Frequency and nature of drug-drug interactions in a Dutch university hospital. British Journal of Clinical Pharmacology, 68(2), 187-193.
Karapinar-Carkit, F., Borgsteede, S. D., Zoer, J., Smit, H. J., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2009). Effect of medication reconcilation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Annals of Pharmacotherapy, 43(6), 1001-1010.
Verdel, B. M., Souverein, P. C., Meyboom, R. H. B., Kardaun, S. H., Leufkens, H. G. M., & Egberts, A. C. G. (2009). Risk of drug-induced photosensitivity: focus on spectroscopic and molecular characteristics. Pharmacoepidemiology and Drug Safety, 18(5), 602-609.
van Doormaal, J. E., van den Bemt, P. M. L. A., Mol, P. G. M., Zaal, R. J., Egberts, A. C. G., Haaijer-Ruskamp, F. M., & Kosterink, J. G. W. (2009). Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Quality & safety in health care, 18(1), 22-27.
Floor-Schreudering, A., de Smet, P. G. A. M., Buurma, H., Egberts, A. C. G., & Bouvy, M. L. (2009). Documentation Quality in Community Pharmacy: Completeness of Electronic Patient Records after Patients' First Visits. Annals of Pharmacotherapy, 43, 1787-1794.
ten Berg, M. J., van Solinge, W. W., van den Bemt, P. M. L. A., Huisman, A., Schobben, A. F. A. M., & Egberts, A. C. G. (2009). Platelet measurements versus discharge diagnoses for identification of patients with potential drug-induced thrombocytopenia: a cross-sectional study in the Netherlands. Drug Safety, 32(1), 69-76.
Arbouw, M. E. L., Movig, K. L. L., Egberts, A. C. G., Poels, P. J. E., van Vugt, J. P. P., Wessels, J. A. M., van der Straaten, R. J., Neef, C., & Guchelaar, H. J. (2009). Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease. European Journal of Clinical Pharmacology, 65, 1245-1251.
Kleijer, B. C., van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., Knol, W., & Heerdink, E. R. (2009). Risk of cerebrovascular events in elderly users of antipsychotics. Journal of Psychopharmacology, 23(8), 909-914.
Kleijer, B. C., van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., Frijters, D., Heerdink, E. R., & Ribbe, M. (2009). The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, 21(5), 931-940.
Knol, M. J., Geerlings, M. I., Grobbee, D. E., Egberts, A. C. G., & Heerdink, E. R. (2009). Antidepressant use before and after initiation of diabetes mellitus treatment. Diabetologia, 52(3), 425-432. http://www.springerlink.com/content/u324jr7323l70536/fulltext.pdf
Wilting, I., Heerdink, E. R., Mersch, P. P. A., den Boer, J. A., Egberts, A. C. G., & Nolen, W. A. (2009). Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study. Bipolar Disorders, 11, 434-440.
Bartelink, I. H., Bredius, R. G. M., Belitser, S., Suttorp, M. J., Bierings, M. B., Knibbe, C. A. J., Egeler, R. M., Lankester, A. C., Egberts, A. C. G., Zwaveling, J., & Boelens, J. J. (2009). Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation. Biology of Blood and Marrow Transplantation, 15, 231-241.
van der Wammes-van der Heijden, E. A., Tijssen, C. C., & Egberts, A. C. G. (2009). Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile. Cephalalgia, 29, 322-330.
Gardarsdottir, H., Egberts, A. C. G., van Dijk, L., Sturkenboom, M. C. J. M., & Heerdink, E. R. (2009). An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiology and Drug Safety, 18(1), 7-15. [DOI]
van Rosse, F., Maat, B., Rademaker, C. M. A., van Vught, A. J., Egberts, A. C. G., & Bollen, C. W. (2009). The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review. Pediatrics, 123(4), 1184-1190.
Gregoor, J. G., van der Weide, J., Mulder, H., Cohen, D., van Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2009). Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication. Journal of Clinical Psychopharmacology, 29(1), 21-25.
Ververs, F. F. T., van Wensen, K., Freund, M. W., van der Heide, M., Visser, G. H. A., Schobben, A. F. A. M., van den Berg Jong, L. T. W., & Egberts, A. C. G. (2009). Association between antidepressant drug use during pregnancy and child healthcare utilisation. BJOG - An International Journal of Obstetrics and Gynaecology, 116(12), 1568-1577.
Ververs, F. F. T., Voorbij, H. A. M., Zwarts, P., Belitser, S., Egberts, A. C. G., Visser, G. H. A., & Schobben, A. F. A. M. (2009). Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy. Clinical Pharmacokinetics, 48, 677-683.
ten Berg, M. J., van den Bemt, P. M. L. A., Huisman, A., Schobben, A. F. A. M., Egberts, A. C. G., & van Solinge, W. W. (2009). Compliance with Platelet Count Monitoring Recommendations and Management of Possible Heparin-Induced Thrombocytopenia in Hospitalized Patients Reiceving Low-Molecular-Weight Heparin. Annals of Pharmacotherapy, 43, 1405-1412.
Leufkens, H. G. M., & Egberts, A. C. G. (2009). Pharmacovigilance: from signal to action. In Clinical Nephrotoxins (pp. 85-90). Springer.
Stuijt, C. C. M., Franssen, E. J. F., Egberts, A. C. G., & Hudson, S. A. (2009). Reliability of the mediciation appropriateness index in Dutch residential home. Pharmacy World & Science, 31(3), 380-386.
Derijks, H. J., Janknegt, R., Heerdink, E. R., De Koning, F. H. P., Krekels, M. M., Looij, B. J., & Egberts, A. C. G. (2009). Influence of antidepressant use on glycemic control in patients with diabetes mellitus: An open-label comparative study. Journal of Clinical Psychopharmacology, 29(4), 405-408. [DOI]
Vinks, M. H. A. M., Egberts, A. C. G., de Lange, T. M., & De Koning, F. H. P. (2009). Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs & Aging, 26(2), 123-133.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2009). Unexpected lower prevalence of depression in patients with diabetes. Epidemiology, 20(3), 419-423. http://www.ncbi.nlm.nih.gov/pubmed/19289958?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=11
Knol, W., Keijsers, C. J. P. W., Jansen, P. A. F., Belitser, S. V., Schobben, A. F. A. M., Egberts, A. C. G., & van Marum, R. J. (2009). Validity and reliability of the Simpson-Angus Scale (SAS) in dry induced Parkinsonism in the elderly. International Journal of Geriatric Psychiatry, 24(2), 183-189.
van Geffen, E. C. G., Kruijtbosch, M., Egberts, A. C. G., Heerdink, E. R., & van Hulten, R. (2009). Patients perceptions of information received at the start of selective serotonin reuptake inhibitors: implications for community pharmacy. Annals of Pharmacotherapy, 43(5), 642-649.
Professional publications
Brassé, B. P., Roijers, J. F. M., Chahid, Y., Van Geest-Daalderop, J. H. H., De Vries-Goldschmeding, H., Van Wijk, E. M., De Boer, A., Egberts, A. C. G., & Schalekamp, T. (2009). Invloed van de genotypen VKORC1 en CYP2C9 op acenocoumarol-dosisbehoefte: Interactie tussen genotypen bepaalt overontstolling. Pharmaceutisch Weekblad, 144(4), 4-8.
Bartelink, I. H., Bredius, R. G. M., Belitser, S. V., Knibbe, C. A. J., Egberts, A. C. G., Zwaveling, J., & Boelens, J. J. (2009). Associatie tussen blootstelling aan busulfan en behandel- Resultaten bij kinderen die beenmergtransplantatie ondergaan. Pharmaceutisch Weekblad, 144(12), 49-52.
Derijks, H. J., Meyboom, R. H. B., Heerdink, E. R., de Koning, G. H. P., Janknegt, R., Lindquist, M., & Egberts, A. C. G. (2009). Associatie tussen antidepressivagebruik en glucosedisregulatie: bewijs op basis van bijwerkingenmelding. Pharmaceutisch Weekblad, 3(2), 22-27.
Stuijt, C. C. M., Franssen, E. J. F., Egberts, A. C. G., & Hudson, S. A. (2009). Effect van door een apotheker geleide medicatiereviews op de voorschrijfkwaliteit voor verpleeghuisbewoners. Pharmaceutisch Weekblad, 3(2), 28-33.
Smink, B. E., & Egberts, A. C. G. (2009). The relationship between drug use and traffic accident severity. In JC. Verster, SR. Pandi-Perumal, JG. Ramaekers, & JJ. de Gier (Eds.), Drugs, Driving and Traffic Safety (pp. 135-150). Birkhäuser Verlag AG.
Bartelink, I. H., Bredius, R. G. M., Belitser, S. V., Knibbe, C. A. J., Egberts, A. C. G., Zwaveling, J., & Boelens, J. J. (2009). Associatie tussen blootstelling aan busulfan en behandelresultaten bij kinderen die beenmergtransplantatie ondergaan. Pharmaceutisch Weekblad, 3(3), 49-52.
Butterhoff-Terlingen, M. H., Stuffken, R., Egberts, A. C. G., Heerdink, E. R., van Marum, R. J., & Kalisvaart, K. J. (2009). Vergelijking van meetmethoden voor anticholinerge belasting door geneesmiddelen en de relatie met delier bij ouderen die een heupoperatie ondergaan. Pharmaceutisch Weekblad, 3(10), 178-182.
Brassé, B. P., Chahid, Y., Roijers, J. F. M., van Geest-Daalderop, J. H. H., de Vries-Goldschmeding, H., van Wijk, E. M., de Boer, A., & Egberts, A. C. G. (2009). Invloed van de genotypen VKORC1en CYP2C9 op acenocoumarol-dosisbehoefte. Interactie tussen genotypen bepaalt overstolling. Pharmaceutisch Weekblad, 2009(3), 4-8.
Buurma, H., de Gier, J. J., & Egberts, A. C. G. (2009). De apotheker als zorgverlener. In H. Buurma, HJ. Beudeker, LTW. de Jong - van den Berg, & HGM. Leufkens (Eds.), Het geneesmiddel (pp. 137-160). Elsevier Gezondheidszorg.
Other output
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Souverein, P. C., Schuurmans, M. J., & Egberts, A. C. G. (2009). Prescription Changes and Chronic Disease Score as Predictors for Hospitalization. Pharmacoepidemiology and Drug Safety, 18, S102.
Kröger, E., van Marum, R. J., Souverein, P. C., & Egberts, A. C. G. (2009). Factors Associated with Discontinuation of Cholinesterase Inhibitors in the Netherlands. Pharmacoepidemiology and Drug Safety, 18, S109.
van der Baan, F. H., Knol, M. J., de Bruin, M. L., Leufkens, H. G. M., Klungel, O. H., & Egberts, A. C. G. (2009). Impact of a Safety Issue on the Number and Type of Publications: The Example of Sertindole. Pharmacoepidemiology and Drug Safety, 18, S170.
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Meijboom, R. H. B., Leufkens, H. G. M., & Egberts, A. C. G. (2009). Unraveling the safety profile of biologicals using postmarketing safety data. Drug Safety, 32(10), 966.
Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2009). Constructing Drug Treatment Episodes from Individual Dispensed Prescriptions: The Influence of the Gap-Length. Pharmacoepidemiology and Drug Safety, 18, S63.
Arbouw, M. E. L., Movig, K. L. L., Egberts, A. C. G., Poels, P. J. E., van Vugt, J. P. P., Wessels, J. G. H., van der Straaten, T. R. J. H. M., Neef, C., & Guchelaar, H. J. (2009). Pharmacogenetic Determinants for Discontinuation of Non-Ergoline Dopamine Agonists in Parkinson's Disease. Pharmacoepidemiology and Drug Safety, 18, S163.
Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., & de Vries, F. (2009). Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study. Pharmacoepidemiology and Drug Safety, 18, S201.
2008
Scholarly publications
Handoko, K. B., Van Puijenbroek, E. P., Bijl, A. H., Hermens, W. A. J. J., Zwart-Van Rijkom, J. E. F., Hekster, Y. A., & Egberts, T. C. G. (2008). Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: The role of the aromatic ring. Drug Safety, 31(8), 695-702. [DOI] [Portal]
Stuijt, C. C. M., Franssen, E. J. F., Egberts, A. C. G., & Hudson, S. A. (2008). Appropriateness of prescribing among elderly patients in a Dutch residential home: Observational study of outcomes after a pharmacist-led medication review. Drugs and Aging, 25(11), 947-954. [DOI]
Knol, W., Van Marum, R. J., Jansen, P. A. F., Souverein, P. C., Schobben, A. F. A. M., & Egberts, A. C. G. (2008). Antipsychotic drug use and risk of pneumonia in elderly people. Journal of the American Geriatrics Society, 56(4), 661-666. [DOI]
Swen, J. J., Wilting, I., De Goede, A. L., Grandia, L., Mulder, H., Touw, D. J., De Boer, A., Conemans, J. M. H., Egberts, T. C. G., Klungel, O. H., Koopmans, R., Van Der Weide, J., Wilffert, B., Guchelaar, H.-J., & Deneer, V. H. M. (2008). Corrigendum: Pharmacogenetics: From bench to byte (Clinical Pharmacology and Therapeutics (2008) 83, 5, (781-787) DOI: 10.1038/sj.clpt.6100507). Clinical Pharmacology and Therapeutics, 84(1), 175. [DOI]
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Schellekens, H., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA - The Journal of The American Medical Association, 300(16), 1887-1896. [DOI]
Swen, J. J., Wilting, I., de Goede, A. L., Grandia, L., Mulder, H., Touw, D. J., de Boer, A., Conemans, J. M. H., Egberts, T. C. G., Klungel, O. H., Koopmans, R., van der Weide, J., Wilffert, B., Guchelaar, H.-J., & Deneer, V. H. M. (2008). Pharmacogenetics: from bench to byte. Clinical Pharmacology and Therapeutics, 83(5), 781-787. [DOI]
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Gorter, K. J., Grobbee, D. E., & Egberts, A. C. G. (2008). Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiology and Drug Safety, 17(6), 577-586.
Tlusta, E., Handoko, K. B., Majoie, M., Egberts, A. C. G., Vlcek, J., & Heerdink, E. R. (2008). Clinical relevance of patients with epilepsy included in clinical trials. Epilepsia, 49(8), 1479-1480.
Gregoor, J. G., van der Weide, J., Mulder, J., van Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2008). Polymorphisms of the LEP- and LEPR Gene and Obesity in Psychiatric Patients Using Antipsychotic Medication. In Pharmacoepidemiology and Drug Safety (pp. S203)
Derijks, H. J., Meyboom, R. H. B., Heerdink, E. R., de Koning, G. H. P., Janknegt, R., Lindquist, M., & Egberts, A. C. G. (2008). The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. European Journal of Clinical Pharmacology, 64, 531-538.
Buurma, H., Bouvy, M. L., de Smet, P. G. A. M., Floor-Schreudering, A., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Prevalence and determinants of pharmacy shopping behaviour. Journal of Clinical Pharmacy and Therapeutics, 33, 17-23.
Handoko, K. B., Zwart-van Rijkom, J. E. F., Visee, H. F., Hermens, W. A. J. J., Hekster, Y. A., & Egberts, A. C. G. (2008). Drug treatment-related factors of inadequate seizure control. Epilepsy & Behavior, 13, 545-548.
Kuijpers, M. A. J., van Marum, R. J., Egberts, A. C. G., & Jansen, P. A. F. (2008). Relationship between polypharmacy and underprescribing. British Journal of Clinical Pharmacology, 65(1), 130-133. [Repository]
Wilting, I., Egberts, A. C. G., Movig, K. L. L., van Laarhoven, J. H. M., Heerdink, E. R., & Nolen, W. A. (2008). The Association between Concomitant Use of Serotonergic Antidepressants and Lithium-Induced Polyuria. A Multicenter Medical Chart Review Study. Pharmacopsychiatry, 41, 129-133.
Wilting, I., Souverein, P. C., Nolen, W. A., Egberts, A. C. G., & Heerdink, E. R. (2008). Changes in outpatient lithium treatment in the Netherlands during 1996-2005. Journal of Affective Disorders, 111, 94-99.
Hougardy, D. M. C., Egberts, A. C. G., van der Graaf, F., Brenninkmeijer, V. J., & Derijks, L. J. J. (2008). Serotonin transporter polymorphism and bleeding time during SSRI therapy. British Journal of Clinical Pharmacology, 65(5), 761-766. [Repository]
Smink, B. E., Hofman, B. J. A., Dijkhuizen, A., Lusthof, K. J., de Gier, J. J., Egberts, A. C. G., & Uges, D. R. A. (2008). The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. British Journal of Clinical Pharmacology, 66(4), 556-560.
van Melick, E. J., Meinders, A. E., Hoffman, T. O., & Egberts, A. C. G. (2008). Renal effects of long-term lithium therapy in the elderly: a cross-sectional study. International Journal of Geriatric Psychiatry, 2008(23), 685-692.
Waller, P., Beard, K., Egberts, A. C. G., Evans, S., Hallas, J., Hasford, J., Laporte, J. R., Moore, N., Shakir, S., & Sturkenboom, M. (2008). European commission consultation on pharmacovigilance. Pharmacoepidemiology and Drug Safety, 17, 108-109.
Stuijt, C. C. M., Franssen, E. J. F., Egberts, A. C. G., & Hudson, S. A. (2008). Appropriateness of Prescribing among Elderly Patients in a Dutch Residential Home. Drugs & Aging, 25(11), 947-954.
Arbouw, M. E. L., Movig, K. L. L., Guchelaar, H. J., Poels, P. J. E., van Vugt, J. P. P., Neef, C., & Egberts, A. C. G. (2008). Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials. European Journal of Clinical Pharmacology, 64, 1021-1026.
Willemen, M. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Leufkens, H. G., & Egberts, A. C. G. (2008). Psychiatric and Cardiovascular Comorbidities in Patients With Diabetes Mellitus Starting Antiobesity Drugs. Obesity Research, 16(10), 2331-2335.
Stuffken, R., Heerdink, E. R., De Koning, F. H. P., Souverein, P. C., & Egberts, A. C. G. (2008). Association Between Hospitalization and Discontinuity of Medication Therapy Used in the Community Setting in the Netherlands. Annals of Pharmacotherapy, 42, 933-939.
Handoko, K. B., van Puijenbroek, E. P., Bijl, A. H., Hermens, W. A. J. J., Zwart-van Rijkom, J. E. F., Hekster, Y. A., & Egberts, A. C. G. (2008). Influence of Chemical Structure on Hypersensitivity Reactions Induces by Antiepileptic Drugs. Drug Safety, 31(8), 695-702.
van Doormaal, J. E., Mol, P. G. M., van den Bemt, P. M. L. A., Zaal, R. J., Egberts, A. C. G., Kosterink, J. G. W., & Haaijer-Ruskamp, F. M. (2008). Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiology and Drug Safety, 17, 645-654.
Derijks, H. J., Heerdink, E. R., de Koning, F. H., Janknegt, R., Klungel, O. H., & Egberts, A. C. G. (2008). The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiology and Drug Safety, 2008(17), 336-344.
Derijks, H. J., Heerdink, E. R., Janknegt, R., De Koning, F. H. P., Olivier, B., Loonen, A. J. M., & Egberts, A. C. G. (2008). Visualizing pharmacological activities of antidepressants: A novel approach. The Open Pharmacology Journal, 2, 54-62. [DOI] [Repository]
Layton, D., Souverein, P. C., Heerdink, E. R., Shakir, S. A., & Egberts, A. C. G. (2008). Prescriber adoption of newly approved selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety, 2008(17), 1168-1174.
Smink, B. E., Lusthof, K. J., de Gier, J. J., Uges, D. R. A., & Egberts, A. C. G. (2008). The relation between the blood benzodiazepine concentration and perfomance in suspected impaired drivers. Journal of Forensic and Legal Medicine, 15, 483-488.
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Drug-Related Nephrotoxic and Ototoxic Reactions: A Link through a Predictive Mechanistic Commonality. Drug Safety, 31(10), 877-884.
van Geffen, E. C. G., van Hulten, R., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2008). Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor Treatment. Annals of Pharmacotherapy, 42, 218-225.
Layton, D., Souverein, P. C., Heerink, E. R., Shakir, S. A. W., & Egberts, A. C. G. (2008). Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands. Drug Safety, 31(2), 143-158. [Repository]
Smink, B. E., Movig, K. L. L., Lusthof, K. J., de Gier, J. J., Uges, D. R. A., & Egberts, A. C. G. (2008). The Relation Between the Use of Psychoactive Substances and the Severity of the Injury in a Group of Crash-Involved Drivers Admitted to a Regional Trauma Center. Traffic Injury Prevention, 9, 105-110. [Repository]
Leendertse, A. J., Egberts, A. C. G., Stoker, L. J., & van den Bemt, P. M. L. A. (2008). Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands. Archives of Internal Medicine, 168(17), 1890-1896.
Knol, W., van Marum, R. J., Jansen, P. A. F., Souverein, P. C., Schobben, A. F. A. M., & Egberts, A. C. G. (2008). Antipsychotic Drug Use and Risk of Pneumonia in Eldery People. Journal of the American Geriatrics Society, 56(4), 661-666.
Professional publications
Wilting, I., van Laarhoven, J. H. M., de Koning-Verest, I. F., & Egberts, A. C. G. (2008). Krullen bij gebruik van valproinezuur. Psyfar, 3, 32-34.
Van Geffen, E. C. G., Brugman, M., Van Hulten, R., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2008). Vragen en problemen bij stoppen met antidepressiva. Pharmaceutisch Weekblad, 2(5), 106-108.
Stolker, J. J., Scheifes, A., Egberts, A. C. G., & Heerdink, E. R. (2008). Antipsychotica ten onrechte voorgeschreven aan mensen met een verstandelijke beperking en probleemgedrag met agressie. Nederlands Tijdschrift voor Geneeskunde, 152(27), 1501-1502.
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Lithium: farmacologie in de psychiatrie. Neuropraxis, 5, 147-153.
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Samenhang tussen serumspiegels, bijwerkingen en stemming. Lithium, een waardevol zorgenkind. Pharmaceutisch Weekblad, 51, 24-27.
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Nier en binnenoor delen iontransportsysteem. Pharmaceutisch Weekblad, 23 mei(2008), 20-22. [Repository]
Handoko, K. B., Majoie, H. J. M., Hermans, M., Hermens, W. A. J. J., Zwart-van Rijkom, J. E. F., Hekster, Y. A., & Egberts, A. C. G. (2008). Rol van P-glycoproteïne bij therapieresistente epilepsie ondergeschikt. Pharmaceutisch Weekblad, 2(9), 203-207.
Derijks, L. J. J., Derijks, H. J., Touw, D. J., Conemans, J. M. H., & Egberts, A. C. G. (2008). Pharmacogenetics in clinical practice. EJHP Practice, 14(1), 25-29.
van den Broek, M., Rademaker, K. M. A., Rongen, H. A. H., & Egberts, A. C. G. (2008). Geneesmiddelen bij overgewicht complex. Ook vetvrije massa van invloed op dosering. Pharmaceutisch Weekblad, 143(49), 32-34.
Arbouw, M. E. L., Movig, K. L. L., Guchelaar, H. J., Poels, P. J. E., van Vugt, J. P. P., Neef, C., & Egberts, A. C. G. (2008). Discontinueren van ropinirol of pramipexol door parkinsonpatienten. Patiëntkarakteristieken en incidentie in de klinische praktijk vergeleken met klinische studies. Pharmaceutisch Weekblad, 2(1), 14-18. [Repository]
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Lithium, een waardevol zorgenkind. Samenhang tussen serumspiegels, bijwerkingen en stemming. Pharmaceutisch Weekblad, 2008(19 december), 24-26.
Other output
Gardarsdottir, H., Egberts, T. C. G., & Heerdink, E. R. (2008). Neglected and immortal time bias in observational studies: Antidepressant drug use and risk of relapse/recurrence. Pharmacoepidemiology and Drug Safety, 17, S135-S136.
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2008). Evaluating Prescriber Characteristics Associated with NSAID Prescribing Practices in the Netherlands. S66. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2008). Unexpected Lower Prevalence of Depression in Patients with Diabetes: Potential for Selection Bias in Waiting Room Population. S253. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
van Rosse, F., Maat, B., Rademaker, C. M. A., van Vught, A. J., Egberts, A. C. G., & Bollen, C. W. (2008). The effect of computerized physician order entry in pediatric and intensive care: a systematic review. Poster session presented at 11th biannual ESDP congress, Rotterdam.
van Doormaal, J. J., Zaal, R. J., Mol, P., Haaijer-Ruskamp, F. M., Egberts, A. C. G., Lenderink, A. W., & van den Bemt, P. M. L. A. (2008). Effect of a Computerized Physician Order Entry (CPOE) System on Prescribing Errors and Preventable Adverse Drug Events (pADEs). S6. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Egberts, A. C. G., Persson, I., & Leufkens, H. G. M. (2008). Methodological Analysis of Post-Authorisation Safety Studies as Part of the First Cohort of Risk Management Plans: Small Molecules vs. Biologicals. S189. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Gardarsdottir, H., Egberts, A. C. G., van Dijk, C. E. M. J., Sturkenboom, M. C. J. M., & Heerdink, E. R. (2008). An Algorithm To Identify Antidepressant Users with a Diagnosis of Depression from Prescription Data. S1. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Willemen, M. J. C., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Egberts, A. C. G., Leufkens, H. G. M., & Sturkenboom, M. C. J. M. (2008). Patients Starting Anti-Obesity Drugs Carry Higher Psychiatric and Cardiovascular Risk. S178. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Oostveen, M. I., Rademaker, C. M. A., Krediet, T. G., Egberts, A. C. G., & Bollen, C. W. (2008). Improved efficiency and consistent accuracy in prescribing glucose intake using a Computer Assisted Prescribing and Calculation system (CPOE) in the Neonatal Intensive Care Unig (NICU). Poster session presented at 11th biannual ESDP congress, Rotterdam.
Arbouw, M. E. L., Movig, K. L. L., Guchelaar, H. J., Neef, C., & Egberts, A. C. G. (2008). Risk of Ischemic Events among Patients with Parkinson's Disease Using Dopamine Agonists. S21. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Tlusta, E., Handoko, K. B., Majoie, M., Egberts, A. C. G., Vlcek, J., & Heerdink, E. R. (2008). Highly Selected Subset of Clinical Patients with Epilepsy Qualifies for Antiepileptic Drug Trials. S30. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
ten Berg, M. J., van den Bemt, P. M. L. A., Huisman, A., Schobben, A. F. A. M., Egberts, A. C. G., & van Solinge, W. W. (2008). Adherence to Guidelines for Monitoring for Heparin-Induced Thrombocytopenia in Patients Treated with Low Molecular Weight Heparin. 463-464. Abstract from ASH Annual Meeting.
Verdel, B. M., Souverein, P. C., Meyboom, R. H. B., Leufkens, H. G. M., & Egberts, A. C. G. (2008). Photochemical and Other Molecular Characteristics and the Risk of Drug-Related Photosensitivity. S113. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
2007
Scholarly publications
Thio, B. M. K. S., de Vries, F., Egberts, T. C. G., Leufkens, H. G. M., & van Staa, T. P. (2007). Use of selective serotonin reuptake inhibitors and risk of hip/femur fractures: A population-based case-control study. Calcified Tissue International, 80, S26-S27.
Schalekamp, T., Brassé, B. P., Roijers, J. F. M., van Meegen, E., van der Meer, F. J. M., van Wijk, E. M., Egberts, A. C. G., & de Boer, A. (2007). VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement. Clinical Pharmacology and Therapeutics, 81(2), 185-193. [DOI]
Wilting, I., Fase, S., Martens, E. P., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2007). The impact of environmental temperature on lithium serum levels. Bipolar Disorders, 2007(9), 603-608. [Repository]
Handoko, K. B., Zwart-van Rijkom, J. E. F., Hermens, W. A. J. J., Souverein, P. C., & Egberts, A. C. G. (2007). Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiology and Drug Safety, 16, 189-196. [Repository]
van Geffen, E. C. G., van der Wal, S. W., van Hulten, R., de Groot, M. C., Egberts, A. C. G., & Heerdink, E. R. (2007). Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. European Journal of Clinical Pharmacology, 2007(63), 1193-1199. [Repository]
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Association between aggression and medication changes. In P. Callaghan, T. Palmstierna, H. Nijman, & N. Oud (Eds.), Violence in Clinical Psychiatry: proceedings of the 5th European congress (pp. 82-83). Kananah.
Stolk, P., Souverein, P. C., Leufkens, H. G. M., Weil, J. G., Egberts, A. C. G., & Heerdink, E. R. (2007). The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. Pharmacopsychiatry, 40, 111-115. [Repository]
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Geerlings, M. I., Gorter, K. J., Numans, M. E., Grobbee, D. E., Klungel, O. H., & Burger, H. (2007). Depressive symptoms in subjects with diagnosed and undiagnosed Type 2 diabetes. Psychosomatic Medicine, 69(4), 300-305. [Repository]
Mulder, J., Aart-van der Beek van der, A., Franke, B., Arends, J., Wilmink, F. W., Scheffer, H., & Egberts, A. C. G. (2007). The association between HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia. Journal of Clinical Psychopharmacology, 27(4), 338-343. [Repository]
Wilting, I., van den Bemt, P. M. L. A., Brenninkmeijer, S. J., Spooren, P. F. M. J., Siemons, A. A., & Egberts, A. C. G. (2007). Invloed van een maagband op farmacotherapie: nog weinig bekend. Nederlands Tijdschrift voor Geneeskunde, 151(20), 1112-1115. [Repository]
Stolker, J. J., Goedhard, L. E., Egberts, A. C. G., & Heerdink, E. R. (2007). Treatment of aggression with psychotropic drugs: bridge between evidence based practice and practice based evidence. In P. Callaghan, T. Palmstierna, H. Nijman, & N. Oud (Eds.), Violence in Clinical Psychiatry: proceedings of the 5th European congreass (pp. 308-313). Kavanah.
Wilting, I., Baumgarten, R., Movig, K. L. L., van Laarhoven, J., Apperloo, A. J., Nolen, W. A., Heerdink, E. R., Knoers, V. A. M., & Egberts, A. C. G. (2007). Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration. European Journal of Pharmacology, 566(2007), 50-57. [Repository]
Arbouw, M. E. L., Movig, K. L. L., Neef, C., Guchelaar, H. J., & Egberts, A. C. G. (2007). Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients. European Journal of Clinical Pharmacology, 63, 181-187. [Repository]
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Aggression of Psychiatric Patients Associated with the Use of As-needed Medication. Pharmacopsychiatry, 2007(40), 25-29. [Repository]
Wilting, I., de Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2007). Lithium use and the risk of fractures. Bone, 40(5), 1252-1258. [DOI]
Buurma, H., Schalekamp, T., Egberts, A. C. G., & de Smet, A. G. M. (2007). Compliance with National Guidelines for the Management of Drug-Drug Interactions in Dutch Community Pharmacies. Annals of Pharmacotherapy, 41, 2024-2031. [Repository]
Mulder, J., Franke, B., Aart-van der Beek, A., Arends, J., Wilmink, F. W., Egberts, A. C. G., & Scheffer, H. (2007). The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics; a cross-sectional study. The Pharmacogenomics Journal, 7(5), 318-324. [DOI]
Mulder, J., Heerdink, E. R., van Iersel, E. E., Wilmink, F. W., & Egberts, A. C. G. (2007). Prevalence of Patients Using Drugs Metabolized by Cytochrome P450 2D6 in Different Populations: a Cross Sectional Study. Annals of Pharmacotherapy, 41, 408-413. [Repository]
ten Berg, M. J., Huisman, A., van den Bemt, P. M. L. A., Schobben, A. F. A. M., Egberts, A. C. G., & van Solinge, W. W. (2007). Linking Laboratory and medication data: new opportunities for pharmacoepidemiological research. Clinical Chemistry and Laboratory Medicine, 45(1), 13-19. [Repository]
Knol, M. J., Geerlings, M. I., Egberts, A. C. G., Gorter, K. J., Grobbee, D. E., & Heerdink, E. R. (2007). No increased incidence of diabetes in antidepressant users. International Clinical Psychopharmacology, 22(6), 382-386. [Repository]
Egberts, A. C. G. (2007). Signal Detection: historical Background. Drug Safety, 30(7), 607-609. [Repository]
Wilting, I., van Laarhoven, J. H. M., de Koning-Verest, I. F., & Egberts, A. C. G. (2007). Valproic Acid-induced Hair-texture Changes in a White Woman. Epilepsia, 48(2), 400-401. [Repository]
Arbouw, M. E. L., van Vugt, J. P. P., Egberts, A. C. G., & Guchelaar, H. J. (2007). Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Pharmacogenomics, 8(2), 159-176. [Repository]
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2007). Indications for antidepressant drug prescribing in general practice in the Netherlands. Journal of Affective Disorders, 98(1-2), 109-115. [DOI]
Professional publications
Jansen, P. A. F., Van Maanen, A. C., Van Marum, R. J., Van Der Linden, C. M. J., Beers, E., & Egberts, A. C. G. (2007). Systeem voor Individuele Elektronische Pharmacovigilantie biedt uitkomst: Vermijdbare bijwerkingen. Pharmaceutisch Weekblad, 142(15), 32-33.
Buurma, H., de Smet, P., & Egberts, A. C. G. (2007). Risicomanagement in de zorgpraktijk van de openbare apotheker. Huisarts en Wetenschap, 50(12), 623-627.
Jansen, P. A. F., van Maanen, C., van Marum, R. J., van der Linden, C. M. J., Beers, E., & Egberts, A. C. G. (2007). Vermijdbare bijwerkingen. Systeem voor individuele Electronische Pharmacovigilantie biedt uitkomst. Pharmaceutisch Weekblad, 142, 32-34. [Repository]
Giezen, T., Straus, S., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Egberts, A. C. G. (2007). Risk management of biopharmaceuticals: a regulatory perspective. EJHP Practice, 13(6), 72-74. [Repository]
Mulder, J., Egberts, A. C. G., & Wilmink, F. W. (2007). Farmacogenetica compenseert variaties. Pharmaceutisch Weekblad, 2007(140), 32-33. [Repository]
Derijks, H. J., Derijks, L. J., Wilting, I., & Egberts, A. C. G. (2007). Introduction to pharmacogenetics. EJHP Practice, 13(6), 32-36. [Repository]
van den Bemt, P. M. L. A., Leendertse, A. J., & Egberts, A. C. G. (2007). Het HARM-onderzoek: een observationeel multicenteronderzoek naar geneesmiddelgerelateerde ziekenhuisopnames. Bijblijven, 23, 47-56.
Jansen, P. A. F., van Marum, R. J., Linden van der, C. M., Beers, E., & Egberts, A. C. G. (2007). Vermijdbare bijwerkingen. Systeem voor Individuele Elektronische Pharmacovigilantie biedt uitkomst. Medisch Contact, 2007(62), 637-640. [Repository]
Marczinski, S. C., van der Meer, Y. G., van der Beek, M., & Egberts, A. C. G. (2007). Desmopressine preoperatief vermindert bloedverlies bij SSRI-gebruikers: gerandomiseerd, placebogecontroleerd, dubbelblind onderzoek. Pharmaceutisch Weekblad, 1(3), 60-63. [Repository]
van den Bemt, P. M. L. A., & Egberts, A. C. G. (2007). Drug related problems: definitions and classification. EJHP Practice, 2007(13), 62-64. [Repository]
Smals, O. M., Wilting, I., Holwerda, N. J., & Egberts, A. C. G. (2007). Een oudere dame die wel eens flauwvalt, afwachten of toch maar niet. Tijdschrift voor Verpleeghuisgeneeskunde, 32(1), 26-29. [Repository]
Hougardy, D. M. C., Egberts, A. C. G., van der Graaf, F., Brenninkmeijer, V. J., & Derijks, L. J. J. (2007). Invloed van serotoninetransporter-S/L-polymorfisme op bloedingstijd bij paroxetinegebruikers niet aangetoond. Pharmaceutisch Weekblad, 2007(1), 160-163. [Repository]
van Geffen, E. C. G., Brugman, M., van Hulten, R., Bouvy, M. L., & Egberts, A. C. G. (2007). Patients' concerns about and problems experienced with discontinuation of antidepressants. The International Journal of Pharmacy Practice, 2007(15), 291-293. [Repository]
Other output
ten Berg, M. J., Huisman, A., van den Bemt, P. M. L. A., Schobben, A. F. A. M., & Egberts, A. C. G. (2007). Case-Finding of Possible Heparin-Induced Thrombocytopenia in an Academic Teaching Hospital by Linking Laboratory and Medication Data. S51. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Leendertse, A. J., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2007). Frequency and Potential Risk Factors of Hospital Admissions Related to Medication (HARM) in the Netherlands. S27. Abstract from Unknown event, Asilomar, USA.
Willemen, M. J. C., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Leufkens, H. G. M., & Egberts, A. C. G. (2007). Characteristics of Diabetic Patients Starting Anti-Obesity Drugs. P.114. Abstract from ISoP.
Verdel, B. M., van Puijenbroek, E. P., Souverein, P. C., Leufkens, H. G. M., & Egberts, A. C. G. (2007). Auricular and Renal Pharmacovigilance Data Are Linked Through a Predictive Mechanistic Commonality. S251. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Arbouw, M. E. L., Movig, K. L. L., Guchelaar, H. J., Poels, P. J. E., van Vugt, J. P. P., Neef, C., & Egberts, A. C. G. (2007). Persistence of New Dopaminergic Agents in Clinical Practice Remarkably Comparable with Clinical Trial Data. S86. Abstract from Unknown event, Asilomar, USA.
Kleijer, B. C., van Marum, R. J., Knol, W., Egberts, A. C. G., & Heerdink, E. R. (2007). The Temporal Relationship between Antipsychotic Use and Stroke among Community-Dwelling Elderly: Further Support for a Causal Relationship. S074. Abstract from Unknown event, Asilomar, USA.
van Doormaal, J. E., van den Bemt, P. M. L. A., Mol, P. G. M., Zaal, R. J., Egberts, A. C. G., Haaijer-Ruskamp, F. M., & Kosterink, J. G. W. (2007). Medication Errors: Impact of Prescribing and Transcription Errors on Preventable Harm in Hospitalised Patients. S27. Abstract from Unknown event, Asilomar, USA.
van der Hulst, R., Stolker, J. J., Hugenholtz, G. W. K., Egberts, A. C. G., & Heerdink, E. R. (2007). Channelling of Aripiprazole to More Complex Psychiatric Patients. S157. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
van Geffen, E. C. G., Van Hulten, R. P., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2007). Characteristics Associated with Non-Acceptance of Antidepressant Treatment. S221. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Grobbee, D. E., & Egberts, A. C. G. (2007). Influence of Antidepressant Use on Insuline Need in Diabetes Mellitus Patients. S127. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., Souverein, P. C., & Egberts, A. C. G. (2007). Hospitalisation as a Determinant for Discontinuity of Drug Use. P.014. Abstract from ISoP.
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Association between Aggression and Medication Changes. S127. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
van Doormaal, J. E., Mol, P. G. M., Zaal, R. J., van den Bemt, P. M. L. A., & Egberts, A. C. G. (2007). Reliability of a Method for the Assessment of Medication Errors Related Adverse Events. S185. Abstract from Unknown event, Asilomar, USA.
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2007). Nonsteroidal Anti-Inflammatory Drug (NSAID) Utilisation Factors in the Netherlands. P.029. Abstract from ISoP.
Goedhard, L. E., Heerdink, E. R., Stolker, J. J., Nijman, H. L. I., & Egberts, A. C. G. (2007). Leidt agressie tot veranderingen in de reguliere medicatie. S113. Abstract from Unknown event, Asilomar, USA.
Giezen, T. J., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Schellekens, H., Egberts, A. C. G., & Leufkens, H. G. M. (2007). Safety Warning Issues for Biotechnology Derived Pharmaceuticals Approved Since 1995. P.115. Abstract from ISoP.
2006
Scholarly publications
Heerdink, E. R., Stolker, J. J., & Egberts, A. C. G. (2006). Reactie op 'Imago'. Tijdschrift voor Psychiatrie, 48(2), 165-166.
Wilting, I., De Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2006). The risk of fractures in patients currenly or previously using lithium. British Journal of Clinical Pharmacology.
Verdel, B. M., Souverain, P. C., Egberts, A. C. G., & Leufkens, H. G. M. (2006). Difference in risks of allergic reactions to sulfonamide drugs based on chemical structure. Annals of Pharmacotherapy, 40(6), 1040-1046. [DOI]
Wammes-Van Der Heijden, E. A., Rahimtoola, H., Leufkens, H. G. M., Tijssen, C. C., & Egberts, A. C. G. (2006). Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology, 67(7), 1128-1134. [DOI]
Schalekamp, T., Brassé, B. P., Roijers, J. F. M., Chahid, Y., van Geest-Daalderop, J. H. H., de Vries-Goldschmeding, H., van Wijk, E. M., Egberts, A. C. G., & de Boer, A. (2006). VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation. Clinical Pharmacology and Therapeutics, 80(1), 13-22. [DOI]
Gardarsdottir, H., Heerdink, ER., & Egberts, ACG. (2006). Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiology and Drug Safety, 15(5), 338-343. [DOI]
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2006). Drug-Induced Thrombocytopenia. A Population Study. Drug Safety, 29(8), 713-721. [Repository]
Moolenaar, M., Poorter, R. L., van der Toorn, P. P. G., Lenderink, A. W., Poortmans, P., & Egberts, A. C. G. (2006). The effect of honey compared to conventional treatment on healing of radiotherapy-induced skin toxicity in breast cancer patients. Acta Oncologica, 45, 623-624. [Repository]
Handoko, K. B., Souverein, P. C., van Staa, T. P., Meijboom, R. H. B., Leufkens, H. G. M., & Egberts, A. C. G. (2006). Risk of Aplastic Anemia in Patients Using Antiepileptic Drugs. Epilepsia, 47(7), 1232-1236. [Repository]
Ververs, T., Kaasenbrood, A. J. A., Visser, G. H. A., Schobben, A. F. A. M., de Jong-van den Berg, L. T. W., & Egberts, A. C. G. (2006). Prevalence and patterns of antidepressant drug use during pregnancy. European Journal of Clinical Pharmacology, 62(10), 863-870. [Repository]
Mulder, J., Herder, A., Wilmink, F. W., Tamminga, W. J., Belitser, S., & Egberts, A. C. G. (2006). The impact of Cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice. Pharmacoepidemiology and Drug Safety, 15, 107-114. [Repository]
Rommers, M. K., van der Lely, N., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2006). Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Critical Care, 10. [Repository]
Wilting, I., Smals, O. M., Holwerda, N. J., Meyboom, R. H., de Bruin, M. L., & Egberts, A. C. G. (2006). QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine [1]. American Journal of Psychiatry, 163(2), 325. [DOI]
Verdel, B. M., Souverein, P. C., Egberts, A. C. G., & Leufkens, H. G. M. (2006). Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure. Annals of Pharmacotherapy, 40, 1040-1046. [Repository]
van der Linden, C. M. J., Kerkes, M. C. H., Bijl, A. M. H., Maas, H. A. A. M., Egberts, A. C. G., & Jansen, P. A. F. (2006). Represcription After Adverse Drug Reaction in the Elderly: A Decriptive Study. Archives of Internal Medicine, 166, 1666-1667. [Repository]
Smink, B. E., Mathijssen, M. P. M., Lusthof, K. J., de Gier, J. J., Egberts, A. C. G., & Uges, D. R. A. (2006). Comparison of Urine and Oral Fluid as Matrices for Screening of Thirty-Three Benzodiazepines and Benzodiazepine-like Substances using Immunoassay and LC-MS(-MS). Journal of Analytical Toxicology, 30, 478-485. [Repository]
Hugenholtz, G. W. K., Heerdink, E. R., Stolker, J. J., Meijer, W. E. E., Egberts, A. C. G., & Nolen, W. A. (2006). Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses. Journal of Clinical Psychiatry, 67(6), 897-903.
Souverein, P. C., Webb, D. J., Weil, J. G., van Staa, T. P., & Egberts, A. C. G. (2006). Use of antiepileptic drugs and risk of fractures. Case-control study among patients with epilepsy. Neurology, 66, 1318-1324. [Repository]
Buurma, H., de Smet, P. G. A. M., & Egberts, A. C. G. (2006). Clinical Risk Management in Dutch Community Pharmacies. The Case of Drug-Drug Interactions. Drug Safety, 29(8), 723-732. [Repository]
Mulder, J., Wilmink, F. W., Belitser, S., & Egberts, A. C. G. (2006). The Association Between Cytochrome P450-2D6 Genotype and Prescription of Antiparkinsonian Drugs in Hospitalized Psychiatric Patients Using Antipsychotics. A Retrospective Follow-up Study. Journal of Clinical Psychopharmacology, 26(2), 212-214. [Repository]
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Olivier, B., & Egberts, A. C. G. (2006). The pharmacological management of aggression. In D. Richter, & R. Whittington (Eds.), Violence in Mental Health Settings (pp. 173-192). Springer.
van den Bemt, P. M. L. A., & Egberts, A. C. G. (2006). Drug-related problems: definitions and classification. EJHP Practice, 12 suppl, 10-12.
Vinks, M. H. A. M., de Koning, G. H. P., de Lange, T. M., & Egberts, A. C. G. (2006). Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharmacy World & Science, 28, 33-38. [Repository]
van der Wammes-van der Heijden, E. A., Rahimtoola, H., Leufkens, H. G. M., Tijssen, C. C., & Egberts, A. C. G. (2006). Risk of ischemic complications related to the intensity of triptan and ergontamine use. Neurology, 67, 1128-1134. [Repository]
Geers, H. C. J., de Blaey, C. J., Egberts, A. C. G., Bouvy, M. L., & Heerdink, E. R. (2006). Early Identification of Long-Term Poor Adherence in Ambulatory Patients. Annals of Pharmacotherapy, 40, 2277-2278. [Repository]
Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2006). Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiology and Drug Safety, 15, 338-343. [Repository]
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Nijman, H. L. I., Olivier, B., & Egberts, A. C. G. (2006). Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review. Journal of Clinical Psychiatry, 67(7), 1013-1023.
van den Bemt, P. M. L. A., Cusell, M. B. I., Overbeeke, P. W., Trommelen, M., van Dooren, D., Ophorst, W. R., & Egberts, A. C. G. (2006). Quality improvement of oral medication administration in patients with enteral feeding tubes. Quality & safety in health care, 15, 44-47. [Repository]
van der Wammes-van der Heijden, E. A., Tijssen, C. C., & Egberts, A. C. G. (2006). Right-to-left shunt and migraine: the strength of the relationship. Cephalalgia, 26, 208-213. [Repository]
Professional publications
Van Der Aart-Van Der Beek, A. B., Mulder, H., Arends, J., Scheffer, H., Visser, T., & Egberts, A. C. G. (2006). Associatie tussen polymorfismen van het 5HT2C-receptorgen en overgewicht bij gebruikers van antipsychotica: Een dwarsdoorsnedeonderzoek. Pharmaceutisch Weekblad, 141(11), 384-388.
Graaf, M. R., Beiderbeck, A. B., Egberts, A. C. G., Richel, D. J., & Guchelaar, H. J. (2006). Het risico op kanker onder gebruikers van statines. Substantieel beschermend effect. Pharmaceutisch Weekblad, 46, 458-460. [Repository]
Buurma, H., Egberts, A. C. G., Leufkens, H. G. M., & de Smet, P. G. A. M. (2006). Risicomanagement in de farmacozorgketen. Praktijkonderzoek helpt rol en waarde apotheek belichten. Pharmaceutisch Weekblad, 48, 1537-1539. [Repository]
Wilting, I., Baumgarten, R., Movig, K. L. L., Laarhoven, J., Apperloo, A. J., Nolen, W. A., Heerdink, E. R., Knoers, N. V., & Egberts, A. C. G. (2006). Focus op het onderliggend mechanisme. Lithium-geïnduceerde nefrogene diabetes insipidus. Pharmaceutisch Weekblad, 11, 389-393. [Repository]
Kerskes, M., van den Bliek, B., Maas, H., & Egberts, A. C. G. (2006). Determinanten voor duizeligheid bij ouderen: een dwarsdoorsnede-onderzoek. Een moeilijk te ontrafelen probleem. Pharmaceutisch Weekblad, 20, 685-689. [Repository]
van der Aart-van der Beek, A. B., Mulder, J., Arends, J., Scheffer, H., Visser, T., & Egberts, A. C. G. (2006). Een dwarsdoornsnedeonderzoek. Associatie tussen polymorfismen van het 5HT2c-receptorgen en overgewicht bij gebruikers van antipsychotica. Pharmaceutisch Weekblad, 11, 384-388. [Repository]
van den Bemt, P. M. L. A., Cusell, M. B. I., Overbeeke, P. W., Trommelen, M., van Dooren, D., Ophorst, W. R., & Egberts, A. C. G. (2006). Improving the quality of oral medication administration in enterally fed patients. EJHP Practice, 12(5), 74. [Repository]
Other output
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2006). Indications for antidepressant drug prescribing in general practice in the Netherlands. Pharmacoepidemiology and Drug Safety, 15, S163-S164.
van der Wammes-van der Heijden, E. A., Rahimtoola, H., Leufkens, H. G. M., Tijssen, C. C., & Egberts, A. C. G. (2006). Overuse of Triptans and Ergotamine and the Risk of Vasoconstrictive Complications. S55. Abstract from Unknown event, Asilomar, USA.
Wilting, I., de Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2006). The Risk of Fractures in Patients Currently or Previously Using Lithium. S41. Abstract from Unknown event, Asilomar, USA.
Smink, B. E., Movig, K. L. L., Lusthof, K. J., de Gier, J. J., Uges, D. R. A., & Egberts, A. C. G. (2006). The Relation between the Use of Psychoactive Substances and Injury Severity within a Group of Crash Involved Drivers. S204. Abstract from Unknown event, Asilomar, USA.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Gorter, K. J., Numans, M. E., Grobbee, D. E., Klungel, O. H., & Burger, H. (2006). Depression in type 2 diabetes consequence rather than cause. European Journal of Epidemiology, 21(suppl.), 85.
ten Berg, M. J., Huisman, A., van den Bemt, P. M. L. A., Schobben, A. F. A. M., Egberts, A. C. G., & van Solinge, W. W. (2006). Validity of Hospital Discharge ICD Codes for Identifying Patients with Thrombocytopenia. S232. Abstract from Unknown event, Asilomar, USA.
Mulder, J., Scheffer, H., Aart-van der Beek, A., Arends, J., Wilmink, F. W., & Egberts, A. C. G. (2006). The Association between 5-HT2c Polymorphisms and the Metabolic Syndrome in Patients Using Antipsychotics. S137. Abstract from Unknown event, Asilomar, USA.
Pouwels, S., de Vries, F., Egberts, A. C. G., Leufkens, H. G. M., & van Staa, T. P. (2006). Use of Antipsychotics and Risk of Hip/Femur Fractures: A Population Based Case-Control Study. S34. Abstract from Unknown event, Asilomar, USA.
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2006). Indications for Antidepressant Drug Prescribing in General Practice in the Netherlands. S163. Abstract from Unknown event, Asilomar, USA.
Thio, B. M. K. S., de Vries, F., Egberts, A. C. G., Leufkens, H. G. M., & van Staa, T. P. (2006). Use of Selective Serotonin Inhibitors and Risk of Hip/Femur Fractures: A Population-Based Case-Control Study. S225. Abstract from Unknown event, Asilomar, USA.
Stolk, P., Souverein, P. C., Tatt, I. D., Egberts, A. C. G., Leufkens, H. G. M., Weil, J. G., & Heerdink, E. R. (2006). Do COX-2 Inhibitors Prevent Deterioration of Schizophrenia? A Nested Case-Control Study. S262. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., de Koning, G. H. P., Souverein, P. C., & Egberts, A. C. G. (2006). Is Hospitalisation a Determinant for Discontinuity of Drug Use?. S101. Abstract from Unknown event, Asilomar, USA.
van Geffen, E. C. G., Van Hulten, R. P., Bouvy, M. L., Heerdink, E. R., & Egberts, A. C. G. (2006). Patient Reports on Discontinuation of Antidepressants. S239. Abstract from Unknown event, Asilomar, USA.
Derijks, H. J., de Koning, G. H. P., Heerdink, E. R., Janknegt, R., Klungel, O. H., & Egberts, A. C. G. (2006). The Association between Antidepressant Use and Hypoglycemia in Diabetic Patients: A Nested Case-Control Study. S42. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Speksnijder, N., van Staa, T. P., Olivier, B., Egberts, A. C. G., & Leufkens, H. G. M. (2006). Use of Oral Glucocorticoids and Risk of Suicide: A Cohort Study in the General Practice Research Database. S3. Abstract from Unknown event, Asilomar, USA.
Geers, H. C. J., de Blaey, C. J., Egberts, A. C. G., & Heerdink, E. R. (2006). Early Identification of Long Term Poor Compliance in Ambulatory Patients Using a Multivariate Risk Score Model. S160. Abstract from Unknown event, Asilomar, USA.
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2006). In: Proceedings of the Dutch Society of Clinical Pharmacology and Biopharmacy meeting of October 4th 2005. Abstract from Unknown event, Asilomar, USA.
2005
Scholarly publications
Derijks, H. J., De Koning, F. H. P., Meyboom, R. H., Heerdink, E. R., Spooren, P. F. M. J., & Egberts, A. C. G. (2005). Impaired glucose homeostasis after imipramine intake in a diabetic patient [9]. Journal of Clinical Psychopharmacology, 25(6), 621-623. [DOI]
Hugenholtz, G. W. K., Heerdink, E. R., Meijer, W. E. E., Stolker, J. J., Egberts, A. C. G., & Nolen, W. A. (2005). Reasons for Switching between Antipsychotics in Daily Clinical Practice. Pharmacopsychiatry, 38, 122-124. [Repository]
Knoester, P. D., Belitser, S., Deckers, C. L. P., Keyser, A., Renier, W. O., Egberts, A. C. G., & Hekster, Y. A. (2005). Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not. Pharmacoepidemiology and Drug Safety, 14, 107-112. [Repository]
Hugenholtz, G. W. K., Heerdink, E. R., van Staa, T. P., Nolen, W. A., & Egberts, A. C. G. (2005). Risk of hip/femur fractures in patients using antipsychotics. Bone, 37, 864-870. [Repository]
van Geffen, E. C. G., Hugtenburg, J. G., Heerdink, E. R., Van Hulten, R. P., & Egberts, A. C. G. (2005). Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. European Journal of Clinical Pharmacology, 61, 303-307. [Repository]
van der Wammes-van der Heijden, E. A., Smidt, M. H., Tijssen, C. C., van 't Hoff, A. R., Lenderink, A. W., & Egberts, A. C. G. (2005). Effect of Low-Intensity Acenocoumarol on Frequency and Severity of Migraine Attacks. Headache, 45, 137-143. [Repository]
Egberts, A. C. G. (2005). Causal or casual. Pharmacoepidemiology and Drug Safety, 14, 365-366. [Repository]
Wilting, I., Movig, K. L. L., Moolenaar, M., Hekster, Y. A., Brouwers, J. R. B. J., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disorders, 7, 274-280. [Repository]
Knoester, P. D., Boendermaker, A. J., Egberts, A. C. G., Hekster, Y. A., Keyser, A., Severens, J. L., Renier, W. O., & Deckers, C. L. P. (2005). Cost-effectiveness of add-on lamotrigine therapy in clinical pratice. Epilepsy Research, 67, 143-151. [Repository]
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, A. C. G., & Nolen, W. A. (2005). Langdurig gebruik van antidepressiva in Nederland in 1991-2001: prevalentie, incidentie en risico-indicatoren*. Nederlands Tijdschrift voor Geneeskunde, 149(13), 708-711. [Repository]
Derijks, H. J., de Koning, G. H. P., Meyboom, R. H., Heerdink, E. R., Spooren, P. F. M. J., & Egberts, A. C. G. (2005). Impaired Glucose Homeostasis After Imipramine Intake in a Diabetic Patient. Journal of Clinical Psychopharmacology, 25(6), 621-623. [Repository]
Hugtenburg, J. G., Griekspoor, J. E., de Boer, I., Heerdink, E. R., Tso, Y. H., & Egberts, A. C. G. (2005). Methylphenidate: use in daily practice. Pharmacy World & Science, 27, 197-201. [Repository]
van Deelen, R. A. J., van den Bemt, P. M. L. A., Egberts, A. C. G., van 't Hoff, A., & Maas, H. A. A. M. (2005). Cognitive Impairment as Determinant for Sub-Optimal Control of Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation. Drugs & Aging, 22(4), 353-360. [Repository]
Mulder, J., Wilmink, F. W., Beumer, T. L., Tamminga, W. J., Jedema, J. N., & Egberts, A. C. G. (2005). The Association Between Cytochrome P450 2D6 Genotype and Prescription Patterns of Antispychotic and Antidepressant Drugs in Hospitalized Psychiatric Patients. A Retrospective Follow-up Study. Journal of Clinical Psychopharmacology, 25(2), 188-191. [Repository]
Faber, A., Bouvy, M. L., Loskamp, L., van den Berg, P. B., Egberts, A. C. G., & de Jong-van den Berg, L. T. W. (2005). Dramatic change in prescribing of hormone replacement therapy in the Netherlands after publication of the Million Women Study: a follow-up study. British Journal of Clinical Pharmacology, 60(6), 641-647. [Repository]
Smink, B. E., Ruiter, B., Lusthof, K. J., de Gier, J. J., Uges, D. R. A., & Egberts, A. C. G. (2005). Drug use and the severity of a traffic accident. Accident Analysis & Prevention, 37, 427-433. [Repository]
Buurma, H., de Smet, P. G. A. M., Kruijtbosch, M., & Egberts, A. C. G. (2005). Disease and Intolerability Documentation in Electronic Patient Records. Annals of Pharmacotherapy, 39, 1640-1646. [Repository]
Knoester, P. D., Keyser, A., Renier, W. O., Egberts, A. C. G., Hekster, Y. A., & Deckers, C. L. P. (2005). Effectiveness of lamotrigine in clinical practice: Results of a retrospective population-based study. Epilepsy Research, 65, 93-100. [Repository]
Souverein, P. C., Webb, D. J., Petri, H., Weil, J., van Staa, T. P., & Egberts, A. C. G. (2005). Incidence of Fractures among Epilepsy Patients: A Population-based Retrospective Cohort Study in the General Practice Research Database. Epilepsia, 46(2), 304-310. [Repository]
Kalisvaart, K., de Jonghe, J., Bogaards, R., Egberts, A. C. G., Burger, B. J., Eikelenboom, P., van Gool, W. A., & Vreeswijk, R. (2005). Haloperidol Prophylaxis for Elderly Hip-Surgery Patients at Risk for Delirium: A Randomized Placebo-Controlled Study. Journal of the American Geriatrics Society, 53, 1658-1666. [Repository]
Stuffken, R., Van Hulten, R. P., Heerdink, E. R., Movig, K. L. L., & Egberts, A. C. G. (2005). The impact of hospitalisation on the initiation and long-term use of benzodiazepines. European Journal of Clinical Pharmacology, 61, 291-295. [Repository]
Professional publications
Mulder, H., Wilmink, F. W., Beumer, T. L., Tamminga, W. J., Jedema, J. N., & Egberts, A. C. G. (2005). The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: A retrospective follow-up study [4]. Journal of Clinical Psychopharmacology, 25(2), 188-191. [DOI] [Portal]
Rommers, M. K., Van Der Lely, N., Egberts, A. C. G., & Van Den Bemt, P. M. L. A. (2005). Oedeem en anti-Xa-activiteit na subcutane toediening van dalteparine. Pharmaceutisch Weekblad, 140(20), 682-684.
Chahid, Y., Brassé, B. P., van Wijk, E. M., & Egberts, A. C. G. (2005). Het genotype: een nieuwe parameter voor de instelling van cumarinetherapie? Tromnibus, 33(3), 45-48.
ten Berg, M. J., Huisman, A., van den Bemt, P. M. L. A., Schobben, A. F. A. M., Egberts, A. C. G., & van Solinge, W. W. (2005). Database koppelt gegevens laboratorium en apotheek. Pharmaceutisch Weekblad, 50, 1602-1604. [Repository]
Rommers, M. K., van der Lely, N., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2005). Anti-Xa-activiteit na subcutane toediening van dalteparine op de IC. Subcutaan oedeem maakt geen verschil. Pharmaceutisch Weekblad, 20, 682-684. [Repository]
Egberts, A. C. G., van den Bemt, P. M. L. A., & Lenderink, B. W. (2005). Computersystemen in het ziekenhuis. Evolutie in de medicatiebewaking in ziekenhuizen. Pharmaceutisch Weekblad, 140(10), 334-337. [Repository]
Other output
Faber, A., Bouvy, M. L., Loskamp, L., van den Berg, P. B., Egberts, A. C. G., & de Jong-van den Berg, L. T. W. (2005). Dramatic Change in Use of Hormone Replacement Therapy in The Netherlands after Publication of the Million Women Study. S81. Abstract from Unknown event, Asilomar, USA.
Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2005). Potential Bias in Pharmacoepidemiological Studies Due to the Length of the Drug Free Period: A Study on Antidepressant Drug Use in Adults in the Netherlands. S202. Abstract from Unknown event, Asilomar, USA.
Arbouw, M. E. L., Movig, K. L. L., Neef, C., Guchelaar, H. J., & Egberts, A. C. G. (2005). Relationship between Serontonergic Antidepressants and Worsening of Parkinson's Disease. S158. Abstract from Unknown event, Asilomar, USA.
Rommers, M. K., van der Lely, N., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2005). Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema. Abstract from Unknown event, Asilomar, USA.
Handoko, K. B., Zwart - van Rijkom, J. E. F., Hermens, W. A. J. J., Souverein, P. C., & Egberts, A. C. G. (2005). Changes in Medication in Relation to Epilepsy-Related Hospitalization: A Case Cross-Over Study. S55. Abstract from Unknown event, Asilomar, USA.
ten Berg, M. J., Huisman, A., Souverein, P. C., Schobben, A. F. A. M., Egberts, A. C. G., van Solinge, W. W., & van den Bemt, P. M. L. A. (2005). Drug-induced thrombocytopenia: a population-based case-control study. Abstract from Unknown event, Asilomar, USA.
van den Bemt, P. M. L. A., Souverein, P. C., van Staa, T. P., Meyboom, R. H. B., van Solinge, W. W., & Egberts, A. C. G. (2005). The Association between Antiepileptic Drug Use and Aplastic Anemia. S109. Abstract from Unknown event, Asilomar, USA.
Rommers, M. K., van der Lely, N., Egberts, A. C. G., & van den Bemt, P. M. L. A. (2005). Anti-Xa activity after subcutaneaous administration of dalteperin in ICU patients with and without subcutaneous oedema. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). Incidence and Prevalence of Antipsychotic Use in Non-Insitutionalised Patients in 1993-2003. S10. Abstract from Unknown event, Asilomar, USA.
Verdel, B. M., Souverein, P. C., Egberts, A. C. G., & Leufkens, H. G. M. (2005). Risk of Hypersensitivity Reactions and Allergic Events after Use of Sulfonamide Drugs in Patients with Diabetes Mellitus. S204. Abstract from Unknown event, Asilomar, USA.
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Nijman, H. L. I., & Egberts, A. C. G. (2005). The Association between p.r.n. (As-Needed) Medication and Aggressive Incidents in Psychiatric Inpatients. S24. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Webb, D. J., Weil, J., van Staa, T. P., & Egberts, A. C. G. (2005). Use of Antiepileptic Drugs and Risk of Fractures: A Case-Control Study among Patients with Epilepsy. S192. Abstract from Unknown event, Asilomar, USA.
Knoester, P. D., Heins, M., Hekster, Y. A., & Egberts, A. C. G. (2005). The Validity of Using Pharmacy Records for Assessing the Retention Time of Drug Therapy. S176. Abstract from Unknown event, Asilomar, USA.
Fase, S., Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). The Influence of Environmental Temperature on Lithium Serum Levels. S5. Abstract from Unknown event, Asilomar, USA.
van Geffen, E. C. G., Hugtenburg, J. G., Heerdink, E. R., Van Hulten, R. P., & Egberts, A. C. G. (2005). Discontinuation Symptoms in SSRI Users in Clinical Practice: Tapering Versus Abrupt Discontinuation. S130. Abstract from Unknown event, Asilomar, USA.
2004
Scholarly publications
Bouvy, M. L., Egberts, T. C. G., & De Jong-Van Den Berg, L. T. W. (2004). Gevolgen van de publiciteit rondom de Million Women Study. Pharmaceutisch Weekblad, 139(14), 473-474.
Hugtenburg, J. G., Heerdink, E. R., & Egberts, A. C. G. (2004). Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. European Journal of Clinical Pharmacology, 60, 377-379. [Repository]
Smink, B. E., Brandsma, J. E., Dijkhuizen, A., Lusthof, K. J., de Gier, J. J., Egberts, A. C. G., & Uges, D. R. A. (2004). Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry. Journal of chromatography. B, 811, 13-20. [Repository]
Waller, P., van Puijenbroek, E. P., Egberts, A. C. G., & Evans, S. (2004). The reporting odds ratio versus the proportional reporting ratio: 'deuce'. Pharmacoepidemiology and Drug Safety, 13(8), 525-526. [Repository]
Mantel-Teeuwisse, A. K., Klungel, O. H., Egberts, T. C. G., Verschuren, W. M. M., Porsius, A. J., & de Boer, A. (2004). Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin. Drug Safety, 27(1), 63-70. [Repository]
van der Wammes-van der Heijden, E. A., Tijssen, C. C., van 't Hoff, A. R., & Egberts, A. C. G. (2004). A Thromboembolic Predisposition and the Effect of Anticoagulants on Migraine. Headache, 44, 399-402. [Repository]
Souverein, P. C., Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart, 90, 859-865. [Repository]
Lenderink, B. W., & Egberts, A. C. G. (2004). Closing the loop of the medication use process using electronic medication administration registration. Pharmacy World & Science, 26, 185-190. [Repository]
Graaf, M. R., Beiderbeck, A. B., Egberts, A. C. G., Richel, D. J., & Guchelaar, H. J. (2004). The Risk of Cancer in Users of Statins. Journal of Clinical Oncology, 22(12), 2388-2394. [Repository]
Heerdink, E. R., Stolker, J. J., Meijer, W. E. E., Hugenholtz, G. W. K., & Egberts, A. C. G. (2004). Need for medicine-based evidence in pharmacotherapy. British Journal of Psychiatry, 184, 452. [Repository]
Stuffken, R., & Egberts, A. C. G. (2004). Discontinuities in drug use upon hospital discharge. Pharmacy World & Science, 26, 268-270. [Repository]
van den Bemt, P. M. L. A., Meyboom, R. H. B., & Egberts, A. C. G. (2004). Drug-Induced Immune Thrombocytopenia. Drug Safety, 27(5), 1243-1252. [Repository]
Knoester, P. D., Belitser, S., Deckers, C. L. P., Keyser, A., Renier, W. O., Egberts, A. C. G., & Hekster, Y. A. (2004). Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands. Journal of Clinical Pharmacy and Therapeutics, 29, 131-138. [Repository]
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., & Egberts, A. C. G. (2004). Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants. Archives of Internal Medicine, 164, 2364-2370. [Repository]
Knoester, P. D., Belitser, S., Deckers, C. L. P., Keyser, A., Renier, W. O., Egberts, A. C. G., & Hekster, Y. A. (2004). Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice. European Journal of Clinical Pharmacology, 60, 751-758. [Repository]
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2004). Less medication switching after initial start with atypical antipsychotics. European Neuropsychopharmacology, 14, 1-5. [Repository]
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2004). Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy-a pilot study. Pharmacoepidemiology and Drug Safety, 13, 41-47. [Repository]
Movig, K. L. L., Mathijssen, M. P. M., Nagel, P. H. A., van Egmond, T., de Gier, J. J., Leufkens, H. G. M., & Egberts, A. C. G. (2004). Psychoactive substance use and the risk of motor vehicle accidents. Accident Analysis & Prevention, 36, 631-636. [Repository]
Buurma, H., Smet, P. A. G. M., Leufkens, H. G. M., & Egberts, A. C. G. (2004). Evaluation of the clinical value of pharmacists' modifications of prescription errors. British Journal of Clinical Pharmacology, 58(5), 503-511. [Repository]
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, A. C. G., & Nolen, W. A. (2004). Incidence and determinants of long-term use of antidepressants. European Journal of Clinical Pharmacology, 60, 57-61. [Repository]
Professional publications
Cusell-Borgh, M. B. I., Van De Bemt, P. M. L. A., Lenderink, A. W., De Koning, G. H. P., & Egberts, A. C. G. (2004). Medicatieveiligheidsspecialist: Een nieuwe dimensie in transmurale medicatiebegeleiding. Pharmaceutisch Weekblad, 139(50), 1678-1681.
Herder, A. J., Mulder, J., Wilmink, F. W., Groenewold, O. G., & Egberts, A. C. G. (2004). Gericht zoeken naar inadequate doseringen. CYP2D6-genotype en plasmaconcentraties van antidepressiva en antipsychotica. Pharmaceutisch Weekblad, 139(47), 1561-1564. [Repository]
Derijks, H. J., Derijks, L. J. J., & Egberts, A. C. G. (2004). Farmacogenetica: een eerste kennismaking. Extract, 15(2), 7-10. [Repository]
Mulder, J., Wilmink, F. W., Beumer, T. L., Tamminga, W. J., Jedema, J. N., & Egberts, A. C. G. (2004). CYP2D6-genotype heeft invloed op voorschrijfpatronen van psychofarmaca. Genotypering vooraf geeft betere instelling op antidepressiva. Pharmaceutisch Weekblad, 139(3), 86-89. [Repository]
Wilting, I., Heerdink, E. R., Egberts, A. C. G., & Nolen, W. A. (2004). Therapeutische voor- en nadelen van lithium. Elementaire behandeling van bipolaire stoornis. Pharmaceutisch Weekblad, 10(139), 328-322. [Repository]
Fijn, R., Lenderink, A. W., Egberts, A. C. G., Brouwers, J. R. B. J., & de Jong-van den Berg, L. T. W. (2004). Naleving ziekenhuisformularia strandt niet op personen. Farmaco-epidemiologie model levert indicatoren voor non-conform voorschrijfgedrag. Pharmaceutisch Weekblad, 139(47), 1550-1553. [Repository]
Moolenaar, M., Poorter, R. L., Lenderink, A. W., van der Toorn, P. P. G., & Egberts, A. C. G. (2004). Zoete optie biedt te weinig winst. Honing vergeleken met conventionele behandeling bij radiotherapie-geïnduceerde acute huidtoxiciteit. Pharmaceutisch Weekblad, 139(47), 1557-1560. [Repository]
Kerskes, C. H. M., Cusell-Borgh, M., van den Bliek, B., van Vugt, A., Maas, H. A. A. M., & Egberts, A. C. G. (2004). Geneesmiddelgerelateerde problemen bij ouderen. Een greep uit de praktijk. Pharmaceutisch Weekblad, 139, 1487-1488. [Repository]
Cusell-Borg, M. B. I., van den Bemt, P. M. L. A., Lenderink, A. W., de Koning, G. H. P., & Egberts, A. C. G. (2004). Medicatieveiligheidsspecialist: een nieuwe dimensie in transmurale medicatiebegeleiding. Vier projecten tegen medicatiefouten. Pharmaceutisch Weekblad, 139(50), 1678-1681. [Repository]
Other output
van den Bemt, P. M. L. A., Meyboom, R. H. B., & Egberts, A. C. G. (2004). Drug-Induced Thrombocytopenia: A Case-Control Study. S30. Abstract from Unknown event, Asilomar, USA.
van Deelen, R. A. J., van den Bemt, P. M. L. A., Egberts, A. C. G., van 't Hoff, A., & Maas, H. A. A. M. (2004). Cognitieve functie als determinant voor een inadequate therapie met acenocoumarol bij ouderen met boezemfibrilleren. Abstract from Unknown event, Asilomar, USA.
Derijks, H. J., de Koning, G. H. P., Meyboom, R. H. B., & Egberts, A. C. G. (2004). The Association between Antidepressant Use and Hypoglycemia and Hyperglycemia. S21. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2004). Acute and Long-Term Risk of Femur Fractures in Patients on Antipsychotics. S21. Abstract from Unknown event, Asilomar, USA.
Hugtenburg, J. G., Heerdink, E. R., & Egberts, A. C. G. (2004). Drug Prescribing by Dutch Child and Adolescent Psychiatrists. S95. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Movig, K. L. L., & Egberts, A. C. G. (2004). Is Hospitalisation a Determinant of Initiation and Long-Term Use of Benzodiazepines?. S154. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Webb, D. J., Petri, H. L., van Staa, T. P., & Egberts, A. C. G. (2004). Incidence of Fracatures among Epilepsy Patients: A Cohort Study in the General Practice Research Database. S94. Abstract from Unknown event, Asilomar, USA.
Arana, A., Rivero, E., & Egberts, A. C. G. (2004). What Do We Show and Who Does So? An Analysis of the Abstracts Presented at the 19th ICPE. S330. Abstract from Unknown event, Asilomar, USA.
Mulder, J., Herder, A., Wilmink, F. W., Tamminga, W., & Egberts, A. C. G. (2004). The Association between Cytochrome P450-2D6 Genotype and Plasma Concentrations of Antipsychotic and Antidepressant Drugs in Daily Clinical Practice. S22. Abstract from Unknown event, Asilomar, USA.
2003
Scholarly publications
Zwart-Van Rijkom, J. E. F., Breekveldt-Postma, N. S., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Diffusion of new medicines into hospital practice [3]. European Journal of Clinical Pharmacology, 59(5-6), 495-496. [DOI]
Movig, K. L. L., Baumgarten, R., Leufkens, H. G. M., van Laarhoven, J. H. M., & Egberts, A. C. G. (2003). Risk factors for the development of lithium-induced polyuria. British Journal of Psychiatry, 182, 319-323. [Repository]
Movig, K. L. L., Janssen, M. W. H. E., de Waal Malefijt, J., Kabel, P. J., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients. Archives of Internal Medicine, 163, 1254-2358. [Repository]
Bouvy, M. L., Buurma, H., & Egberts, A. C. G. (2003). Determinants for successful smoking cessation with bupropion in daily practice. Pharmacy World & Science, 25(5), 207-211. [Repository]
Souverein, P. C., van Staa, T. P., Egberts, A. C. G., de la Rosette, J. J. M. C. H., & Cooper, C. (2003). Use of alpha-blockers and the risk of hip/femur fractures. Journal of Internal Medicine, 254, 548-554. [Repository]
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Incidence and determinants of antidepressant drug use in migraine patients. International Clinical Psychopharmacology, 18, 331-339. [Repository]
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Single Use of Sumatriptan: A Patient Interview Study. Headache, 43, 109-116. [Repository]
Movig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., & Egberts, A. C. G. (2003). Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. Journal of Clinical Epidemiology, 56, 530-535. [Repository]
Zwart - van Rijkom, J. E. F., Breekveldt-Postma, N. S., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Diffusion of new medicines into hospital practice. European Journal of Clinical Pharmacology, 59, 495-496. [Repository]
Heerdink, E. R., Hugenholtz, G. W. K., Meijer, W. E. E., & Egberts, A. C. G. (2003). Channeling new antidepressants to problem patients may be factor in fatal toxicity. BMJ (International edition), 326, 600. [Repository]
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Migraine prophylactic medication usage patterns in The Netherlands. Cephalalgia, 23, 293-301. [Repository]
Buurma, H., de Smet, P. G. A. M., van den Hoff, O. P., Sysling, H., Storimans, M. J., & Egberts, A. C. G. (2003). Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies. Pharmacy World & Science, 25(6), 280-287. [Repository]
Brouwers, J. R. B. J., Hekster, Y. A., & Egberts, A. C. G. (2003). Farmaceutisch praktijkonderzoek in ziekenhuizen. Veiligheid van patiënt staat voorop. Pharmaceutisch Weekblad, 138(10), 331-333. [Repository]
Professional publications
Arts, J., Mulder, J., van Roon, E., Wilbers, C. M. T., & Egberts, A. C. G. (2003). Creatininebepaling belangrijk bij urinetest op cannabisgebruik. Uniforme rapportage reduceert foute interpretaties. Pharmaceutisch Weekblad, 138(47), 1650-1654. [Repository]
Thies, B. J., van der Hoeven, R. T. M., & Egberts, A. C. G. (2003). Patiëntgebonden interventies in de Nederlandse ziekenhuisapotheek. Speerpunt moet nog aangescherpt. Pharmaceutisch Weekblad, 138(38), 1318-1322. [Repository]
van der Heijden, E. A., Smidt, M., Tijssen, C. C., van 't Hoff, A. R., Lenderink, A. W., & Egberts, A. C. G. (2003). Effect van een lage dosis acenocoumarol op frequentie en ernst van de aanvallen. De zoektocht naar een migraineprofylacticum. Pharmaceutisch Weekblad, 138(3), 94-98. [Repository]
Stolk, P., Hugtenburg, J. G., & Egberts, A. C. G. (2003). Onttrekkingsverschijnselen bij SSRI's. Kennis inzetten tegen ongerustheid. Pharmaceutisch Weekblad, 138(46), 1607-1612. [Repository]
de Moor, R. A., Mourad, L., ter Haar, J., & Egberts, A. C. G. (2003). Onthoudingsverschijnselen bij een neonatus na blootstelling aan venlafaxine tijdens de zwangerschap. Nederlands Tijdschrift voor Geneeskunde, 147(28), 1370-1372. [Repository]
van der Heijden, E. A., Smidt, M., Tijssen, C. C., van 't Hoff, A. R., Lendering, A. W., & Egberts, A. C. G. (2003). Effect van lage dosis acenocoumarol op de frequentie en ernst van migraine aanvallen: een vergelijking met de basislijnperiode en propranolol. Het LAMP-onderzoek. Medisch Journaal, 32, 10-13. [Repository]
Other output
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Risk of Abnormal Bleeding Associated with Use of Serotonin Reuptake Inhibitors. S98. Abstract from Unknown event, Asilomar, USA.
Movig, K. L. L., Mathijssen, M. P. M., Nagel, P. H. A., de Gier, J. J., van Egmond, T., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Psychoactive Substance Use and the Risk of Motor Vehicle Accidents. S155-S156. Abstract from Unknown event, Asilomar, USA.
Wilting, I., Moolenaar, M., Movig, K. L. L., Hekster, Y. A., Brouwers, J. R. B. J., & Egberts, A. C. G. (2003). Determinants of Elevations of Lithium Serum Levels into the Toxic Range. S144-S145. Abstract from Unknown event, Asilomar, USA.
Buurma, H., Smet, P. A. G. M., & Egberts, A. C. G. (2003). The Clinical value of Pharmacists' Intervention Leading to a Prescription Modification. S9-S10. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Meijer, W. E. E., Stolker, J. J., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2003). Reasons for Switching between Antipsychotics. S111-S112. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., de la Rosette, J. J. M. C. H., van Staa, T. P., Cooper, C., & Leufkens, H. G. M. (2003). Use of Alpha-Blockers and Risk of Hip/Femur Fractures. S152. Abstract from Unknown event, Asilomar, USA.
Mulder, J., Wilmink, F. W., Beumer, T., Tamminga, W., & Egberts, A. C. G. (2003). The Influence of Cytochrome P450-2D6 Genotype on Prescription Patterns of Antipsychotic and Antidepressant Drugs in Hospitalised Psychiatric Patients: A Retrospective Cohort Study. S143-S144. Abstract from Unknown event, Asilomar, USA.
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Increased Intensity of Specific Abortive Migraine Drug Use Associated with Vasoconstrictive Complications. S83-S84. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C. G., Leufkens, H. G. M., & Walker, B. R. (2003). Use of Oral Glucocorticoids and Risk of Cardiovascular and Cerebrovascular Events. S56-S57. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Tijssen, C. C., van der Heijden, E. A., & van 't Hoff, A. R. (2003). Effect of oral anticoagulation on migraine attacks and the possible relationship with prothrombotic predisposition: a case series. 712. Abstract from Unknown event, Asilomar, USA.
2002
Scholarly publications
Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Leufkens, H. G. M., & Waldinger, M. D. (2002). Is sexual dysfunctioning a reason for discontinuation in users of selective serotonin reuptake inhibitors? [5]. Journal of Clinical Psychopharmacology, 22(1), 96-98. [DOI]
Van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002). A comparison of measures of disproportionality for signal detection is spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology and Drug Safety, 11(1), 3-10. [DOI] [Portal]
Derijks, H. J., De Koning, G. H. P., Mantel-Teeuwisse, A. K., & Egberts, A. C. G. (2002). Limited adherence to safety instructions in drug leaflets [1]. British Journal of Clinical Pharmacology, 54(6), 678-679. [DOI]
De Bruin, M. L., van Puijenbroek, E. P., Egberts, A. C. G., Hoes, A. W., & Leufkens, H. G. M. (2002). Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems? British Journal of Clinical Pharmacology, 53(4), 370-4.
Bouvy, M. L., Buurma, H., & Egberts, A. C. G. (2002). Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention. Journal of Clinical Pharmacy and Therapeutics, 27, 107-110. [Repository]
Movig, K. L. L., Leufkens, H. G. M., Belitser, S., Lenderink, A. W., & Egberts, A. C. G. (2002). Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiology and Drug Safety, 11, 1-9. [Repository]
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2002). Incidence and determinants of migraine prophylactic medication in the Netherlands. European Journal of Clinical Pharmacology, 58(2), 149-156. [Repository]
van den Bemt, P. M. L. A., Fijn, R., van der Voort, P. H. J., Gossen, A. A., Egberts, A. C. G., & Brouwers, J. (2002). Frequency and deteminants of drug administration errors in the intensive care unit. Critical Care Medicine, 30(4), 846-850. [Repository]
de Bruin, M. L., van Puijenbroek, E. P., Egberts, A. C. G., Hoes, A. W., & Leufkens, H. G. M. (2002). Non-sedating anthistamine drugs and cardiac arrhytmias - biased risk estimates from spontaneous reporting systems? British Journal of Clinical Pharmacology, 53, 370-374. [Repository]
Breekveldt-Postma, N. S., Zwart - van Rijkom, J. E. F., Egberts, A. C. G., Leufkens, H. G. M., & Herings, R. M. C. (2002). Stijgende kosten van geneesmiddelen in ziekenhuizen in 1996-2000 en de komende jaren. Nederlands Tijdschrift voor Geneeskunde, Dec 28(146 (52)), 2547-2551. [Repository]
Movig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., & Egberts, A. C. G. (2002). Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. European Journal of Clinical Pharmacology, 58(2), 143-148. [Repository]
Stolk, P., Egberts, A. C. G., & Leufkens, H. G. M. (2002). Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999. Pharmacoepidemiology and Drug Safety, 11, 105-111. [Repository]
Derijks, H. J., de Koning, G. H. P., Mantel-Teeuwisse, A. K., & Egberts, A. C. G. (2002). Limited adherence to safety instructions in drug leaflets. British Journal of Clinical Pharmacology, 54, 678-683. [Repository]
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002). A comparison of measures of disproportionality for signal detection in spontaeous reporting systems for adverse drug reactions. Pharmacoepidemiology and Drug Safety, 11(1), 3-10. [Repository]
Movig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., van den Akker, V. G. A., Hodiamont, P. P., Goldschmidt, H. M. J., & Egberts, A. C. G. (2002). Association between antidepressant drug use and hyponatraemia: a case-control study. British Journal of Clinical Pharmacology, 53(4), 363-369. [Repository]
van Puijenbroek, E. P., Egberts, A. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (2002). Different Risks for NSAID-Induces Anaphylaxis. Annals of Pharmacotherapy, 36, 24-29. [Repository]
Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Leufkens, H. G. M., & Waldinger, M. D. (2002). Is sexual dysfunctioning a reason for discontinuation in users of selective serotonin reutake inhibitors? Journal of Clinical Psychopharmacology, 22(1), 96-98.
Egberts, A. C. G., Meyboom, R. H. B., & van Puijenbroek, E. P. (2002). Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Safety, 25(6), 453-458. [Repository]
Meyboom, R. H. B., Lindquist, M., Egberts, A. C. G., & Edwards, I. R. (2002). Signal selection and follow-up in pharmacovigilance. Drug Safety, 25(6), 459-465. [Repository]
Professional publications
Movig, K. L. L., Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Egberts, A. C. G., Sewnath, M. E., & Gouma, D. J. (2002). Toegenomen peroperatief bloedverlies bij paroxetinegebruik. Nederlands Tijdschrift voor Geneeskunde, 146(52), 2564-2565.
Rommers, M. K., Lucas, P. J. A., Simons, K. A., Mourad, L., & Egberts, A. C. G. (2002). Bereidingsvoorschriften met vaste hoeveelheden zuur of loog: Zonder pH-meter toch de juiste pH. Pharmaceutisch Weekblad, 137(48), 1712-1715.
Rommers, M. K., Lucas, P. J. A., Simons, K. A., Mourad, L., & Egberts, A. C. G. (2002). De juiste pH zonder meten. Pharmaceutisch Weekblad, 137(48), 1712-1715.
Breekveldt-Postma, N. S., Zwart-Van Rijkom, J. E. F., Egberts, A. C. G., Leufkens, H. G. M., & Herings, R. M. C. (2002). De kosten van geneesmiddelen in Nederlandse ziekenhuizen. Nederlands Tijdschrift voor Geneeskunde, 146(52), 2547-2551.
Derijks, H. J., Oosterhuis, W. P., de Koning, G. H. P., & Egberts, A. C. G. (2002). Een nieuwe dimensie in medicatiebegeleiding. Pharmaceutisch Weekblad, 137(19), 691-696. [Repository]
van den Bemt, P. M. L. A., & Egberts, A. C. G. (2002). Geneesmiddelgerelateerde problemen gedefinieerd en geclassificeerd. Bijwerkingen en medicatiefouten systematisch ingedeeld. Pharmaceutisch Weekblad, 137(44), 1540-1543. [Repository]
Smits, L. H. P., Knoester, P. D., Movig, K. L. L., Hekster, Y. A., & Egberts, A. C. G. (2002). Het dilemma tussen privacy en wetenschap. Pharmaceutisch Weekblad, 137(35), 1224-1229.
van Deelen, R. A. J., Rommers, M. K., Eerenberg, J. G., & Egberts, A. C. G. (2002). Hyperseksualiteit tijdens gebruik van levodopa. Nederlands Tijdschrift voor Geneeskunde. Studenteneditie, 146(44), 2095-2098. [Repository]
Other output
Egberts, A. C. G., Movig, K. L. L., Janssen, M. W. H. E., de Waal Malefijt, J., Kabel, P., & Leufkens, H. G. M. (2002). Use of serontonergic antidepressants and need for blood transfusion in orthopaedic surgery patients. S232 P004. Abstract from Unknown event, Asilomar, USA.
Mantel-Teeuwisse, A. K., Klungel, O. H., Egberts, A. C. G., Verschuren, W. M. M., Porsius, A. J., & de Boer, A. (2002). Patterns of lipid lowering drug use after the withdrawal of cerivastatin. 234 P011-235. Abstract from Unknown event, Asilomar, USA.
de Bruin, M. L., van Puijenbroek, E. P., Egberts, A. C. G., Hoes, A. W., & Leufkens, H. G. M. (2002). Cardiac arrhytmias associated with the use of antihistamine drugs-A mass media attention reporting bias?. S65-S65. Abstract from Unknown event, Asilomar, USA.
Derijks, H. J., & Egberts, A. C. G. (2002). Incidence and determinants of CK and liverfunction measurements in patients using statins. S75-S75. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2002). Concomitant use of sildenafil and nitrates and risk of ischemic events. S141-S141. Abstract from Unknown event, Asilomar, USA.
Movig, K. L. L., Leufkens, H. G. M., Belitser, S., Lenderink, A. W., & Egberts, A. C. G. (2002). Urinary incontinence induced by serotonergic antidepressants. S25-S25. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Movig, K. L. L., Baumgarten, R., van Laarhoven, J. H. M., & Leufkens, H. G. M. (2002). Concomitant use of serotonergic antideprssants is a risk factor for lithium induced polyuria. S253 P050-S254. Abstract from Unknown event, Asilomar, USA.
Rahimtoola, H., Buurma, H., Tijssen, C. C., Leufkens, H. G. M., & Egberts, A. C. G. (2002). Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy. S13-S13. Abstract from Unknown event, Asilomar, USA.
Mantel-Teeuwisse, A. K., Egberts, A. C. G., Klungel, O. H., Verschuren, W. M. M., Porsius, A. J., & de Boer, A. (2002). Patterns of lipid lowering drug use after the withdrawal of cerivastatin.. 559P. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G. (2002). Tussen de oren. Grafidruk bv.
Movig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., & Egberts, A. C. G. (2002). Validity of hospital discharge ICD-codes for identifying patients with hyponatraemia. S25-S25. Abstract from Unknown event, Asilomar, USA.
2001
Scholarly publications
Buurma, H., De Smet, P. A. G. M., Van Den Hoff, O. P., & Egberts, A. C. G. (2001). Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. British Journal of Clinical Pharmacology, 52(1), 85-91. [DOI]
Rahimtoola, H., Egberts, A. C. G., Tijssen, C. C., & Leufkens, H. G. M. (2001). Patterns of ergotamine and sumatriptan use in the Netherlands from 1991 to 1997. Cephalalgia, 21, 596-603. [Repository]
van Puijenbroek, E. P., Egberts, A. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (2001). Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome. Pharmacoepidemiology and Drug Safety, 10, 135-142. [Repository]
Movig, K. L. L., Egberts, A. C. G., & Lendering, A. W. (2001). Association between oxybutynin and neuropsychiatric advers effects not confirmed in daily practice. Journal of the American Geriatrics Society, 49(2), 234-235. [Repository]
Fijn, R., Lenderink, A. W., Egberts, A. C. G., & de Jong-van den Berg, L. T. W. (2001). Assessment of indicators for hospital drug formulary non-adherence. European Journal of Clinical Pharmacology, 57, 677-684. [Repository]
van Puijenbroek, E. P., van Grootheest, K., Diemont, W. L., Leufkens, H. G. M., & Egberts, A. C. G. (2001). Determinants of signal selection in a spontaneous reporting system for adverse drug reactions. British Journal of Clinical Pharmacology, 52, 579-586. [Repository]
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., & Leufkens, H. G. M. (2001). The Dutch cohort of sildenafil users: baseline characteristics. BJU International, 87, 648-653. [Repository]
Langen, M. C. J., van Hoof, F. W. J. M., & Egberts, A. C. G. (2001). Externe kwaliteitscontrole: gentamicine en immunoassy. Extract, 12, 15-19.
Langen, M. C. J., van Hoof, F. W. J. M., & Egberts, A. C. G. (2001). EMIT II plus benzodiazepines screening using on-line deglucuronidation. Extract, 12, 12-13.
Rahimtoola, H., Egberts, A. C. G., Buurma, H., Tijssen, C. C., & Leufkens, H. G. M. (2001). Reduction in the Intensity of Abortive Migraine Drug Use During Coumarin Therapy. Headache, 41, 768-773. [Repository]
Egberts, A. C. G., & Leufkens, H. G. M. (2001). Ongewenste, onbedoelde en sub-optimale effecten van geneesmiddelen. In H. Timmerman, & A. van den Berg-Jeths (Eds.), Volksgezondheid Toekomst Verkenning 2002. Geneesmiddelen nu en in de toekomst (pp. 521-534). Bohn Stafleu van Loghum.
Buurma, H., de Smet, P. G. A. M., van den Hoff, O. P., & Egberts, A. C. G. (2001). Nature, frequency and determinants of presciption modification in Dutch community pharmacies. British Journal of Clinical Pharmacology, 52, 85-91. [Repository]
Professional publications
Egberts, A. C. G. (2001). Welke factoren spelen een rol bij het toedienen van geneesmiddelen via een sonde. Apothekers vademecum, 9.
van den Akker, V. G. A., Movig, K. L. L., Maas, H. A. A. M., & Egberts, A. C. G. (2001). Hyponatriëmie door antidepressiva. Een veel voorkomend en soms ernstig probleem. Pharmaceutisch Weekblad, 136(13), 456-460. [Repository]
Feenstra, A. J., Egberts, A. C. G., & de Jong-van den Berg, L. T. W. (2001). Nederlandse bergsporters, hoogteziekte en geneesmiddelen. Pharmaceutisch Weekblad, 136, 1686-1691. [Repository]
de Jong-van den Berg, L. T. W., Egberts, A. C. G., & de Vries, C. (2001). Onderzoeksopzetten en risicomaten. Pharmaceutisch Weekblad, 136(34), 1280-1282. [Repository]
Movig, K. L. L., Egberts, A. C. G., van den Akker, V. G. A., Goldschmidt, H. M. J., Leufkens, H. G. M., & Lendering, A. W. (2001). SSRI's anders dan andere antidepressiva. Een grotere kans op hyponatiëmie. Pharmaceutisch Weekblad, 136(13), 461-463. [Repository]
Egberts, A. C. G., & Movig, K. L. L. (2001). Bisfosfonaten: gebruik en switches in de dagelijkse praktijk. Eenmalig recept geen uitzondering. Pharmaceutisch Weekblad, 136(52), 1658-1661. [Repository]
Buurma, H., de Smet, A. G. M., van den Hoff, O. P., & Egberts, A. C. G. (2001). Aard, frequentie en determinanten. Prescriptiewijzigingen door openbare apotheken. Pharmaceutisch Weekblad, 136(31), 1159-1160. [Repository]
Stuffken, R., Egberts, A. C. G., & van Schaik, B. A. M. (2001). Registratie van poliklinische medicatie en ontslagmedicatie. Inzicht in specialistiche receptuur. Pharmaceutisch Weekblad, 136(11), 390-394. [Repository]
Olijslager, E., & Egberts, A. C. G. (2001). Suggesties voor verbetering van de bepaling in serum van gammahydroxyboterzuur. Pharmaceutisch Weekblad, 136, 387.
Stolk, L., & Egberts, A. C. G. (2001). CCKL accrediteert eerste laboratoria ziekenhuisapotheken. Pharmaceutisch Weekblad, 136, 1709. [Repository]
Other output
Egberts, A. C. G., & Leufkens, H. G. M. (2001). Publication frequency of research presented at the ICPE 1999 meeting. S66-S66. Abstract from Unknown event, Asilomar, USA.
Bouvy, M. L., Buurma, H., & Egberts, A. C. G. (2001). Effectiveness of bupropion. S95-S95. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2001). Determinants of sildenafil discontinuation in the Dutch cohort of sildenafil users. 231-231. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Urquhart, J., & Leufkens, H. G. M. (2001). The Dutch cohort of Sildenafil Users: baseline characteristics.. 219. Abstract from Unknown event, Asilomar, USA.
Rahimtoola, H., Egberts, A. C. G., Buurma, H., Tijssen, C. C., & Leufkens, H. G. M. (2001). Reduction in the intensity of abortive migraine drug use during coumarin therapy. S27-S27. Abstract from Unknown event, Asilomar, USA.
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., meuleman, E. J. H., Leufkens, H. G. M., & Urquhart, J. (2001). Determinants of sildenafil discontinuation in the Dutch cohort of sildenafil users. S89-S90. Abstract from Unknown event, Asilomar, USA.
van den Bemt, P. M. L. A., Fijn, R., van der Voort, P. H. J., Gossen, A. A., Egberts, A. C. G., & Brouwers, J. R. B. J. (2001). Frequency and determinants of drug administration errors in the intensive care unit of two Dutch hopitals. S94-S94. Abstract from Unknown event, Asilomar, USA.
Movig, K. L. L., Egberts, A. C. G., Leufkens, H. G. M., & Lendering, A. W. (2001). Risk for hyponatremia in users of antidepressant drugs. S65-S65. Abstract from Unknown event, Asilomar, USA.
2000
Scholarly publications
Langen, M. C. J., De Bijl, G. A., & Egberts, A. C. G. (2000). Automated extraction of 11-nor-Δ9-tetrahydrocannabinol carboxylic acid from urine samples using the ASPEC XL(TM) solid-phase extraction system. Journal of Analytical Toxicology, 24(6), 433-437. [DOI]
van den Bemt, P. M. L. A., Egberts, A. C. G., de Jong-van den Berg, L. T. W., & Brouwers, J. R. B. J. (2000). Drug-Related Problems in Hospitalised Patients. Drug Safety, 22(4), 321-333. [Repository]
Burger, H., Herings, R. M. C., Egberts, A. C. G., Neef, C., & Leufkens, H. G. M. (2000). Cyclical etidronate use is not associated with symptoms of peptic ulcer disease. European Journal of Clinical Pharmacology, 56, 319-322. [Repository]
Bouvy, M. L., & Egberts, A. C. G. (2000). Consequences of a change in reimbursement status on prescription patterns. European Journal of Clinical Pharmacology, 56, 511-512. [Repository]
van Puijenbroek, E. P., Egberts, A. C. G., Heerdink, E. R., & Leufkens, H. G. M. (2000). Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology, 56, 733-738.
van den Bemt, P. M. L. A., Joosten, P., Risselada, A. J., van den Boogaart, M. H. A., Egberts, A. C. G., & Brouwers, J. R. B. J. (2000). Stabilization of oral anticoagulant therapy in hospitalized patients and characteristics associated with lack of stabilization. Pharmacy World & Science, 22(4), 147-151. [Repository]
van den Bemt, P. M. L. A., Egberts, A. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (2000). Risk factors for the development of adverse drug events in hospitalized patients. Pharmacy World & Science, 22(2), 62-66. [Repository]
Movig, K. L. L., Egberts, A. C. G., Lenderink, A. W., & Leufkens, H. G. M. (2000). Selective Prescibing of Spasmolytics. Annals of Pharmacotherapy, 34(6), 716-719.
Langen, M. C. J., de Bijl, G. A., & Egberts, A. C. G. (2000). Automated Extraction of 11-nor^9-Tetrahydrocannabinol Carboxylic Acid from Urine Samples Using the ASPEC XL(tm) Solid-Phase Extraction System*. Journal of Analytical Toxicology, 24(september), 433-437.
Meyboom, R. H. B., Lindquist, M., & Egberts, A. C. G. (2000). An ABC of Drug-Related Problems. Drug Safety, 22(6), 415-423.
Professional publications
Wouterse, J., Willems, M., & Egberts, A. C. G. (2000). Patiëntenervaringen met geneesmiddelen Een bron van informatie. Pharmaceutisch Weekblad, 135(14), 497-500.
Kwint, H. F., Smet, P. A. G. M., Biesma, L. G., Riezebos, J., Werkman, S. E. B., & Egberts, A. C. G. (2000). Helft patiënten blijft slikken na Helicobacter pylori-ereadicatie Vraagtekens bij voortgezet gebruik maagmiddelen. Pharmaceutisch Weekblad, 135(12), 418-423.
Bouvy, M. L., & Egberts, A. C. G. (2000). Bijwerking van de 1-septembermaatregel. Pharmaceutisch Weekblad, 135(12), 424-428.
de Koning, G. H. P., Egberts, A. C. G., & Lenderink, A. W. (2000). Medicatiebreuken bij overgang van intra- naar extramurale gezondheidszorg. Hoe vaak en in welke mate. Pharmaceutisch Weekblad, 135(29), 1071-1078.
Moor, R. A., Egberts, A. C. G., & Schröder, C. H. (2000). Anion vormt onoplosbaar zout met calcium. Nierstenen als gevolg van ceftriaxon. Pharmaceutisch Weekblad, 135(14), 515-516.
Wilbers, C. M. T., & Egberts, A. C. G. (2000). Validatie van een bepaling met capillaire elektroforese. Analyse van histaminefosfaatinhalatievloeistof. Pharmaceutisch Weekblad, 135(16), 562-565.
Meyboom, R. H. B., & Egberts, A. C. G. (2000). Geneesmiddelen op een goudschaaltje. De balans van baat en schade. Pharmaceutisch Weekblad, 135(14), 480-487.
Other output
Souverein, P. C., Egberts, A. C. G., Sturkenboom, M. C. J. M., & Leufkens, H. G. M. (2000). The Dutch cohort of sildenafil users - Baseline characteristics. S79-S79. Abstract from Unknown event, Asilomar, USA.
van Puijenbroek, E. P., Bate, A., Egberts, A. C. G., Lindquist, M., & Leufkens, H. G. M. (2000). Measures of disproportionality in spontaneous reporting systems of adverse drug reactions - How do they relate to each other?. S76-S76. Abstract from Unknown event, Asilomar, USA.
Movig, K. L. L., Egberts, A. C. G., Lenderink, A. W., & Leufkens, H. G. M. (2000). Association between antidepressant drugs and hyponatremia. S87-S87. Abstract from Unknown event, Asilomar, USA.
Fijn, R., Lenderink, A. W., Egberts, A. C. G., Brouwers, J. R. B. J., & de Jong-van den Berg, L. T. W. (2000). Assessment of indicators for hospital drug formulary non-adherence. S20-S20. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., & Lenderink, A. W. (2000). Meta-analysis of adverse drug events - The association between angiotensin II receptor antagonists and upper respiratory tract infections. S78-S78. Abstract from Unknown event, Asilomar, USA.
Bouvy, M. L., & Egberts, A. C. G. (2000). Changes in the prescription of oral antihistaminergic drugs after changes in reimbursement policy in the Netherlands. S4-S4. Abstract from Unknown event, Asilomar, USA.
1999
Scholarly publications
Van Roon, E. N., Verzijl, J. M., Juttmann, J. R., Lenderink, A. W., Blans, M. J., & Egberts, A. C. G. (1999). Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(3), 290-294.
Bouvy, M. L., Egberts, A. C. G., & Leufkens, H. G. M. (1999). Onderzoekers en de farmaceutische industrie: het verhaal van troglitazon en mibefradil. Nederlands Tijdschrift voor Geneeskunde, 143(34), 1727-1729.
van den Bemt, P. M. L. A., Egberts, A. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (1999). Reporting of adverse drug reactions in hospital - A comparison of doctors, nurses and patients as sources of reports. British Journal of Clinical Pharmacology, 46, 619.
Moor, R. A., Egberts, A. C. G., & Schröder, C. H. (1999). Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis. European Journal of Pediatrics, 158, 975-977.
van Puijenbroek, E. P., Egberts, A. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (1999). Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. British Journal of Clinical Pharmacology, 47, 689-693.
van den Bemt, P. M. L. A., Egberts, A. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (1999). Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. European Journal of Clinical Pharmacology, 55, 155-158.
de Boer, D. D., Egberts, A. C. G., & Maes, R. A. A. (1999). Para-methylthioamphetamine, a new amphetamine designer drug of abuse. Pharmacy World & Science, 21(1), 47-48.
Movig, K. L. L., Langen, M. C. J., & Egberts, A. C. G. (1999). Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 21, 845-850.
Egberts, A. C. G., Leufkens, H. G. M., Launer, L. J., Grobbee, D. E., Hofman, A., & Hoes, A. W. (1999). Characteristics of older subjects using antidepressant drugs in the Netherlands. International Journal of Geriatric Psychiatry, 1, 188-192.
Meyboom, R. H. B., & Egberts, A. C. G. (1999). Comparing therapeutic benefit and risk. Therapie, 54, 29-34.
Meyboom, R. H., Egberts, A. C. G., Gribnau, F. W., & Hekster, Y. A. (1999). Pharmacovigilance in perspective. Drug Safety, 21(6), 429-447.
Professional publications
van den Bemt, P. M. L. A., Egberts, A. C. G., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., Leufkens, H. G. M., & Lenderink, A. W. (1999). Meldingen van geneesmiddelenbijwerkingen door artsen, verpleegkundigen en patiënten. Pharmaceutisch Weekblad, 134(33), 1150-1154.
de Hooge, M. N., Movig, K. L. L., & Egberts, A. C. G. (1999). Honing van lekkernij tot wondbehandeling. Pharmaceutisch Weekblad, 134, 423-427.
Bouvy, M. L., Egberts, A. C. G., & Leufkens, H. G. M. (1999). Klinisch onderzoekers en farmaceutische industrie. Troglitazon en mibefradil in opspraak. Nederlands Tijdschrift voor Geneeskunde, 143(34), 1727-1729.
Egberts, A. C. G., Veenstra, M., & de Jong-van den Berg, L. T. W. (1999). Antidepressant drug choice for first users in two regions in the Netherlands. Pharmacy World & Science, 21, 132-136.
Egberts, A. C. G., Woerdenbag, H. J., & Movig, K. L. L. (1999). Zelfmedicatie bij erectiele disfunctie. Pharmaceutisch Weekblad, 134(1), 39-43.
Other output
Schmitz, PJM., Gerrits, C. M. J. M., & Egberts, A. C. G. (1999). Determinants for potentially toxic theophylline serum concentrations. S144-S144. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Waldinger, M. D., & Leufkens, H. G. M. (1999). Sexual dysfunctioning in users of Selective Serotonin Reuptake Inhibitors (SSRIs). S1-S1. Abstract from Unknown event, Asilomar, USA.
Burger, H., Herings, R. M. C., Egberts, A. C. G., Neef, C., & Leufkens, H. G. M. (1999). Etidronate use is not associated with subsequent symptoms of peptic ulcer disease. S163.2-S163.2. Abstract from Unknown event, Asilomar, USA.
van Puijenbroek, E. P., Egberts, A. C. G., & Leufkens, H. G. M. (1999). Arthralgia, fever and urticaria associated with terbinafine: symptoms or syndrome. S163-S163. Abstract from Unknown event, Asilomar, USA.
van Puijenbroek, E. P., Egberts, A. C. G., & Leufkens, H. G. M. (1999). Concomitant use of diuretics and non-steroidal antiinflammatory drugs increase the risk of signs of congestive heart failure: evidence from a spontaneous reporting system. S145-S145. Abstract from Unknown event, Asilomar, USA.
1998
Scholarly publications
Meyboom, R. H. B., Egberts, A. C. G., & Edwards, I. R. (1998). Comparing therapeutic benefit and risk. In U. Singhal (Ed.), International workshop on adverse drug reaction monitoring. India (pp. 59-65)
van den Bemt, P. M. L. A., Egberts, A. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (1998). Reporting of adverse drug reactions in hospital: a comparison of doctors, nurses and patients as sources of reports. Pharmacoepidemiology and Drug Safety, 7, 165-166.
Ros, J. J. W., Pelders, M. G., & Egberts, A. C. G. (1998). Performance of abusign tm Drugs-of-Abuse slide tests with particular emphasis on concentrations near the cutoff:: comparison with FPIA-Adx and confirmation of results with GC-MS. Journal of Analytical Toxicology, 22, 40-44.
Meyboom, R. H. B., Egberts, A. C. G., Edwards, I. R., Hekster, Y. A., de Koning, G. H. P., & Gribnau, F. W. (1998). Principles of signal detection in pharmacovigilance. In U. Singhal (Ed.), International workshop on adverse drug reaction monitoring. India (pp. 97-106)
Professional publications
Egberts, A. C. G., Stuijt, C. C. M., Heerdink, E. R., & Leufkens, H. G. M. (1998). Antidepressiva' als naam aan herziening toe. Pharmaceutisch Weekblad, 133, 776-780.
Meyboom, R. H. B., & Egberts, A. C. G. (1998). De cirkel van ongewenste gevolgen van geneesmiddelen. Pharmaceutisch Weekblad, 133, 1824-1830.
Egberts, A. C. G. (1998). Acetylsalicylzuur als profylaxe voor hoogteziekte. Pharmaceutisch Weekblad, 133, 1766-1767.
Roon, E. N., Verzijl, J. M., Juttmann, J. R., Lendering, A. W., & Egberts, A. C. G. (1998). Switchen van of stoppen met initiële, proteaseremmer bevattende antiretrovirale combinatietherapie: incidentie en determinanten. Ziekenhuisfarmacie, 14, 179-180.
Movig, K. L. L., & Egberts, A. C. G. (1998). De verstoorde balans van een delicaat stollingsevenwicht. Pharmaceutisch Weekblad, 133, 1064-1066.
Roon, E. N., Verzijl, J. M., Egberts, A. C. G., Movig, K. L. L., Simons, K. A., & Lenderink, A. W. (1998). Het gaat om de laatste geïnfecteerde cel. Pharmaceutisch Weekblad, 133, 250-255.
Bouvy, M. L., Kwint, H. F., & Egberts, A. C. G. (1998). Slotbijeenkomst Masterclass Pharmacy Practice Research. Pharmaceutisch Weekblad, 133, 1458-1459.
Other output
Wouterse, J. J., Willems, M., & Egberts, A. C. G. (1998). Experiences of patients concerning medication use. Sources and value of information. S164-S164. Abstract from Unknown event, Asilomar, USA.
van Puijenbroek, E. P., Meijboom, R. H. B., Vinks, M. H. A. M., & Egberts, A. C. G. (1998). Analysis of a suspected interaction between itraconazole an desogestrel-containing oral contraceptives in a spontaneous reporting system. S146-S146. Abstract from Unknown event, Asilomar, USA.
Roon, E. N., Verzijl, J. M., Lenderink, A. W., & Egberts, A. C. G. (1998). Patterns of switching and stopping initial. Highly-active Antiretroviral Therapy (HAART) in a cohort of Dutch HIV-seropositive patients. S166-S166. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Meyboom, R. H. B., & Leufkens, H. G. M. (1998). Transformation of a database of spontaneously reported suspected adverse drug reactions ans its use as a tool in signal detection. S165-S165. Abstract from Unknown event, Asilomar, USA.
1997
Scholarly publications
Egberts, A. C. G., Meyboom, R. H. B., De Koning, F. H. P., Bakker, A., & Leufkens, H. G. M. (1997). Non-puerperal lactation associated with antidepressant drug use. British Journal of Clinical Pharmacology, 44(3), 277-281.
Egberts, A. C. G., De Koning, F. H. P., Meyboom, R. H. B., & Leufkens, H. G. M. (1997). ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: A comparison regarding patients and drugs. Pharmacoepidemiology and Drug Safety, 6(4), 269-276. [DOI]
Egberts, A. C. G., De Koning, F. H. P., Meijboom, R. H. B., & Leufkens, H. G. M. (1997). ADR related questions received by a telephone medicines information service and ADR's received by a spontaneous ADR reporting system; a comparison regarding patients and drugs. Pharmacoepidemiology and Drug Safety, 6, 269-276.
Egberts, A. C. G., Lenderink, A. W., De Koning, F. H. P., & Leufkens, H. G. M. (1997). Channeling of thre newly introduced antidepressants to patients not responding satisfactory of previous treatment. Journal of Clinical Psychopharmacology, 17, 149-155.
Egberts, A. C. G., ter Borgh, J., & Brodie-Meijer, C. C. E. (1997). Serotonin syndrome attributed to tramadol addition to paroxetine therapy. Journal of Clinical Psychopharmacology, 12, 181-182.
Meyboom, R. H. B., & Egberts, A. C. G. (1997). Detection in Pharmacovigilance. Drug Safety, 16, 355-366.
de Koning, G. H. P., Egberts, A. C. G., Leufkens, H. G. M., & Bakker, A. (1997). The expanding role of the pharmacist in pharmacovigilance and pharmaco-epidemiology; the Dutch case. International Pharmacy Journal, 11, 39-41.
van Kan, H. J. M., Egberts, A. C. G., Rijnvos, W. P. M., Pelwijk, N. J., & Lenderink, A. W. (1997). Tetracaïne versus lidocaïne-prilocaïne for preventing venipuncture-induced pain in children. American Journal of Health Studies, 54, 388-392.
Egberts, A. C. G., Meyboom, R. H. B., De Koning, F. H. P., Bakker, A., & Leufkens, H. G. M. (1997). Non-puerperal lactation associated with antidepressant drug use. British Journal of Clinical Pharmacology, 44, 277-281.
Meyboom, R. H. B., Hekster, Y. A., Egberts, A. C. G., Gribnau, F. W., & Edwards, I. R. (1997). Causal of Casual? The role of causality Assessment in Pharmacovigilanc. Drug Safety, 16, 374-389.
Egberts, A. C. G., Leufkens, H. G. M., Hofman, A., & Hoes, A. W. (1997). Incidence of antidepressant drug use in older adults and association with chronic diseases: The Rotterdam study. Journal of Clinical Psychopharmacology, 12, 217-223.
Egberts, A. C. G. (1997). Pharmacoepidemiologic approaches to the evaluation of antidepressant drugs. [Doctoral thesis 1 (Research UU / Graduation UU), Utrecht University].
Professional publications
Bakkel, P. J. T. T. M., Koopmans, J. M., Leufkens, H. G. M., & Egberts, A. C. G. (1997). Na negatieve berichtgeving derde generatie contraceptiva verandering pilgebruik gemeten. Pharmaceutisch Weekblad, 132, 1061-1063.
Egberts, A. C. G., Simons, K. A., Lenderink, A. W., Roon, E. N., & Verzijl, J. M. (1997). HIV-prikaccident vraagt weloverwogen beleid. Richtlijn post-expositie profylaxe. Prikken en pillen of prikken en praten? Pharmaceutisch Weekblad, 132, 980-983.
Roon, E. N., Pelders, M. G., & Egberts, A. C. G. (1997). Nieuwe trends in druggebruik onder jongeren. Pharmaceutisch Weekblad, 132, 447-452.
Other output
Egberts, A. C. G., Veenstra, M., & de Jong-van den Berg, L. T. W. (1997). Choosing the type of antidepressant in first users: situation in different parts of the Netherlands and ints relation in patient characteristics. S116-S116. Abstract from Unknown event, Asilomar, USA.
de Jong-van den Berg, L. T. W., van Oirschot, K., & Egberts, A. C. G. (1997). Determinants of failure of oral contraceptives - A pilot study. S7-S7. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Meyboom, R. H. B., de Koning, G. H. P., Bakker, A., & Leufkens, H. G. M. (1997). Non-puerperal lactation associated with antidepressant drug use. S116-S116. Abstract from Unknown event, Asilomar, USA.
1996
Scholarly publications
Meyboom, R. H. B., Heere, F. J., Egberts, A. C. G., & Lastdrager, C. J. (1996). Potentiering van fenprocoumon door clarithromycine en roxithromycine. Nederlands Tijdschrift voor Geneeskunde, 140(7), 375-377.
van Puijenbroek, E. P., Egberts, A. C. G., & Krom, H. J. (1996). Visual hallucinations and amnesia associated with the use of zolpidem. International Journal of Clinical Pharmacology and Therapeutics, 34, 318-318.
Egberts, A. C. G., Smulders, M., De Koning, F. H. P., Meyboom, R. H. B., & Leufkens, H. G. M. (1996). Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ - Clinical research, 313, 530-531.
van Puijenbroek, E. P., Egberts, A. C. G., Trooster, J. F. G., & Zoerdijk, J. (1996). Reduction of migraineous headaches during the use of acenocoumarol. Headache, 36-48.
Professional publications
Bouvy, M., & Egberts, T. (1996). Bètablokkers en effecten op het centraal zenuwstelsel; Is er een verschil tussen lipofiele en hydrofiele bètablokkers? Pharmaceutisch Weekblad, 131(21), 602-x1.
de Koning, G. H. P., Egberts, A. C. G., Leufkens, H. G. M., & Bakker, A. (1996). Postmarketing surveillance in de farmacie: plaats bepaald? Pharmaceutisch Weekblad, 44-49.
Other output
Egberts, A. C. G., Smulders, M., de Koning, G. H. P., Meyboom, R. H. B., & Leufkens, H. G. M. (1996). Can Adverse Drug Reactions Be Detected Earlier?. S67-S67. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Leufkens, H. G. M., Launer, L. J., Grobbee, D. E., Hofman, A., & Hoes, A. W. (1996). Determinants of Antidepressant Drug Use in Older Subjects. S67-S67. Abstract from Unknown event, Asilomar, USA.
Egberts, A. C. G., Lenderink, A. W., de Koning, G. H. P., & Leufkens, H. G. M. (1996). Channelling of Three Antidepressants in Refractory Patients During the First Year After Introduction in the Netherlands. S66-S66. Abstract from Unknown event, Asilomar, USA.
1995
Scholarly publications
Veninga, C. C. M., Denig, P., Haaijer-Ruskamp, F. M., Dijkers, F. W., Meyboom-de Jong, B., de Vries, C. S., Timmer, J. W., de Jong-van den Berg, L., van Eijk, M. E. C., de Boer, A., van Hemert, T. J. E., van der Horn, J. A., Steerneman, A. G. M., de Jong-van den Berg, L. T. W., de Wit, M. E. C., Stricker, B. H. C., Porsius, A. J., Peters, E. T. J., van der Werf, G. T., ... Stewart, R. (1995). Abstracts of papers and posters. Pharmacy World & Science, 17(9), 3-7. [DOI]